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 Abstract Background 
The Millennium Declaration in 2000 brought special global attention to HIV, tuberculosis and malaria 
through the formulation of Millennium Development Goal 6 (MDG 6).  The Global Burden of Disease 
2013 study provides a consistent and comprehensive approach to disease estimation 1990 to 2013, and 
an opportunity to assess if there has been accelerated progress since the Millennium Declaration.   Methods 
To estimate incidence and mortality for HIV, we used the UNAIDS Spectrum model appropriately 
modified based on a systematic review of the literature on mortality with and without antiretroviral 
therapy (ART). For concentrated epidemics, we calibrated Spectrum models to fit vital registration data 
corrected for misclassification of HIV deaths. In generalized epidemics, we minimized a loss function to 
select epidemic curves most consistent with prevalence data and demographic data on all-cause 
mortality. We analyzed counterfactual scenarios for HIV to assess years of life saved through prevention 
of mother to child transmission (PMTCT) and ART. For tuberculosis, we analyzed vital registration and 
verbal autopsy data to estimate mortality using cause of death ensemble modeling. We analyzed data 
on corrected case-notifications, expert opinions on the case-detection rate, prevalence surveys and 
estimated cause-specific mortality using Bayesian meta-regression to generate consistent trends in all 
parameters. Malaria mortality and incidence were analyzed using an updated cause of death database, a 
systematic analysis of verbal autopsy validation studies for malaria and recent literature on incidence, 
drug resistance and coverage of insecticide treated bed nets. Findings 
Globally in 2013, there were 1.8 million new HIV infections (95% uncertainty interval 1.7 million to 2.1 
million), 29.2 million prevalent HIV cases (28.1 to 31.7) and 1.3 million HIV deaths (1.3 to 1.5). At the 
peak of the epidemic in 2005, HIV caused 1.7 million deaths (1.6 to 1.9). Concentrated epidemics in Latin 
America and Eastern Europe are substantially smaller than previously estimated.  Through interventions 
including PMTCT and ART, 19.1 million life years (16.6 to 21.5) have been saved, 70.3% in the developing 
world. From 2000 to 2011, the ratio of development assistance for health for HIV to years of life saved 
through intervention was $2,928-$4,497 in the developing world. All-forms tuberculosis (including 
individuals who are HIV-positive) incidence, prevalence and death numbers in 2013 were 7.5 million (7.4 
to 7.7), 11.9 million (11.6 to 12.2) and 1.4 million (1.3 to 1.5), the same figures in individuals who are 
HIV-negative were 7.1 million (6.9 to 7.3), 11.2 million (10.8 to 11.6) and 1.3 million (1.2 to 1.4), 
respectively. Annualized rates of change (ARC) for incidence, prevalence and death have become 
negative after 2000. Tuberculosis in HIV-negative individuals disproportionately occurs in males; 64.0% 
of cases (63.6% to 64.3%) and 64.7% of deaths (60.8% to 70.3%). Globally, malaria cases and deaths 
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grew rapidly from 1990 reaching a peak of 232 (143 to 387) million cases in 2003 and 1.2 (1.1 to 1.4) 
million deaths in 2004.  Since 2004 child deaths from malaria in sub-Saharan Africa have declined 31.5% 
(15.7% to 44.1%). Outside of Africa malaria mortality has been steadily declining since 1990. Interpretation 
Our approach produces estimates for the HIV epidemic that are 25% smaller than UNAIDS. Malaria is 
larger than estimated by WHO. HIV, tuberculosis and malaria have all declined since 2000. At the global 
level upward trends for malaria and HIV have been reversed and declines in tuberculosis have 
accelerated. 97 countries (74 developing) still have increasing HIV incidence.  Substantial progress since 
the Millennium Declaration is an encouraging sign of the impact of global action.  Funding 
Bill & Melinda Gates Foundation. 
 Introduction 
The Millennium Declaration in 2000 brought special global attention to HIV, tuberculosis and malaria 
through the formulation of Millennium Development Goal 6 (MDG 6).  The high priority status of these 
three diseases in the development community was confirmed through the creation of the Global Fund 
to Fight AIDS, Tuberculosis and Malaria in 2002.  Bilateral initiatives such as the President’s Emergency 
Plan for AIDS Relief (PEPFAR) and the President’s Malaria Initiative also added substantial new 
resources.   From 2000 to 2011, multilaterals, bilaterals, foundations and NGOs have invested $51.6, 
$11.3 and $8.3 billion 2011 US dollars of development assistance for health (DAH) for HIV, malaria and 
tuberculosis respectively.1  Substantial benefits of these investments have been documented in a 
number of studies.2–9  In the lead up to the MDG deadline of 2015 and the global debate on 
development goals post-2015, important questions have been raised about the advantages and 
disadvantages of maintaining focus on these three diseases.5,10–18   The rise of the importance of non-
communicable diseases in some regions of the developing world19–26 have led to calls for goals that 
cover a broader range of diseases.10,15,17,19,20,24,25,27,28  At the same time, ambitious goals of zero 
tuberculosis and zero HIV have been formulated by some groups;29–34 the Secretary-General of the UN 
had already established a goal of zero malaria deaths by 2015.35   Understanding the distribution and 
trends of these three diseases and how they have been influenced by the MDG era is an important input 
to this wider debate.12,36   
Because of their prominence, there are major UN efforts on an annual basis to track the epidemiology of 
these three diseases.   UNAIDS now produces country estimates of HIV incidence, prevalence, and death 
every year.37   Over many years, they have developed a sophisticated modeling approach to track the 
epidemic whose primary input in generalized epidemics is annual antenatal clinic sero-surveillance data 
and periodic household surveys that include blood testing.38,39  WHO’s annual Global Tuberculosis 
Report provides estimates of incidence and death from tuberculosis by country.  Critical inputs to the 
assessment of incidence are case notifications and national expert opinion on the case-detection rate, 
and separate modeling of cause of death data from vital registration systems and verbal autopsy (VA) 
studies.  For the World Malaria Report, WHO uses a complicated strategy to estimate incidence and 
mortality that varies by region and age-group. For child malaria deaths in Sub-Saharan Africa, the main 
inputs are verbal autopsy studies and estimated malaria risk. Estimates are adjusted post-hoc for 
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coverage of insecticide treated bed nets (ITNs). Outside of sub-Saharan Africa and for low-transmission 
countries in Africa reported case numbers are combined with an assumed case fatality rate. These three 
efforts have provided important insights into the geographical distribution and likely trends in the 
diseases.     
Despite these efforts, there is extraordinary uncertainty at the country level in the burden of all three.   
The burdens of HIV and malaria are concentrated in sub-Saharan Africa; countries that, outside of South 
Africa, have very poor vital registration and incomplete notification systems. Tuberculosis is 
concentrated in Asia and Southern Africa where a few more countries have better data systems but 
there are still huge gaps in information. Modeling strategies for tracking the diseases have evolved to be 
necessarily complex given the incomplete and often conflicting nature of the data. For HIV and malaria, 
UN modeling efforts explicitly use information on intervention delivery and assumed benefits of 
intervention. The distinction between data on disease outcomes and data on intervention coverage 
driving the results of these efforts is blurred.   In the more complex modeling strategies, the 
compounded impact of uncertainty about different parameters can be hard to characterize. Efforts to 
model the three diseases are largely independent of each other – the exception is recent coordinated 
efforts to understand the intersection of tuberculosis and HIV.40 
The Global Burden of Disease 2010 Study provided a comprehensive update on levels and trends of a 
large number of diseases, injuries and risk factors for 187 countries from 1990 to 2010. The Global 
Burden of Disease collaboration is now generating annual updates the first of which is the Global Burden 
of Disease Study 2013 (GBD 2013). The GBD 2013 provides an opportunity to examine the evidence on 
the levels and trends in the three MDG 6 diseases within the comprehensive and coherent framework of 
the GBD. Compared to GBD 2010, special emphasis has been given in the GBD 2013 to incorporate new 
data, more rigorously identify and incorporate further key sources of uncertainty, and incorporate 
adjustments for the biases that are present in different data sources. A critical aspect of the GBD effort 
is to quantify time trends; comparing trends from 1990 to 2000 and from 2000 to 2013 provides an 
opportunity to see if there has been accelerated progress since the Millennium Declaration.  The GBD 
2013 supersedes all previously published GBD results.   Methods 
The overall conceptual and analytical framework for the GBD is described elsewhere.41–48  Major 
refinements of the analytical approach for different diseases and risk factors are explored in other 
papers.49–51 We summarize here the methods used for the analysis of the three diseases emphasizing 
refinements since the GBD 2010. All methods refinements have been applied to the full 1990 to 2013 
time series to ensure comparability of results.  Metadata for input sources used in the GBD 2013 will be 
available in the Global Health Data Exchange upon publication of the full GBD 2013 results.  HIV 
For the GBD 2010, we primarily used estimates of prevalence and mortality developed by UNAIDS. The 
main modification was the requirement that the sum of cause-specific mortality from each cause in a 
country, age, sex and year group equaled the estimate of all-cause mortality for that country, age and 
sex group generated through the analysis of demographic sources.43  Modifications of HIV deaths 
through this internal consistency process did not lead to revisions of incidence or prevalence for HIV in a 
particular country, age, sex and year.  For the GBD 2013, we have sought to develop a set of estimates 
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of incidence, prevalence and mortality from HIV that are internally consistent with each other and also 
meet the GBD requirement that the sum of each cause of death equals all-cause mortality. Internally 
consistent means the incidence, prevalence and death figures are mathematically possible given that 
prevalence is a function of past incidence, remission and death rates for any age cohort.     Modified Spectrum Model 
UNAIDS uses two key analytical components in their epidemiological estimation.  The Estimation and 
Projections Package (EPP) is used to estimate incidence trajectories that are consistent with prevalence 
surveys and other prevalence measurements such as antenatal clinic sero-surveillance.52 Spectrum is a 
compartmental HIV progression model used to generate age-specific incidence, prevalence and death 
rates from the EPP incidence curves and assumptions about intervention scale-up and local variation in 
epidemiology.53 We have recoded Spectrum in Python, an open source higher level language that can 
easily be run on a parallelized computational cluster, following the exact structure of Spectrum to 
facilitate faster computation required for the uncertainty analysis and consistency analysis with all-cause 
mortality. We have also made four important modifications to the assumptions.     
First, we have altered the Spectrum assumptions about mortality without antiretroviral therapy (ART).  
Following UNAIDS assumptions, mortality is modeled as shown in Figure 1.   The death and progression 
rates between CD4 categories vary by age according to four age-groups, 15-24, 25-34, 35-44, and 45 and 
above. UNAIDS estimates a single set of progression and death rates by first fitting a Weibull distribution 
to data from three East African sero-converter cohorts from the ALPHA network and one miners cohort 
from South Africa,54 and then selecting a set of progression and death rates in Excel Solver that 
minimizes the sum of the squared differences between the predicted and Weibull survival 
probabilities.55,56   Uncertainty in their estimates for this component was approximated by assuming a 
coefficient of variation of 0.05 for each mortality rate. To better characterize uncertainty in the 
progression and death rates, we systematically reviewed the literature on mortality without ART. We 
searched terms related to pre-ART or ART-naive survival since seroconversion – exact search terms are 
in the web appendix. After screening, we identified 13 cohort studies which included the cohorts used 
by UNAIDS from which we extracted survival at each one year point after infection. We modeled the 
logit of the conditional probability of death between years in these studies as: 
 
Where m is conditional probability of death from year tj to t j+1, ai is an indicator variable for age group 
at seroconversion (15-24, 25-34, 35-44, and 45+), t j is an indicator variable of year since seroconversion, 
and  is a study-level random effect. By sampling the variance-covariance matrix of the regression 
coefficients and the study level random effect, we generated 1000 survival curves for each age group 
that capture the systematic variation in survival across the available studies (Figure 2 and Appendix 
Figures 1a, 1b, 1c). Across all age groups, median survival ranges from 3.6 to 29.5 years. For each of the 
1000 survival curves, we use the UNAIDS optimization framework to find a set of progression and death 
rates that minimizes the sum of the squared errors for the fit to the survival curve. For the death rates 
generated from the optimization, the coefficient of variation across the set of 1000 is 0.44-1.00 
depending on the age-group which is substantially higher than the UNAIDS assumption of 0.05. 
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Second, for mortality on ART, UNAIDS used data from five regional cohorts from the IeDEA network to 
directly estimate death rates by age, sex, and CD4 count, which have been used as the default for all 
countries in a region.57,58 Through their country consultation process some of these defaults have been 
modified. For example, Myanmar assumes a constant mortality rate by initial CD4 group, without any 
variation by age, sex, or time on treatment. To better characterize real variation in the death rates on 
ART across programs, we searched the published literature. Using the terms HIV mortality antiretroviral 
therapy, we identified 4996 titles. Screening the abstracts and papers yielded 102 total papers for 
extraction (Appendix Table 2). These included mortality and loss to follow-up (LTFU) data for 80 cohorts, 
age hazard ratios for 40 cohorts, and sex hazard ratios for 86 cohorts. We corrected reported 
probabilities of death for loss to follow-up using an update of the approach developed by Verguet et 
al.59   Verguet et al used tracing and follow-up studies to empirically estimate the relationship between 
death in LTFU and the rate of LTFU. We used DisMod-MR 2.0 to conduct a meta-regression of the data 
for on-ART mortality by initial CD4 count separately for high-income countries, GBD developing 
countries outside of sub-Saharan Africa, and sub-Saharan Africa; see Appendix section 2.3 for additional 
information. We meta-analyzed region-specific age hazard ratios using DisMod-MR 2.0, and region-
specific sex hazard ratios using the Stata command metan. The age and sex hazard ratios were applied 
to the CD4-specific mortality rates, accounting for the distribution of ages and sexes in the mortality 
data.  We used 1000 draws from the posterior distribution for each age, sex and CD4 category for 
conditional probabilities of death for 0-6 months, 7-12 months and 13-24 months after initiation of ART 
as inputs to Spectrum. Table 1 shows HIV-specific mortality rates for 25-34 year olds on ART in sub-
Saharan African; see Appendix Table 3 for HIV specific mortality for other age groups and regions. 
Third, to better reflect variation in the age-pattern of incidence, we used the UNAIDS distributions of the 
relative incidence by age prepared for UNAIDS based on selected cohort studies. To capture the 
possibility that there is greater variation across countries in the age incidence pattern than in these 
studies, we increased the uncertainty ranges by an arbitrary 50%.    
Fourth, for all other input parameters including the number of individuals receiving ART, PMTCT or co-
trimoxazole prophylaxis we randomly sampled a uniform distribution from 0.9 to 1.1 and used the draw 
to adjust each parameter. For the sex ratio of incidence, we sampled a wider but arbitrary range from 
0.8 to 1.2 reflecting the demographic data in many generalized epidemics that there is less of a 
difference between the sexes than observed in the population prevalence surveys.    Generalized Epidemics 
UNAIDS identifies 43 countries as generalized epidemics; this distinction is important because for these 
epidemics the primary sources of information on prevalence come from antenatal clinic sero-
surveillance and household surveys. In addition to these 43 countries, we have included in this category 
Senegal, Niger, and India because of the availability of population-based surveys. Prevalence data from 
countries with generalized epidemics has been analyzed by UNAIDS using EPP to generate 1000 samples 
of incidence curves for adults 15-49 consistent with the prevalence data. For each of these 1000 
incidence curves, we randomly sample the parameter distributions for all input parameters ten times to 
generate 10 000 epidemic curves of incidence, prevalence and death by age and sex. The selection of 10 
000 iterations was based on testing that it would ensure stable uncertainty intervals. Some of these 10 
000 death curves exceed in one or more age-sex-year groups the estimate of all-cause mortality based 
on demographic sources. Because the demographic estimates of all-cause mortality are based on 
substantial empirical data, these HIV epidemic curves are unlikely to represent reality. These 
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mismatches occur more often in Southern Africa.  We identify the 250 modified Spectrum curves and all-
cause mortality curves that are most consistent with each other. We define a loss function:  
 
For run r of a given country, excess mortality, e, is equal to the sum of all non-zero differences between 
HIV mortality, mHIV, and 0.8 times a randomly selected all-cause mortality draw, mall-cause, across all year-
age-sex combinations (t, a, and s respectively). We compare the Spectrum estimates to 0.8 times the all-
cause estimates because this is the highest observed fraction of deaths in any age-group in any country’s 
cause of death data due to HIV.  We randomly pair each of the 10 000 modified spectrum outputs with 
one of the 1000 all-cause mortality curves generated from the demographic analysis. The 250 pairs that 
minimize the loss function are selected.  When more than 250 have a loss function equal to zero, we 
randomly choose among this set.  We resample the 250 draws to 1000; 250 are used with resampling for 
computational convenience. Annex Figures 2a, 2b and 2c show mortality at ages 15-59 from the full set 
of 10 000 modified spectrum models and the subset that is selected through the matching process for 
Uganda, South Africa and Ghana. Demographic data matching selects in South Africa epidemic curves 
that are at the low end of the distribution with longer median survival; in Uganda this effect is slightly 
less pronounced and in Ghana pre and post matching are identical.  Concentrated Epidemics with Vital Registration Data  
UNAIDS estimates for concentrated epidemics depend critically on two inputs: first, the assessment of 
prevalence of HIV in high-risk groups (people who inject drugs, men who have sex with men (MSM), and 
female sex workers) for which there is considerable information in many countries;60–72 and second, 
assumptions on the percentage of the population in high risk groups.  Although there is guidance on 
measurement,73 real data in most countries are extremely limited. In many countries, UNAIDS estimates 
are based on local opinion.  Resulting assumptions have been highly variable across countries. For 
example, Uruguay defines 4.5% of its population as MSM while neighboring Argentina defines only 1% 
of its population as MSM. An alternative source in many countries is cause of death data from national 
vital registration systems. To track the epidemic using cause of death data can require up to three 
important adjustments.  First, in some middle-income countries, vital registration is incomplete. Wang 
et al have used death distribution methods43 to assess completeness in all countries with vital 
registration (VR); we have used this information to correct upwards incomplete registration.  Second, a 
key aspect of the GBD is to redistribute deaths that are assigned to immediate or intermediate causes of 
death rather than underlying causes of death (garbage codes).74 In addition to garbage codes, because 
HIV was not included in ICD-9 until 1986 and not implemented in many countries until later, deaths 
were often assigned to other codes such as graft versus host disease or Kaposi’s sarcoma. Third, in some 
places due to stigma or misdiagnosis, HIV deaths may be assigned to other underlying causes of death 
such as tuberculosis, endocrine disorders, meningitis or encephalitis. Birnbaum et al developed a 
method to identify these misclassified deaths.75  We applied this method to all countries. 
Misclassification of HIV deaths in the Birnbaum et al method is based on fulfilling three criteria.  First, 
the temporal trend for a cause should coincide with the HIV epidemic.  Second, the pattern of the 
relative death rate by age should shift towards the ages 15-49 during the epidemic years.  Third, the 
temporal and age-pattern shifts cannot be explained by other known epidemiological trends.  Applying 
these methods, we transfer deaths from 47 causes in 52 countries. Figure 3 shows the number of HIV 
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deaths directly coded to HIV, the number of deaths re-assigned to HIV from garbage code redistribution, 
and the number of deaths from the application of the HIV misclassification method for Thailand and 
Russia.  The height of the bar is the final number of deaths in each age-group.   
For countries with corrected vital registration, we impute missing years of data to generate a complete 
time series for HIV from the estimated start year of the epidemic using spatial-temporal Gaussian 
Process Regression (ST-GPR).43,76,77  ST-GPR using a linear mean function and a Matern covariance has 
been widely used for time-series estimation in global health descriptive studies such as for tobacco 
prevalence, obesity prevalence or child and adult mortality. To generate an internally consistent set of 
incidence, prevalence and death curves with uncertainty, we use the observed HIV death numbers to 
calibrate the modified Spectrum models. First, we start with a modified Spectrum model constructed 
based on the analysis of high-risk groups – where no high-risk group analysis is available we use a 
regional default model. Second, for each of the 1000 draws from this model, we modify the incidence at 
time t by the ratio of observed deaths to modified spectrum deaths at time t+λ, where λ is the lag 
between incidence and death. We draw from a distribution of lags of 10 to 15 years to generate 6000 
different adjusted incidence curves. For incidence for the last λ time periods, we draw a random weight 
between 0 and 1 from a uniform distribution and use it to calculate a weighted average of adjusted 
incidence in year t + λ and unadjusted incidence multiplied by the deaths ratio in year t + λ. Using these 
modified incidence curves, we rerun the modified Spectrum generating 6000 possible epidemic curves.  
As a final step, for each of these 6000 we compute the mean squared error of predicted deaths 
compared to observed deaths.  The 1000 curves with the lowest mean squared error are selected as the 
final set for analysis. Figure 4 shows the results of this process for Panama and the comparison to the 
UNAIDS high-risk group analysis; the corrected vital registration data suggests a much smaller epidemic 
with different timing.   Concentrated Epidemics with High-Risk Group Analysis and Insufficient or No Cause of Death Data 
There were 20 countries with concentrated epidemics where we had no or insufficient vital registration 
or verbal autopsy data to inform our cause of death analysis. For these countries we ran modified 
Spectrum to output 1000 draws of incidence, randomly selecting 1000 time series of the death ratios 
generated in the process described above, and multiplying each draw of incidence by the selected set of 
ratios. We selected incidence adjustments only for countries with a cumulative number of HIV deaths 
greater than 5000 to avoid exaggerated stochastic variation in the ratios. We then derived estimates of 
mortality by running the adjusted incidence curves back through Spectrum. By using random draws 
across these countries, the average correction and uncertainty in this correction is propagated into the 
corrections for these countries with limited or no data.     Concentrated Epidemics with No High-Risk Group Analysis and No Cause of Death Data 
For 13 countries (Andorra, United Arab Emirates, Iraq, Federated States of Micronesia, Libya, Marshall 
Islands, State of Palestine, Solomon Islands, Timor-Leste, Vanuatu, Samoa, Tonga, and North Korea) no 
analysis of high-risk groups has been undertaken and no cause of death data are available. For these 
countries, we picked regional or neighboring countries to approximate the death rate in these places. 
We used these approximate death rates to fit a Spectrum model.  In all these cases, the number of 
estimated deaths was less than 250 per year.   
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Comparisons to Prevalence Survey Data  
As a form of empirical validation, we compare our final estimated prevalence with national population-
based surveys collected through the Demographic and Health Surveys, AIDS Indicator Surveys, the 2005-
2006 Indian National Family Health Survey, and the 2012 South African National HIV Prevalence, 
Incidence and Behaviour Survey.78–80 In total, we extracted data from 46 surveys in 35 countries 
between 2001 and 2012. These surveys had response rates for HIV testing ranging from 63% in males in 
Malawi in 2004 to 98% for both sexes in Rwanda in 2011; median response rate was 85%. These 
comparisons are made for adults 15-49 by sex and five-year age groups. We tested for significant 
differences in means (p<0.05) for each estimate and compared the distribution of survey estimates to 
GBD and UNAIDS via OLS regression with robust standard errors to account for heteroscedasticity. HIV Intervention Counterfactual Scenario 
Spectrum uses as inputs the numbers reported by governments of individuals receiving PMTCT, co-
trimoxazole, and child and adult ART. To help understand the role of interventions including ART, 
PMTCT, and co-trimoxazole prophylaxis, we have rerun the final 1000 modified Spectrum models for 
each country using a no intervention counterfactual scenario. We turn all HIV related interventions to 
zero including ART, PMTCT and co-trimoxazole prophylaxis for all years. We compare the number of 
deaths and person-years lived each year from the base case to this counterfactual to assess the changes 
due to intervention.  Using published results on development assistance for health (DAH) for HIV, we 
compute the ratio of DAH to years of life saved.   Tuberculosis 
For the GBD 2010, we estimated tuberculosis mortality and then estimated population incidence 
through mixed effects regression as a function of tuberculosis mortality, case-notifications and an 
indicator variable for health system access used as a proxy for completeness of registration. For GBD 
2013, we have shifted to using all available data on different outcomes and simultaneously estimating 
incidence, remission, excess mortality, prevalence and cause-specific mortality using the GBD Bayesian 
meta-regression environment, DisMod-MR 2.0 (appendix section 2.4). There are four potential sources 
of information to estimate national levels and trends for tuberculosis in a country: annual case 
notifications, expert judgment on the case-detection rate, prevalence surveys and cause of death data.  
In addition, to facilitate convergence of the meta-regression, estimated excess mortality and remission 
rates have been used. The approach is predicated on the principle that incidence, prevalence and 
mortality may be measured imperfectly and that a statistical triangulation of all the sources for a 
country will provide a more robust assessment. Our meta-regression analysis was conducted for all 
forms of tuberculosis. As a final step we estimated incidence, prevalence and death in individuals who 
are HIV-positive and those who are HIV-negative. We explain in more detail the preparation of each of 
these sources.   Adjusted Case Notifications and Incidence   
Case definitions for tuberculosis since 1995 have been standardized by WHO and widely applied. 
Countries have varied however in the completeness of reporting for younger age-groups and some 
countries have reported only pulmonary smear-positive cases for selected years. We use the age and 
sex-specific notifications in our analysis and impute the missing age-groups for three forms of 
tuberculosis notifications (pulmonary smear-positive, pulmonary smear-negative, or extra-pulmonary) 
in two steps. First, for each country-sex category with missing age-groups in some years, we imputed the 
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missing values by regressing the log of the case notification rate on dummy variables for 5-year age-
groups and random effects on year using all the data observed in a country over the interval 1990 to 
2013.       
Second, we estimated the relationships between all forms of tuberculosis and smear-positive 
tuberculosis and the relationship between all forms and bacteriologically positive tuberculosis. Using 
country-years with complete notifications (all three forms), we used a compositional analysis model to 
simultaneously estimate the fraction of cases due to all three forms as a function of dummy variables for 
five-year age-groups and sex and the smear-positive tuberculosis rate. This regression was used to 
impute missing values for pulmonary smear-negative and extra-pulmonary cases. Because of marked 
variation in the diagnostic rates for extrapulmonary tuberculosis and the potential for misclassification, 
we used the predicted values for extrapulmonary cases for all countries from the regression.  
At the country-level a number of smear-unknown and relapsed cases are recorded that are not captured 
in the age and sex-specific notifications.  We use the relationship between these forms and pulmonary 
smear-positive cases in the country-level data to inflate the adjusted age and sex-specific pulmonary 
smear-positive notifications used in our analysis. Case notifications, however, do not capture all true 
incidence cases in the population. Case notifications can be incomplete because some cases are not 
diagnosed and some diagnosed cases are not reported to the national tuberculosis program.  
Population-based incidence studies for tuberculosis based on active surveillance are rare and have not 
been conducted at the national level. 81 In the absence of direct measurement of true incidence, the 
case detection rate must be approximated.  Since 2008 the WHO has been consulting with national 
tuberculosis program managers in 96 countries to collect expert opinion on the case detection rate 
including some notion of subjective uncertainty.82 For the remaining countries, case-detection estimates 
are based on the judgment of WHO staff. We divided adjusted case notifications by the estimated case 
detection rate to generate the incidence inputs used for DisMod-MR 2.0. We expanded the subjective 
uncertainty intervals reported so they are at a minimum plus or minus 20% from the estimated values or 
for values less than 20% we assume the standard error is half the midpoint estimate. Tuberculosis Prevalence Surveys 
Prevalence surveys have been periodically undertaken in a limited number of countries.  WHO has 
standardized the protocol83 and the Global Fund to fight AIDS Tuberculosis and Malaria (GFATM )has 
funded a recent round of surveys of which 16 are completed or ongoing and 10 more are planned .84  
Because the prevalence rates for tuberculosis are often comparatively low, e.g. 200 per 100 000, 
prevalence surveys need to be large to provide breakdowns by age and sex. Based on the literature and 
country reports, we have identified 27 national and 24 subnational prevalence surveys in 24 countries 
spanning the time period 1985 to 2013. We have included in our analysis, surveys reporting on 
pulmonary smear-positive tuberculosis and bacteriologically positive tuberculosis. We included in the 
Bayesian meta-regression study level dummy variables for the different measured outcomes with the 
reference category being bacteriologically positive. We allowed for non-sampling variance for sub-
national surveys to be larger which effectively down-weighted their importance for the estimation in a 
given country. Because mortality and incidence data are for all forms of tuberculosis, we adjusted 
prevalence surveys to account for extra-pulmonary cases using the same factors used in the adjustment 
of case notification data.  
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Tuberculosis Mortality 
We used 2731 country-years of nationally representative vital registration data and 166 site-years of 
verbal autopsy data to estimate tuberculosis mortality. Vital registration data were adjusted for garbage 
coding following GBD algorithms74,85 and misclassified HIV deaths described above.  Deaths by age and 
sex for tuberculosis were modeled using the Cause of Death Ensemble modeling (CODEm) approach.76  
CODEm has been extensively used in global cause of death analyses.74  Using CODEm we test a very wide 
range of potential models and use out of sample predictive validity to select the best individual models 
and the best ensemble of these models.  Appendix Tables 5, 6a and 6b provide details on the application 
of CODEm to tuberculosis. CODEm was run separately for males and females. The final ensemble models 
selected had a root-mean squared error of the log of the age-specific death rate of 0.29 in-sample and 
0.63 out-of-sample for males and 0.70 in-sample and 1.05 out-of-sample for females. In the out-of-
sample predictive validity testing (cross-validation), the coverage of the 95% data prediction uncertainty 
interval was 93% and 91% for males and females, respectively.   
CODEm results are largely informed by ICD coded data which by definition exclude tuberculosis 
mortality in HIV positives. The overall Bayesian model, however, is for all forms of tuberculosis in HIV 
negatives and positives because prevalence data rarely distinguish HIV status. We estimated the fraction 
of HIV deaths due to TB-HIV and added these to tuberculosis mortality in HIV negatives. The model for 
the fraction of TB-HIV mortality was based on 1022 country-years of data where cause of death data for 
TB-HIV and HIV overall were available. We estimated the relationship between the logit-transformed 
fraction of HIV deaths due to TB-HIV and the log-transformed tuberculosis death rate, a dummy variable 
for sex, year and country random effects. This regression was used to predict the fraction of HIV deaths 
due to HIV-TB in all countries.  Remission and Excess Mortality Estimates 
To help inform the model, we generated a prior for remission by examining the ratio of incidence to 
prevalence in the country-years where prevalence surveys have been undertaken. We used a simple 
regression with random effects to generate priors for countries with surveys and those without. Cause-
specific mortality estimates inform estimates of prevalence through excess mortality in DisMod-MR 2.0. 
To provide the model with the range of age- and sex-specific excess mortality hazards associated with 
tuberculosis we analyzed historical data where we had both tuberculosis mortality data and incidence 
data that were believed to be nearly complete. For this analysis, we used the WHO case notifications 
from 1980 onwards with the supplement of age-sex-specific case notifications back to the 1950s for 
Australia, Canada, United Kingdom, United States, Japan, and Germany. Case notification data were 
combined with tuberculosis deaths recorded in the vital registration systems to generate 743 country-
year observations from 70 countries that could be used to inform our analysis. We estimated the 
relationship between incidence and mortality for each sex, by regressing the logit-transformed ratio of 
incidence to mortality against age, lag-distributed income per capita and country random effects. The 
addition of HIV prevalence off-ART to the regression gave inconsistent coefficients between females and 
males and was not included in the final model. We estimated the relationship between incidence and 
prevalence as a function of lag-distributed income per capita with country random effects.  Predicted 
death to incidence ratios and incidence to prevalence ratios were transformed into estimates of excess 
mortality and remission using the mathematical relationships between them (see Appendix section 2.2 
for additional information).   
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DisMod-MR 2.0 
For each country we included in the DisMod-MR 2.0 estimation the adjusted case notifications, 
prevalence survey data if available, estimated excess mortality hazard by age and sex, estimated 
remission and the TB-HIV adjusted cause-specific mortality estimates from our CODEm model. DisMod-
MR 2.0 provides internally consistent estimates for 1990, 1995, 2000, 2005, 2010 and 2013 for 188 
countries of incidence, remission, excess mortality, prevalence and cause-specific mortality using all 
forms of data or priors in the estimation. Figure 5 illustrates the internally consistent fit for Kenya in 
2013.  For intervening years, we interpolated rates.      Estimating Tuberculosis Incidence, Prevalence and Death in Individuals who are HIV-positive 
Tuberculosis all forms estimates coming from DisMod-MR 2.0 were used to estimate incidence and 
prevalence in HIV positives using a relative risk (RR) approach. We reviewed the literature using the 
search terms incidence risk ratio HIV tuberculosis antiretroviral therapy and used meta-regression to 
estimate a RR of tuberculosis incidence in HIV positive individuals in the absence of ARTs based on 7 
studies86–92 of 8.7 (5.9 to 11.7).  Studies show that the RR of tuberculosis incidence is a function of CD4 
count and ART; to parse out the increasing risk ratios of tuberculosis by decreasing CD4 count and the 
decreasing risk ratio on ART we relied on data from the Badri et al93 study.  The RRs we calculated from 
this analysis are 15.7 (10.6 to 21.1), 10.8 (7.3 to 14.5), 3.2 (2.2 to 4.3), and 1.7 (1.2 to 2.3) for the <200, 
200-350, and >350 CD4 count categories and the ART category. We computed population attributable 
fractions (PAFs) for each category using the outputs of Spectrum above.  For prevalence we assumed, 
that each category of incident tuberculosis cases in HIV positives has the same duration. TB-HIV 
mortality was estimated as described above.   Malaria 
Murray et al developed estimates of mortality and incidence for malaria for the GBD 2010.74,94 They 
estimated malaria mortality using vital registration and verbal autopsy data analyzed using CODEm.  
Published community incidence studies were meta-analyzed to generate a model of incidence as a 
function of mortality, age, sex and region. We have modified this method for the GBD 2013 update.  
Considerable debate emerged since the publication of that analysis on the validity of verbal autopsy 
(VA) for adult malaria deaths.95–100 For the GBD 2013, we undertook a systematic review of the literature 
on the validity of VA for malaria. Our inclusion criteria were validation studies that used physician-
certified verbal autopsies, reported both sensitivity and specificity for malaria, and had hospital 
diagnosis as the gold standard. However, the quality of the gold standards used in these studies is 
variable, and in some of them malaria cases were not confirmed with a blood smear and/or did not use 
a case definition with a threshold of parasitemia. We identified seven studies.101–107 We first tested in a 
meta-regression if there was any significant difference between studies with and without parasitemia 
confirmation and found none.  We meta-analyzed these studies to estimate sensitivity and specificity, 
separately for children and adults. Forest plots for adult and children are shown in Figure 6a and 6b, 
respectively.  We have as a sensitivity analysis undertaken to use this correction but it leads to 
substantially larger numbers of estimated deaths in adults from malaria – see Appendix Figure 3 for 
details.  We have chosen not to correct the data for the main results of this paper because it would 
adjust deaths in adults upwards which is contrary to expert opinion in the literature.   
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Given that we have not applied the sensitivity and specificity corrections, we have instead modified the 
redistribution of garbage codes such as fever of unknown origin or ill-defined deaths, so that we do not 
redistribute garbage codes to malaria in adults. We have also updated all the times-series covariates 
tested in the models: rainfall, health-system access, antimalarial drug resistance weighted by drug use, 
ITN coverage, indoor residual spraying coverage, income per head and educational attainment. We have 
also included in the model the 2010 Plasmodium falciparum parasite rate (PfPR) map from the Malaria 
Atlas Project.108  A coherent analysis of PfPR overtime is underway but was not available for this analysis. 
Appendix Table 14 provides details on the CODEm model analysis. As in the Murray et al study, we 
developed separate models for sub-Saharan Africa and outside of Africa (with the exception of South 
Africa, which was modelled with countries outside of Africa, given the low malaria endemicity), age 
under 5 years and 5 years or higher, and males and females.  
For countries that have only or mainly Plasmodium vivax transmission we used the number of deaths by 
year and age from vital registration data as a simple predictor of malaria mortality using a negative 
binomial regression model. 
Malaria cases were estimated separately for three sets of countries, which were divided based on the 
availability and quality of malaria incidence data – see Appendix Table 15 for the list of countries. The 
first group contained countries with unavailable or unreliable malaria case reporting systems. We 
estimated malaria incidence in these countries using a mortality-incidence model, in which we predicted 
malaria incidence by regressing the log-transformed study-level incidence on the log-transformed 
malaria mortality rate, age-group indicators, a sub-Saharan Africa indicator, an indicator distinguishing 
active vs. passive case detection (set to active when generating predictions), and the ratio of the site-
specific PfPR to national PfPR (from MAP 2010; set to the value “1” when generating predictions so that 
the estimates are nationally representative).  In this model the incidence data came from studies 
published in the literature and the mortality data came from our CODEm analysis. The second group 
included countries for which there were incomplete administrative data, for which we predicted malaria 
incidence by regressing incidence data from the World Malaria Report 2013 on national-level PfPR. We 
corrected for underreporting using a composite indicator for health system access as a proxy. The third 
group contained countries with complete and reliable administrative case reports, for which we used 
reported numbers as published in the World Malaria Report.  CodCorrect Algorthm 
As with all causes of death analyzed for the GBD, we require that the sum of each individual cause of 
death for a country, age, sex, year equals the estimate of all-cause mortality. The CodCorrect algorithm 
rescales the sum of causes at the individual draw level. The effect of this simple algorithm is to change 
causes that have larger uncertainty intervals if there is a mismatch between the sum of cause-specific 
mortality and all-cause mortality. In order to preserve the relationships between incidence, prevalence 
and death that come from the Spectrum analysis, the entire epidemic curve for HIV is scaled in 
CodCorrect.   Role of the funding source 
The sponsor of the study had no role in study design, data collection, data analysis, data interpretation, 
or writing of the report.  The authors had access to the data in the study and the final responsibility to 
submit the paper. 
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Results HIV 
Figures 7a, 7b and 7c show the estimated trend in global numbers of incident cases, people living with 
HIV (prevalence) and deaths from HIV.  UNAIDS estimates are shown for comparison. Global HIV 
incidence peaked in 1997 with 2.8 million (2.7 to 3.1) new infections and has declined since the peak at 
2.7% (2.0% to 3.1%) per year. From 1997 to 2005, incidence declined at 3.8% (3.0% to 4.6%) per year 
and from 2005 to 2013 at 1.6% (0.6% to 2.4%) per year.  New infections in children declined from 340 
thousand (323 to 363) in 2000 to 134 thousand (123 to 152) in 2013 at an annualized rate of change 
(ARC) of -7.2% (-7.8% to -6.4%), while new infections in adults declined from 2.3 million (2.1 to 2.4) to 
1.7 million (1.6 to 2.0), falling at 2.4% (1.6% to 3.0%) per year, on average, over this period. Annual 
incidence estimated by UNAIDS is uniformly higher in the years shown and shows a sharper rate of 
decline.  Prevalence of individuals infected with HIV has steadily risen to 29.2 million (28.1 to 31.7) in 
2013 rising more rapidly from 1990 until about 2000 at an annual rate of change of 10.6% (10.1% to 
11.3%) , increasing at 1.2% (0.9% to 1.4%) per year since then (Figure 7b). Compared to UNAIDS, we find 
in 2012, 6.6 million fewer individuals living with HIV. 32.0% of this difference is in sub-Saharan Africa and 
68.0% is elsewhere.  Figure 7c shows a substantially different trend for HIV deaths compared to UNAIDS, 
with a peak mortality of 1.7 million (1.6 to 1.9) in 2005. Annual mortality has subsequently fallen to 1.3 
million (1.3 to 1.5) in 2013, an ARC of -3.1% (-4.0% to 2.2%). As for incidence and prevalence, while the 
time trend of mortality estimated by UNAIDS is similar to ours, the estimated number of deaths is 
substantially greater. At the peak of the epidemic in 2005, our revised assessment of the HIV epidemic 
suggests 635 thousand fewer deaths  than UNAIDS although the difference (240 thousand) had 
narrowed considerably by 2012, the last year available from UNAIDS.  For the interval 2005 to 2012, the 
UNAIDS ARC for death numbers was -5.0% (-5.6% to -4.5%) reflecting the lower assumed death rates on 
ART in the UNAIDS version of Spectrum.  
New HIV infections are concentrated in young adults and to a much lesser extent, in children under 5, as 
shown in Figure 8a; 4.1% (3.8% to 4.5%) of new infections occur over age 60.  New cases in 2013 
occurred equally in males and females. However, there are more infections in women compared to men 
at ages 15-24 years. Incidence in children, as well as older adults, is similar for males and females.  
Reflecting a mean survival time of more than 10 years in most countries and age-groups, the age pattern 
of deaths peaks in women at ages 30-34 years and in men at a 10 years older age group (Figure 8b).  
More (53.9% [51.9% to 56.1%]) deaths are in males than in women and girls. A larger share, 6.8% (6.2% 
to 7.4%), of deaths occur beyond age 60 compared to incident cases (4.1% [3.8% to 4.5%]).    
Table 2 quantifies the ARCs for 1990-2000 and 2000-2013 for incidence, prevalence and death for the 21 
GBD regions and the world. ARCs between two fixed time periods need to be interpreted bearing in 
mind that measures of the HIV epidemic such as incidence and death will have peaked and declined in 
particular countries at different times during the interval. Nevertheless, the table clearly shows the 
accelerated progress in most of the world’s regions. The only regions with a reversal in the ARC such 
that incidence was declining but in the later period is increasing or stagnating are  Southeast Asia, North 
America High Income, Western Europe, Australasia and Tropical Latin America. The former is explained 
by the large decline in the 1990s achieved by a successful campaign to reduce infection through 
commercial sex encounters in Thailand, the country in the region with the largest epidemic. The reversal 
of incidence trend in North America may reflect a wearing off of the effect of public health measures to 
reduce the risk of transmission in MSM populations. The only regions with an ongoing increase in 
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mortality in the 2000-2013 period are East Asia, Eastern and Central Europe and North Africa Middle 
East.   
Age-standardized HIV incidence rates (Figure 9a) in 2013 ranged from below 0.7 per 100 000 in a group 
of countries ringing the Eastern Mediterranean , parts of northern and central Europe, as well as 
Mongolia to more than 550 per 100 000 in  South Africa, Lesotho and Swaziland. HIV infection follows 
distinct geographic patterns with continued high levels of infection throughout Eastern and Southern 
Africa, with some exceptions. Rwanda, Burundi, Democratic Republic of the Congo (DRC), Congo and 
Gabon all have incidence rates less than 120 per 100 000, lower than their neighbors. Incidence rates 
vary widely in sub-Saharan Africa, but are more homogenous across countries in Asia as well as North 
and South America. Important exceptions to these patterns include incidence rates above 16 per 100 
000 in many Caribbean countries. Incidence rates are notably higher in Portugal and the Ukraine, as well 
as Russia and some Central Asia republics. Figure 9b shows prevalence rates in countries in 2013. 
Geographical patterns are similar to incidence, although some differences are noteworthy.  Prevalence 
levels are highest in Botswana, Lesotho and Swaziland (above 12 000 per 100 000 population). As for 
incidence, there is substantial variation within sub-Saharan Africa; prevalence rates in Botswana, for 
example, are 16 times higher than in the DRC and 41 times higher than Niger. In Southeast Asia, 
prevalence is substantially higher in Thailand and Papua New Guinea. Prevalence rates are 
comparatively high in parts of Europe and Central Asia (Portugal, Spain, Ukraine, Russia and Kazakhstan) 
and in Latin America and the Caribbean (Panama, Honduras, Belize, Guatemala, Guyana, Suriname, 
Haiti, Dominican Republic, Jamaica and Bahamas) where prevalence levels exceed 220 per 100 000.   
Comparison of Figure 9a and 9b highlights some differences for countries in their comparative ranking 
for incidence and prevalence such as for Sweden and Australia.  Cross-national variations in HIV 
mortality rates, shown in Figures 9c, largely mirror the pattern reported for prevalence, varying from 
less than 0.2 per 100 000 in northern and central Europe and the Eastern Mediterranean, to more than 
510 per 100 000 in Southern Africa, a roughly 2500 fold difference.  More detail on the estimated 
number of new infections and deaths in 2013 for males and females and for both sexes combined for 
188 countries, along with ARCs in age-standardized incidence and death rates for both sexes combined, 
is given in Table 3. 
By comparing the estimated number of person-years lived in a no intervention scenario with actual 
estimates, we can compute the years of life saved through ART, PMTCT and co-trimoxazole prophylaxis.  
Figure 10 shows cumulative years of life saved by GBD Region as a result of these interventions during 
three phases of scale-up. From 1990 to 2003, 1.5 million years of life (1.2 to 1.9) were saved, of which 
only 22.7% (14.2% to 32.1%) were in populations living in the developing world largely in Brazil.  The 
number of years of life gained increased dramatically in the period 2004 to 2008 to 3.9 million (3.2 to 
4.7), and the share in populations in the developing world increased to 52.6% (44.1% to 62.2%). 
Between 2009 and 2013, the number of life-years gained was 13.7 million (11.8 to 15.7). More 
importantly, a much greater share (40.8% [33.8%-47.6%]) of these life years saved were in Eastern and 
Southern Sub-Saharan Africa, and a further 12.1% (9.0-15.7) in Western Sub-Saharan Africa. Other 
regions to benefit substantially from HIV interventions include High-Income North America, Western 
Europe and South Asia. The number of years of live saved continues to grow rapidly due both to the 
continued expansion of ART as well as the cumulative impact of infections prevented in children. By 
2013, the global cumulative number of years of life gained was 19.1 million (16.6 to 21.5); 14.2% (12.4% 
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to 16.2%) under age 15, 49.7% (45.8% to 53.4%) in 15-49 year olds, and 36.1% (32.7% to 39.5%) over age 
50.    
Since 2000, cumulatively DAH for HIV up through 2011 totals $51.6 billion dollars for HIV of which $33.6 
billion can be traced to specific country programs in 2011 US dollars.109 Comparing the total invested in 
HIV prevention and treatment to the years of life saved 2000 to 2011 yields in developing countries a 
ratio between $2928 to $4497 per life-year saved depending on which total figure you use. Of note, the 
ratio of DAH for HIV to years of life saved varies widely from $2.38 in Uruguay per life-year saved to 
$1.87 million in Mongolia per life-year saved.  
The scale-up of ART has been variable across countries. Because of the temporal dynamics of the 
epidemic in different countries, comparisons of intervention scale-up are confounded by the timing of 
incidence. Nevertheless, Annex Figure 4 shows a crude comparison of years of life saved over the age of 
15 divided by prevalent cases over 15 in 2013. This ratio ranges from less than 0.05 in countries with 
minimal intervention to over 0.45 in most high-income countries. In developing countries, Brazil stands 
out with a ratio of 0.41.  In the next tier, with ratios between 0.3 and 0.4 includes many countries in 
Latin America, Botswana, Namibia, Thailand, Cambodia, South Korea, and selected countries in Central 
Europe. In Eastern and Southern Africa, Mozambique, Ethiopia, Rwanda and Burundi have higher ratios 
than many neighbors. Marked variation within regions points to the historical variation in the timing of 
the epidemic response.    
Figure 11 shows a comparison of our estimated prevalence for country-age-sex groups against national 
population prevalence surveys. For comparison, the figure shows UNAIDS estimated prevalence as well. 
This comparison provides a rough check that at the end of the modeling process our assessment 
remains consistent with population-based prevalence measurements as well as being consistent with 
data on all-cause mortality. In general, there is a strong correlation (0.96) of our country-age-sex 
estimates with survey prevalence – UNAIDS prevalence is also correlated 0.96 with survey data.  
However, in 21% of cases, there is a statistically significant difference (19% for UNAIDS). The coefficients 
obtained by regressing both GBD and UNAIDS estimates on survey estimates showed that both methods 
tended to be slightly higher than the surveys; however, only the UNAIDS coefficient was statistically 
significantly larger than one – UNAIDS: 1.08 (1.03 to 1.13), GBD: 1.02 (0.98 to 1.06).  Country-specific 
graphs comparing GBD, UNAIDS and survey prevalences by age and sex are provided in Appendix Figure 
6.  Tuberculosis 
Figure 12 shows the evolution of tuberculosis incident case numbers, the number of prevalent cases and 
the number of deaths from 1990 to 2013. Total tuberculosis numbers are shown as well as numbers for 
tuberculosis in individuals who are HIV-negative – WHO estimates are included for comparison. The 
number of incident cases for tuberculosis in individuals who are HIV-negative has increased from 5.0 
million (4.8 to 5.1) in 1990 to 7.1 million (6.9 to 7.3) in 2013, a 1.5% (1.4% to 1.6%) annual change.  
Prevalence in 1990 and 2013 was 1.6 times higher than incidence implying a duration of 20 months on 
average for a case. Prevalence rates rose slightly between 1990 and 2000 (ARC 0.4%, 0.2% to 0.6%) but 
declined by 1.3% (1.4% to 1.2%) per year from 2000 to 2013. Deaths from tuberculosis in individuals 
who are HIV-negative are declining at a faster rate from 1.8 million (1.7 to 1.9) in 1990 to 1.3 million (1.2 
to 1.4) in 2013, a -1.4% (-1.9% to -1.0%) annual change. Declining death numbers and rising incidence 
numbers implies that the case-fatality rate has been declining over the period; the ratio of deaths to 
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incidence overall went from 0.36 (0.33 to 0.39) in 1990 to 0.18 (0.16 to 0.20) in 2013, a -2.9% (-3.4% to -
2.5%) per year rate of change. The majority of global tuberculosis incidence cases and deaths in 
individuals who are HIV-negative are in men and boys, 64.0% (63.6% to 64.3%) incidence and 64.7% 
(60.8% to 70.3%) mortality (Figure 13). Although age-specific rates rise with age up to age 70, given the 
comparatively young age-structure of countries with substantial burden of tuberculosis in individuals 
who are HIV-negative, 83.2% (82.6% to 83.8%) of cases and 58.8% (56.7% to 60.6%) of deaths are under 
age 60 in 2013.   
Table 4 provides a summary at the global and regional level of the ARCs for age-standardized rates of 
incidence, prevalence and death for tuberculosis in individuals who are HIV-negative (see Appendix 
Table 10 for tuberculosis including HIV-positives). At the global level, age-standardized mortality rates 
declined by 3.3% (4.1% to 2.6%), while incidence remained stable (0.0%, -0.2% to 0.2%) and prevalence 
rates increased by 0.4% (0.2% to 0.6%) during the period 1990 to 2000. Global declines continued in the 
period 2000 to 2013 for mortality, -3.7% (-4.4% to -3.0%) while incidence and prevalence started 
declining by 0.6% (0.7% to 0.5%) and 1.3% (1.4% to 1.2%), respectively. Across regions, in the period 
2000 to 2013, incidence rate ARCs in individuals who are HIV-negative ranged from 0.9% (0.7% to 1.1%) 
in Oceania to -3.3% (-3.1% to -3.6%) in high-income North America.   Twelve of 21 regions had a greater 
decline in the incidence rate from 2000 to 2013 than for 1990 to 2000. Mortality rate declines in 
individuals who are HIV-negative were greater in the period 2000 to 2013 than the declines in 
prevalence in all 21 regions. The global decline in prevalence from 2000 to 2013 is largely accounted for 
by the large declines in just two regions: East and South Asia. In South Asia, which accounts for 34.8% 
(33.9% to 35.6%) of incident cases and 47.7% (43.5% to 51.8%) of deaths in 2013, the ARCs for 2000 to 
2013 were -1.1% (-1.3% to -0.8%), -2.4% (-2.7% to -2.2%) and -4.2% (-5.6% to -2.9%) for incidence, 
prevalence and mortality rates respectively. Accelerated declines in prevalence, incidence and mortality 
occurred in East Asia from 2000 to 2013; -3.2% (-3.4% to -2.9%) for prevalence, -2.1% (-2.4% to -1.9%) 
for incidence and -7.5% (-8.5% to -6.6%) for mortality. The tuberculosis trend in Eastern Europe has 
turned around; in the 1990s mortality, incidence and prevalence rates were all on the rise, ARCs of 5.5% 
(0.6% to 6.5%), 1.3% (1.0% to 1.7%) and 1.7% (1.4% to 2.0%), respectively. However, in the period 2000 
to 2013 the trends for all there of these indicator have improved, ARCs -5.0% (-5.8% to -4.0%), -0.6% (-
0.8% to -0.4%) and -0.7% (-1.0% to -0.5%).  Table 5 shows incidence numbers and death numbers by 
country in 2013 along with ARCs for age-standardized rates. 
Figures 14a and 14b show maps of age-standardized incidence rates and death rates for tuberculosis in 
individuals who are HIV-negative in 2013. Age-standardized incidence of tuberculosis in individuals who 
are HIV-negative is over 200 per 100 000 in 24 countries in sub-Saharan Africa as well as North Korea, 
Timor-Leste, Cambodia, Laos, Philippines and Kiribati (Figure 14a). There are an additional 16 countries 
with rates over 150 per 100,000 that include Bangladesh, Myanmar, India, Pakistan, Ethiopia and 
Malawi. Figure 14b shows tuberculosis death rates in individuals who are HIV-negative which are above 
10 per 100 000 in all countries in sub-Saharan Africa and reach to levels over 50 per 100 000 in 
40countries. Among middle-income countries outside of sub-Saharan Africa, Afghanistan, Indonesia, 
India, Myanmar, and the Philippines stand out as countries with death rates over 50 per 100 000. The 
highest age-standardized death rates in Latin America and the Caribbean are in Haiti followed by Bolivia 
and Peru. Death rates are highly variable in North Africa and the Middle-East ranging from very low 
rates in Syria and Jordan to higher rates in Morocco and Yemen with 0.5 (0.3 to 0.9), 0.8 (0.6 to 1.0), 
14.3 (11.2 to 17.5), and 19.9 (11.5 to 41.5) per 100 000 respectively in 2013. Eastern Europe and Central 
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Asia stand out with death rates that are dramatically higher than Western or Central Europe. China has 
lower rates of death than Eastern Europe and Central Asia. Our findings are reasonably consistent with 
the list of high-burden countries used by WHO; however, our top 22 countries in terms of case numbers 
or death numbers that are not on the WHO high-burden list include South Korea, North Korea, and 
Madagascar for case numbers and Angola and Zambia for mortality. WHO high-burden countries that 
did not make our top 22 list for case numbers include Afghanistan, Cambodia, and Tanzania, while the 
WHO high-burden countries that did not make our top 22 list for mortality include Brazil and Cambodia.  Malaria  
Trends in the annual number of new cases of malaria, and annual deaths from malaria, are shown in 
Figure 15a and 15b, respectively for the period since 1990. For comparison, the estimates contained in 
the World Malaria Report 2013 are shown for a somewhat shorter period. Global incidence appears to 
have peaked in 2003 at 232 million cases (143 to 387) and has since fallen by about 29% to 165 million 
new cases (95 to 284) in 2013. What is clear is that there is massive uncertainty around these estimates; 
the 2013 estimate, for example, could be anywhere between 95 million and 284 million. The estimates 
of new malaria cases in the World Malaria Report fall within the uncertainty intervals of the GBD 
estimates with a mean number of new cases in 2012 of 207 million (135 to 287). In contrast, the World 
Malaria Report estimates of malaria deaths are somewhat lower (Figure 15b). There are also some 
important differences in the timing of the peak and decline in malaria mortality. Annual malaria deaths 
began to decline from a peak of 1.2 million (1.1 to 1.4) in 2004 to about 855 thousand (703 to 1032) in 
2013, having increased from 888 thousand (793 to 993) in 1990. According to the World Malaria 
Report,110 malaria caused about 627 thousand deaths in 2012, having reached a peak of about 900 
thousand around the turn of the century. The age-sex pattern of global malaria incident cases and 
deaths in 2013 is shown in Figure 16a and 16b, respectively. The largest number of cases is in the age 
groups under 15. Malaria deaths, in contrast, are concentrated at ages under 5 years although malaria 
caused between 10 and 25 thousand deaths in each 5 year age group beyond age 15, so that the 
cumulative fraction of malaria deaths in adults reaches 33.75%.  
Globally age-standardized malaria incidence and death rates were increasing in the period 1990 to 2000 
(Table 6), but many regions outside of sub-Saharan Africa and North Africa and the Middle-East saw 
declines in age-standardized incidence and/or death rates. In the period since 2000, the vast majority of 
regions including in sub-Saharan Africa saw declines in age-standardized incidence and death rates. 
Incidence declined 38% (37% - 40%) in Central Asia since 2000, which relates to increased elimination 
efforts in the region. Figure 17A shows the distribution of the age-standardized incidence rate in 2013. 
The geographic distribution of the age-standardized mortality rate (Figure 17B) shows a similar pattern 
with the highest rates in Mozambique, Burkina Faso, Guinea-Bissau, Mali, Sierra Leone, The Gambia and 
Guinea.  Rwanda stands out as having comparatively low rates compared to its neighbors. Outside of 
Africa, Yemen, India, Myanmar and Papua New Guinea have death rates over 8.5 per 100 000.  In 
Southeast Asia, Thailand and Malaysia have achieved very low death rates. Table 7 shows incidence 
numbers and death numbers by country in 2013 along with ARCs for age-standardized rates. Four 
countries have over 5 million cases a year including India with over 61 million cases, Nigeria (with 30), 
Democratic Republic of the Congo (6), and Mozambique (6). Three countries - Nigeria, DRC, and India - 
account for roughly 50% of all malaria deaths in 2013.   
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Discussion 
HIV, tuberculosis, and malaria remain major health challenges in 2013 causing 1.3 (1.3 to 1.5), 1.3 (1.2 to 
1.4) and 0.9 (0.7 to 1.0) million deaths respectively. The mean age of death differs substantially between 
them, 15.3 years (12.7 to 18.3) for malaria, 38.6 years (38.1 to 39.2) for HIV and 52.9 years (52.1 to 53.9) 
for tuberculosis in HIV-negatives which means that the burden in terms of years of life lost varies across 
the diseases. Tuberculosis death declined globally since 1990 and after 2000 incidence, prevalence and 
death have declined. HIV incidence peaked in 1997 and mortality in 2005 with substantial declines since 
the peak in each. Malaria incidence and mortality peaked and began declining in 2004 with substantial 
drops in child deaths in sub-Saharan Africa over the last 5 years. There is marked variation both in levels 
and trends for all three diseases across countries.  Notably HIV and malaria incidence and death are 
concentrated in sub-Saharan Africa while tuberculosis burden is more widespread but most pronounced 
in South and Southeast Asia.   
A notable finding from our analysis of HIV data is that the HIV epidemic is smaller than estimated by 
UNAIDS. Our global epidemic curve for mortality ranges was lower than estimated by UNAIDS for every 
year, at the peak in 2005 our estimates are 27.0 % lower and 14.5% lower in 2012. Our estimates of 
global prevalence differ by 17.1% in 2005 and 18.7% in 2012. The substantial differences in the number 
of deaths stem from two key differences in our analysis compared to that conducted by UNAIDS. First, in 
the 125 concentrated epidemics with some cause of death data on mortality due to HIV, our estimated 
mortality is 52.2% lower in 2000 and 58.4% lower in 2012. Our prevalence estimates for example for 
Panama, Colombia, or Russia are 36.3%, 52.2% and 58.4% lower, respectively. Second, in the large 
generalized epidemics, selecting epidemic curves that are consistent with prevalence data, all-cause 
mortality, and published studies on survival with and without ART shifted median survival up. For 
example, in Southern Africa, median survival off-ART for the age-group 25-34 was shifted from 10.5 to 
11.5 years.  Longer or shorter survival off-ART in some countries could be explained by genetic 
factors,111–115 co-factors such as the presence of other diseases like malaria,116–118 differential access to 
treatments for opportunistic infections or other co-factors that have yet to be described.  These findings 
are important in terms of identifying the magnitude and comparative burden of HIV.   
Comparison of population-based surveys with our estimates of prevalence suggest reasonable 
alignment and the regression analysis of estimated prevalence on measured prevalence suggest there is 
not systematic tendency in our estimates to over or under-estimate prevalence. However, there is still 
considerable variation by age and sex with nearly one in five of our age-sex specific prevalence 
estimates statistically different than the survey prevalences. There are a number of potential 
explanations. Our assumptions on the relative incidence pattern by country may not reflect local reality.  
Differential non-response in the surveys by age and sex is also a potential factor. The adjustments made 
in through the demographic matching and CodCorrect algorithm may contribute to the differences. 
More analysis on a country by country basis will be helpful in exploring these issues in future research.  
Revisions of the global epidemiology of HIV of this magnitude given the weakness of direct 
measurement of incidence and death should not be surprising. As prevalence surveys became more 
widely available, UNAIDS revised downward their global prevalence estimates by 18% in 2007 and their 
global mortality estimates by nearly 24%.119 Taking into account more data on survival on and off ART as 
well as all-cause mortality data has led to revisions of a similar magnitude. Our revision also suggests 
that there is greater uncertainty for incidence, prevalence and death than previously estimated.  
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Regardless of the specific estimates generated from imperfect data, however, our assessment of 
prevalence continues to point to the very large and steadily growing numbers of infected individuals 
many of whom are in need of antiretroviral therapy. Great progress has been achieved reducing 
infections in children (62.4% reduction since the incidence peak in 2002) due to the scale-up of 
interventions.  The continued 1.7 million new infections per year in adults down 32.7% from the peak of 
the epidemic at the global scale, however, is a stark reminder of the continuing epidemic.   
A key finding that confirms many local, regional and global studies120–125 is that interventions especially 
ART, PMTCT and co-trimoxazole have had a profound effect. Cumulatively 19.1 million years of life have 
been saved since 1996, 5.7 million in developed countries and 13.4 million in developing countries.   The 
ratio of DAH to years of live saved is less than $4500 for the average of the period. Given the very rapid 
increase in years of life saved in 2012 and 2013, the ratio for the period 2000-2013 when DAH figures 
are available will likely be significantly lower. The scale-up, number of lives saved and comparatively low 
price per year of life saved is one of the major achievements in global health in the last decade. Many 
groups, local, national and global, deserve a share of the credit for this accomplishment.  DAH does not 
count national contributions to the cost of HIV programs; real variation in the ratio of the total cost per 
year of life saved is likely much smaller because many middle-income countries receive little DAH and 
fund most HIV interventions from their own resources. Micro-economic studies of the cost per years of 
life saved have also reported wide variation across locations.126–128  We would expect given investments 
in initial program start-up including capital equipment investments that the ratio of DAH to life-years 
saved will decrease overtime. With prevalence growing 5.8% per year over the past 5 years, the need to 
learn from more efficient programs is paramount. Our analysis of survival on ART showed wide variation 
in program outcomes within sub-Saharan Africa. Counterfactual analysis of what might happen if all 
programs achieved the levels of mortality seen in the programs with the best outcomes or even what 
would happen if high-income country on ART death rates were achieved would help shed further light 
on the importance of quality improvement for future HIV death reductions.     Improving cost-
effectiveness of ART programs will require a process of continuously documenting costs, outcomes and 
efficiency along with a mechanism for shared learning across programs on improving quality.  HIV 
infected intravenous drug users have not benefited as much from treatment as those infected through 
sexual transmission. The only regions with an ongoing increase in mortality from HIV in the 2000 to 2013 
period are Asia East, Eastern and Central Europe and North Africa Middle East where large proportions 
of HIV cases are found among intravenous drug users for whom countries may be less inclined to 
provide treatment services. Even in countries with a greater emphasis on harm-reduction strategies 
drug users may still be a more difficult group for health services to reach.129 
Age-standardized tuberculosis mortality rates including tuberculosis in HIV positive individuals at the 
global level changed at -2.8% (-3.6% to -2.2%) per year from 1990 to 2000 and around a percentage 
point faster from 2000 to 2013, -3.7% (-4.4% to -3.0%) per year. When examining tuberculosis mortality 
in individuals who are HIV-negative, the acceleration was smaller from -3.3 (-4.1% to -2.6%) to -3.7% (-
4.4% to -3.0%) change per year but still significant.  There has been comparatively little decline in the 
global age-standardized tuberculosis incidence rate in HIV negative individuals although some regions 
such as South Asia and East Asia have seen accelerated declines since 2000. Prevalence has declined 
much faster than incidence, which is consistent with earlier and more effective treatment shortening 
durations. In addition to shorter duration, the death to incidence ratio changed from 0.36 in 1990 to 
0.18 in 2013 also a likely consequence of treatment. There has been considerable regional and country 
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variation in progress on tuberculosis with the ARC for mortality ranging from -10.3% to 2.5% from 1990 
to 2013 and the ARC for incidence ranging from -3.3% to 2.5% over the same period. This variation 
implies that more rapid progress is possible at the global scale if lessons can be learned from countries 
with more rapid achievement. Since 2000, as for HIV and malaria, global progress in terms of prevalence 
and mortality has accelerated. We are unable to compute the extra years of life saved for tuberculosis as 
we can for HIV; but the comparatively modest DAH for tuberculosis over the period 2000-2011 ($8.3 
billion) has been associated with over this time period with greater reductions in incidence, prevalence 
and death rates. Tuberculosis is different from HIV and malaria in that the rising incidence and death 
rates with age mean that demographic aging of the world’s population in the absence of other changes 
will naturally lead to higher numbers of cases and deaths. Demographic changes in essence slow the 
progress of tuberculosis control; a factor that should be built into considerations of funding and 
program strategy. The established links between alcohol, diabetes, tobacco smoking and tuberculosis 
also mean that trends in these risk factors can modulate trends in tuberculosis.130–132 In this analysis, we 
have not separately examined the incidence, prevalence and mortality related to multi-drug resistant 
tuberculosis (MDR-TB). There are concerns that even in places with substantial declines in tuberculosis 
incidence, prevalence and death such as China, MDR-TB may be a substantial challenge.82,133–136 
Modeling exercises have shown that under certain circumstances MDR-TB could reverse important gains 
made in combatting tuberculosis.82,136,137 Future revisions of the burden of disease should examine more 
carefully the evidence on the levels and trends in MDR-TB.   
Our results for tuberculosis differ from WHO estimates in some important ways. In general, we estimate 
higher mortality, lower prevalence and incidence and a smaller fraction of tuberculosis related to HIV.  
Our estimates of prevalence are driven by the available prevalence surveys and are not back calculated 
from incidence. Our incidence estimates start with case-notifications corrected for missing age-groups 
and case types such as smear-negative pulmonary or extra-pulmonary and expert judgment of the case-
detection rate. For some countries, with implausibly large numbers of smear-negative and extra-
pulmonary cases notified in individuals under 15, we have excluded these data from the analysis.  
However, the Bayesian meta-regression identifies a solution for incidence that is consistent with 
prevalence data and estimates of cause-specific mortality. Because this analysis as undertaken using age 
and sex-specific rates, it also takes into account the changing relationship between incidence, 
prevalence, remission, excess mortality and cause-specific mortality with age and sex. Because true 
incidence in any country is not known, our estimates as well as WHO’s depend on expert judgment on 
the case-detection rate.  Systematic bias in the estimated case-detection rate, particularly for earlier 
time periods, will affect not only the volume of estimated tuberculosis cases and time trends.  India 
accounts for 27.1% (26.3% to 27.9%) of global incident cases in 2013; systematic errors in the estimated 
incidence in India in the 1990s would have a profound effect on global trends.  Perhaps more 
importantly, our assessment of global trends for prevalence and death are similar to WHO but differ for 
incidence. WHO estimates accelerated declines in incidence post 2005 whereas we are estimating at the 
global scale comparatively constant incidence rates.  Since total age-sex-specific case notifications 
reported to WHO for smear-positive pulmonary tuberculosis have continued to increase, 1.1 million in 
2000, 2.3 million in 2005 and 2.5 million in 2012, differences in time trends stem from assumptions 
about the case-detection rate and in our case, the incorporation of information from prevalence surveys 
and all-cause mortality.      
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Malaria burden rose steadily until 2004 and has since declined.  The GFATM, President’s Malaria 
Initiative and other bilateral and private initiatives have spent $11.3 billion in DAH from 2000 to 2011.  
The hypothesis that global action has been an important factor in these declines is highly 
plausible.6,110,138–141 The decline in our assessment is driven by the statistical model fitted to the available 
but sparse verbal autopsy data. Key independent variables in the model that drive this estimated decline 
are the variable on resistance for first line agents and ITN coverage. Noor et al’s142 assessment of trends 
in PfPR from 2000 to 2010 indicate that some countries such as Malawi, Zambia or DRC have had 
substantial scale-up of ITNs with minimal reduction or increases in PfPR.  Explanations for the mismatch 
between ITN scale-up and changes in PfPR could lie in the estimation of both PfPR, ITNs or local factors 
that affect who actually receives and uses ITNs or could be a function of other factors, e.g. climate, 
driving changes over this period. There may also be important threshold or saturation effects for ITNs on 
PfPR.  While the substantial decline in child mortality in the last five years is welcome news, 
understanding the relative role of artemisinin combination therapy (ACT) scale-up and vector control is 
challenging and may well vary by country. The variability in the relationship between ITNs and PfPR at 
the national level emphasize the risks of simply assuming that ITN scale-up at the national level will yield 
the percentage reduction in child death observed in the randomized trials; a strategy employed by Child 
Health Epidemiology Reference Group (CHERG) in their child mortality estimates.  It is also important to 
note that the CHERG models did not include a first-line drug resistance as a covariate. We found this to 
be an important predictor in the Africa models in particular and a key driver of the temporal trend noted 
in this region.       
MDG6 brought global attention to these three diseases, ushering in an unprecedented focus on specific 
diseases in the broader development agenda. Despite many who questioned the wisdom of a focus on 
specific diseases, there has been accelerated progress on HIV, malaria and tuberculosis since 2000. In 
the case of HIV, our estimation strategy allows for direct quantification of years of life saved which have 
been substantial. For tuberculosis and malaria, we observe accelerated reductions in deaths and cases 
compared to the decade before the Millennium Declaration. Rigorously assigning causality to these 
accelerations to the global collective action catalyzed by the Millennium Declaration is beyond the scope 
of this paper and likely impossible given the data limitations. Nevertheless, as governments and the 
global community debate the nature, scope and utility of setting new global targets post-2015, these 
findings should be taken into consideration.   
Our comparative analysis of these three diseases demonstrates marked differences in data gaps and 
measurement challenges. Antenatal clinic sero-surveillance and population surveys in generalized 
epidemics have been a powerful tool for tracking evolution of the HIV epidemic with real data collected 
on an annual basis. Cause of death data in many countries with concentrated epidemics also provides a 
relatively timely way to examine the impact of HIV. On the other hand, national data on the outcome of 
ART is extremely weak. Measures such as retention in care and loss to follow-up are often incomplete 
and difficult to compare across facilities, programs and countries. UNAIDS and our modeling do not 
routinely use national data on treatment outcomes and depend on cohort or published studies. Given 
the huge impact of ART on death and prevalence, more accurate and continuous monitoring of ART 
outcomes and costs must be a high priority. In contrast to HIV, tuberculosis results of treatment for 
those diagnosed is highly standardized and reported to WHO at least through the end of treatment.  
However, real-time data on the evolution of tuberculosis is extremely hard to come by. Case 
notifications can only be interpreted by resorting to expert opinion on the case detection rate and 
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prevalence surveys are infrequent and require large sample sizes. A system analogous to the antenatal 
clinic sero-surveillance for tuberculosis would be possible if new diagnostics emerge that can 
quantitatively assess load of bacilli in an individual who is infected.  Pending such a technological 
advance, more frequent prevalence surveys and perhaps capture-recapture studies82 are the only direct 
measurement available to track evolution of the epidemic. In our study, ARC for incidence and 
prevalence 2000 to 2013 is correlated (0.93). Information on malaria clinical cases and deaths is much 
weaker than for HIV or tuberculosis. Case reports are extraordinarily incomplete. Most death occurs in 
places without vital registration systems. Verbal autopsy is widely believed to exaggerate malaria deaths 
particularly in adults,143–145 given the tendency to overdiagnose malaria in African hospital settings;146–149 
yet our systematic review of validation studies shows low sensitivity (33%) and low specificity (93%). 
Bias is a function of both sensitivity and specificity. If these validation studies that are published are 
correct we may in fact be undercounting not over-counting malaria deaths in adults and children in 
areas with substantial malaria and the reverse in areas with relatively little malaria. The only 
comparatively easy to measure outcome related to malaria is the Plasmodium falciparum parasite rate.  
Local surveys have been usefully collated and analyzed by Noor et al and the Malaria Atlas Project.142 
These provide hard evidence on the trends in a measurable outcome; the challenge is that there is a 
relatively loose relationship in the available data between PfPR and incidence or mortality. Given how 
important malaria is, the state of monitoring systems for malaria burden is extraordinarily poor. 
Repeated verbal autopsy studies combined with carefully designed validation studies would be helpful. 
Better data on the incidence of clinical episodes confirmed with rapid diagnostic tests and how it varies 
as a function of the PfPR would improve incidence estimation.  
The three diseases highlight the difference between ICD assigned underlying cause of death and the 
total mortality attributable to a disease including through pathways where a disease aggravates other 
conditions. ICD rules treat conditions -not just these three diseases- in this regard in markedly different 
ways. All deaths directly related to pregnancy and childbirth and any deaths aggravated by pregnancy 
are counted as maternal deaths. For HIV, all deaths in individuals who are HIV-positive are assigned to 
HIV unless they are due to completely incidental causes such as a road traffic injury. Following this 
convention, tuberculosis deaths in HIV positives are assigned to HIV not tuberculosis. In the case of 
malaria, there has long been the recognition that malaria may increase the risk of death in children and 
adults from other causes150–152 such as septicemia or chronic kidney disease. Early studies after the 
eradication or rapid control of malaria documented rapid changes in deaths from pneumonia, and 
chronic kidney disease153,154 suggesting the full effects of malaria on mortality are greater than the ICD 
coded malaria deaths. The ITN RCTs based on verbal autopsy documented that approximately half of the 
declines in under-five mortality were in causes other than malaria assigned through a VA.155,156  It is 
important to recognize that our understanding of the magnitude of each disease is influenced by the at 
times arbitrary rules governing assigning causes of death.   
There are two important general observations from our analysis of HIV compared to prior analyses that 
may be relevant to other diseases. First, we find that concentrated epidemics have been systematically 
over-estimated by a factor on average of more than two. Over-estimation is most likely related to a 
tendency to over-estimate the size of high-risk groups for which there is little information. Why would 
expert judgment be on average so wrong? The disconnect in many countries between expert judgment 
and the results emerging from the analysis of cause of death data should caution us in the future from 
too much dependence on expert judgment in descriptive epidemiology. Second, we find a systematic 
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under-estimation of uncertainty in many countries in the UNAIDS analysis. Their assessment for South 
Africa, for example, had for 2010 an uncertainty interval with a coefficient of variation of 0.03. Our 
assessment prior to matching on all-cause mortality had a coefficient of variation almost six times higher 
(0.19) in the same year.  There is a general tendency, we believe, in many modeling efforts to 
underestimate uncertainty when arbitrary assumptions about parameters are made. For example, the 
default assumptions for uncertainty in the UNAIDS Spectrum model is a coefficient of variation 0.05 for 
mortality on and off ART.  We find from our empirical analysis coefficients of variation that range from 
0.44 in age group 15 to 24 and CD4 count greater than 500 to 1.00 in age-group 45 and above and CD4 
count greater than 500. In other words, uncertainty in these parameters appears to have been under-
estimated by an order of magnitude. This is not a critique of the UNAIDS Spectrum modeling effort 
rather a reminder that statistical analysis of parameter uncertainty often reveals that we know much 
less than we think.   
Our analysis of HIV in India based on the 2005-2006 National Family Health Survey and antenatal clinic 
sero-surveillance suggests that in 2002 there were 287 thousand (199 thousand to 377 thousand) 
deaths. Cause of death data, however, are available from several sources all pointing to substantially 
lower numbers of deaths than then UNAIDS high-risk group analysis. The Million Death Study reported 
using data for 2001-2003 estimated 59,000 to 140,000 deaths in 2004. The urban Medical Certification 
of Causes of Death system recorded a peak age-standardized death rate in 6.3 per 100,000 equivalent at 
the national level to 57 thousand deaths. We did not use these sources in our assessment, the 
substantial mismatch between our estimates highlights the need for improved understanding of causes 
of death in India.       
Some global health efforts to develop robust estimates of the burden of disease sometimes end up 
using both empirical measurement on incidence, prevalence and cause-specific mortality plus coverage 
of interventions and assumed effectiveness of interventions. The blending of real measurement of 
outcome and assumed mapping of interventions to outcome is justified because recent scale-up of 
interventions may not be reflected in the sparse measurements that are available. Our assessments 
used the modified Spectrum model to map ART coverage into likely changes in mortality from HIV.  
These are supported in some countries by measured declines in all-cause mortality or cause-specific 
mortality but in other countries are entirely based on the presumed relationship between intervention 
roll-out and mortality. Examples abound of this blending of data on outcome and intervention coverage: 
CHERG estimates of declines in child deaths due to ITNs and Hemophilus influenza type B vaccine 
coverage are not based on any statistical relationship observed but on the assumption that 
interventions will yield the declines seen in randomized trials. These are reasonable assumptions but 
there is a fundamental difference between observing the change in outcome as opposed to assuming 
the outcome has changed; this difference is not immediately evident in global health estimation efforts.  
It can yield circular analyses where estimates are used by other authors to evaluate impact. In general in 
the GBD 2013, we have sought to largely use empirical data and statistical associations seen in the data 
to make estimates.  But for HIV in particular, we have used the approach embodied in Spectrum.   
This analysis of data on HIV, tuberculosis and malaria has many limitations given the ambition to track 
incidence, prevalence and mortality for 188 countries from 1990 to 2013.  First, ART estimates for 2013 
are actually highly preliminary.  Countries have reported ART scale-up up through 2012 and provided 
estimates for 2013.  Many of these estimates were aspirational and we have used growth rates over the 
five years 2008-2012 to adjust these 2013 estimates. Second, we have not independently validated the 
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country reports of ART scale-up. We have added to the uncertainty by randomly varying ART scale up by 
sampling a uniform distribution from plus to minus 10% but this presumes that on average ART scale-up 
is not exaggerated. Third, we have used 102 studies on ART outcomes to inform our assumptions of 
death rates on ART. There is marked variation across sites. More recent programs may be achieving 
better outcomes than the published literature if there has been shared learning across programs.  The 
published literature may be biased towards better outcomes through the publication bias; poor 
programs are unlikely to seek to publish their results. There was insufficient national data to use local 
information for each country on ART programs. Our estimates may be biased up or down for a particular 
country because local ART outcomes may be better or worse than the sub-Saharan Africa average. 
Future rounds of estimation will be substantially improved by more robust ART treatment outcome data 
collected from nationally representative samples of ART patients across a wider array of countries.  
Fourth, we have sought to find epidemic curves for the major generalized epidemics that are both 
consistent with available prevalence data and all-cause mortality data derived from sources such as vital 
registration or sibling histories in household surveys. The process of matching all-cause mortality draws 
and Spectrum outputs that are consistent also substantially reduces uncertainty. Given the mismatch of 
these data sources, we are likely underestimating uncertainty in these countries. Fifth, we have not 
modified the UNAIDS assumptions for survival in children infected with HIV. However, published studies 
from high-income countries pre-ART suggest much higher survival.157 Our estimates of death in the age-
groups 5-9 and 10-14 may therefore be exaggerated. Sixth, our estimates of uncertainty for HIV may be 
under-estimated because some of our uncertainty ranges for parameter inputs have been selected 
arbitrarily and true variation for example in age-sex patterns of incidence may be larger. This is 
supported by the number of country-age-sex years where our estimates of prevalence are different than 
available national prevalence surveys. Seventh, based on debate on the burden of malaria in adults, we 
have chosen to not redistribute garbage code deaths onto malaria in verbal autopsy studies in adults.  
This leads to a reduction in the estimated number of adult malaria deaths. While this choice is 
motivated by expert opinion, it is not based on any direct data. Even without the redistribution of 
garbage codes, the percentage of deaths occurring in adults in Africa is still high and has to be 
interpreted with caution given the potential for misclassification bias in verbal autopsies. On the other 
hand, the choice not to redistribute ill-defined codes onto malaria may bias our adult deaths 
downwards. Eighth, Noor et al.  have recently published PfPR for 2000 and 2010.142  A full time series of 
PfPR would be a useful covariate for modeling the burden of malaria.  The Malaria Atlas Project is 
working on this time series analysis of PfPR and when it is finalized it would strengthen the analysis of 
malaria trends. Ninth, our uncertainty intervals for malaria incidence and mortality reflect sampling, 
non-sampling uncertainty and model specification uncertainty but do not reflect the uncertainty that 
may stem from misclassification biases in verbal autopsy.  Uncertainty is likely underestimated due to 
the limitations of VA for malaria in children and adults. Tenth, other studies in countries such as the 
Gambia suggest substantial declines in malaria in these settings; in our analysis of mortality, however, 
these types of studies have not been used.158,159 Eleventh, our analysis of tuberculosis assumes that local 
expert judgment about the case-detection rate is unbiased; this assumption, however, may be incorrect 
with some countries with higher or lower case-detection rates. Twelfth, our uncertainty intervals for 
tuberculosis incidence and prevalence generated from DisMod-MR 2.0 are likely underestimated. The 
intervals are narrow because we have extensive data inputs for essentially all countries in the form of 
adjusted case-notifications and CODEm estimates of all-cause mortality. While each data point has 
considerable uncertainty, the meta-regression produces narrow estimates of the predicted mean value 
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for an age, sex, country-year because of the extensive and often consistent data. These intervals do not 
capture the potential for systematic error in some of the data processing steps such as the use of the 
expert-based case-detection rate.   Despite these important limitations, the GBD approach has many 
advantages primarily because it is a comprehensive and clearly documented approach to disease burden 
estimation that examine all the available data and invests substantial effort in standardization of 
definitions, data adjustments and modeling across all diseases and injuries.   
The focus of the global health community on action to  reduce HIV/AIDS, tuberculosis and malaria , 
enshrined in MDG6, was not only appropriate in 2000 at the Millennium Declaration, but is increasingly 
relevant today given the slow, but important progress that disease control strategies have yielded, 
particularly in recent years. Much remains to be done, however, while there is now evidence that the 
implementation of known interventions is beginning to have an effect, it is probably less than is widely 
believed, or hoped. But these interventions are working , and need to be rapidly scaled up with more 
funding, more emphasis on national health system strengthening in key affected countries to increase 
access to them by the poor, and more targeted research to accelerate progress. What is also clear from 
this analysis as we enter the final phase of the MDG era is how little we reliably know in many countries 
to track progress. Rapidly  reducing the massive uncertainty that surrounds the measurement of these 
diseases, particularly malaria, will be essential if we are to better monitor, and respond to evidence 
about progress, or not, with their control. Author Contributions 
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Figure 1. UNAIDS compartmental model for estimating mortality in HIV positive individuals in the 
absence of ART. 
  
Figure 2. Mean and 95% uncertainty interval for HIV relative survival after seroconversion for age-group 
25-34 based on the analysis of 13 pre-ART cohort studies.  The UNAIDS assumption for survival is shown 
for comparison. 
  
Table 1. HIV-specific mortality rates for 25-34 year olds on ART in sub-Saharan Africa, by time since 
initiation, sex, and initial CD4 count (per 100 person-years)  
 
Figure 3. Vital registration deaths assigned to HIV (red), deaths coded to garbage codes redistributed to 
HIV (blue), and deaths misclassified reassigned to HIV (green) in Thailand (a) and the Russian Federation 
(b) in 2005. 
  
Figure 4. Vital registration inputs, and Spectrum and UNAIDS HIV mortality draws for Panama. 
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Figure 5. Bayesian meta-regression estimates for tuberculosis incidence, prevalence, remission, excess 
mortality, and cause-specific mortality for Kenya 2013.  For each observation in grey, the width of the 
bar refers to the age interval of the observation and the height the uncertainty interval.  To stabilize 
estimates, all data from 2008-2013 are included. 
  
Figure 6. Meta-analysis of published validation studies of verbal autopsy for malaria in adults (a) and 
children (b). 
  
Figure 7. Estimated global incidence (a), prevalence (b) and mortality (c) of HIV with 95% uncertainty 
intervals, 1990-2013. UNAIDS estimates shown for comparison. 
  
Figure 8. Age-sex distribution of new HIV infections (a) and deaths (b) in 2013. 
  
Table 2. Age-standardized HIV/AIDS incidence, prevalence, and mortality rates (per 100 000) and 
annualized rates of change (%), with 95% UI, for 21 GBD regions. 
  
Figure 9. Age-standardized HIV incidence (a), prevalence (b) and mortality (c) in 2013. Rates per 100 000 
population.  
  
Table 3. HIV/AIDS incidence and deaths for all ages by sex and combined and annualized rates of change 
(%), with 95% UI, for 21 GBD regions and 188 countries. 
  
Figure 10. Years of life saved (YLS) through ART, PMTCT, and co−trimoxazole prophylaxis by GBD region, 
1990−2003 (A), 2004−2008 (B), and 2009−2013 (c) 
  
Figure 11. Comparison of 43 national HIV prevalence survey results for age groups 15-49 to prevalence 
estimates from the GBD 2013 and UNAIDS for the same year and age-group.  Each point corresponds to 
an estimate for a particular country, survey year, sex, and five-year age group.  The solid line indicates 
the line of equivalence. 
  
Figure 12. Global tuberculosis incident cases (a), prevalent cases (b) and deaths (c) 1990-2013. WHO 
estimates shown for comparison. Both all forms and tuberculosis in HIV negatives are shown. 
  
Figure 13. Age-sex distribution of tuberculosis incident cases (a) and deaths (b) in HIV negatives in 2013. 
  
Table 4. Age-standardized tuberculosis without HIV incidence, prevalence, and mortality rates (per 100 
000) and annualized rates of change (%), with 95% UI, for 21 GBD regions. 
  
Table 5. Tuberculosis without HIV incidence and deaths for all ages by sex and combined and annualized 
rates of change (%), with 95% UI, for 188 countries. 
  
Figure 14. Age-standardized tuberculosis incidence (a) and death rates (b) in HIV negatives in 2013. 
Rates per 100 000 population. 
  
Figure 15. Global malaria cases (a) and deaths (b) with 95% uncertainty intervals. World Malaria Report 
2013 estimates shown for comparison. 
  
Figure 16. Age-sex distribution of malaria cases (a) and deaths (b) in 2013. 
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Table 6. Age-standardized malaria incidence, prevalence, and mortality rates (per 100 000) and 
annualized rates of change (%), with 95% UI, for 16 GBD regions. 
  
Figure 17. Age-standardized malaria incidence (a) and death (b) rates in 2013. Rates per 100 000 
population. 
  
Table 7. Malaria incidence and deaths for all ages by sex and combined and annualized rates of change 
(%), with 95% UI, for 103 countries. 
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Figure 3a − Raw, redistributed, and corrected HIV deaths in Thailand by age in 2005 for both sexes combined
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Figure 3b − Raw, redistributed, and corrected HIV deaths in Russia by age in 2005 for both sexes combined
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Figure 5. Bayesian meta-regression 
estimates for tuberculosis incidence, 
prevalence, remission, excess mortality, 
and cause-specific mortality for Kenya 
2013. For each observation in grey, the 
width of the bar refers to the age 
interval of the observation and the 
height the uncertainty interval. To 
stabilize estimates, all data from 
2008-2013 are included.
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Figure 6a. Meta-analysis of published validation studies of verbal autopsy for 
malaria in adults.
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Figure 6b. Meta-analysis of published validation studies of verbal autopsy for 
malaria in children.
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Figure 7a:
 Global incidence numbers of HIV 1990−2013, all ages and both sexes combined
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Figure 7b:
 Global prevalence numbers of HIV 1990−2013, all ages and both sexes combined
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Figure 7c:
 Global number of deaths due to HIV 1990−2013, all ages and both sexes combined
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Figure 8a − Global cases for HIV (with ART) by age and sex in 2013
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Figure 8b − Global deaths for HIV (with ART) by age and sex in 2013
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Figure 9a. Age−standardized HIV incidence in 2013.
Rates per 100 000 population.
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Figure 9b. Age−standardized HIV prevalence in 2013.
Rates per 100 000 population.
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Figure 9c. Age−standardized HIV death rates in 2013.
Rates per 100 000 population.
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Figure 10. Years of life saved (YLS) through ART, PMTCT, and co−trimoxazole 
prophylaxis by GBD region, 1990−2003 (A), 2004−2008 (B), and 2009−2013 (C)Confidential draft. Please do not cite or circulate.
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Figure 11. Comparison of 43 national HIV prevalence survey results for age groups 15-49 to prevalence estimates from the GBD 2013 and UNAIDS
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Figure 12a:
 Global tuberculosis incident cases 1990−2013. WHO estimates shown for comparison. 
Both all forms and tuberculosis in HIV negatives are shown.
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Figure 12b:
 Global tuberculosis prevalent cases 1990−2013. WHO estimates shown for comparison. 
Both all forms and tuberculosis in HIV negatives are shown.
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Figure 12c:
 Global tuberculosis deaths 1990−2013. WHO estimates shown for comparison. Both all forms and 
tuberculosis in HIV negatives are shown.
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Figure 13a − Global cases for tuberculosis (without HIV) by age and sex in 2013
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Figure 13b − Global deaths for tuberculosis (without HIV) by age and sex in 2013
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Figure 14a. Age−standardized tuberculosis incidence in HIV negatives in 2013.
Rates per 100 000 population
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Figure 14b. Age−standardized tuberculosis death rates in HIV negatives in 2013
Rates per 100 000 population
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Figure 15a:
 Global incidence numbers of malaria 1990−2013, all ages and both sexes combined
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Figure 15b:
 Global number of deaths due to malaria 1990−2013, all ages and both sexes combined
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Figure 16a − Global cases for malaria by age and sex in 2013
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Figure 16b − Global deaths for malaria by age and sex in 2013
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Figure 17a. Age−standardized malaria incidence rates in 2013.
Rates per 100 000 population
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Figure 17b. Age−standardized malaria death rates in 2013.
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(7·0-14·8)
4·4
(3·0-6·0)
2·0
(1·4-2·7)
14·0
(9·3-19·4)
5·7
(3·9-7·8)
2·6
(1·8-3·6)
350-499
8·1
(4·7-12·0)
3·1
(1·8-4·8)
1·4
(0·7-2·2)
10·5
(6·0-15·8)
4·1
(2·4-6·2)
1·8
(1·0-2·8)
500+
6·3
(0·9-11·0)
2·3
(0·1-4·4)
0·9
(0·0-2·0)
8·2
(1·2-14·7)
3·0
(0·1-5·7)
1·2
(0·0-2·6)
Table 1. HIV-specific  mortality rates for 25-34 year olds on ART in sub-Saharan Africa, by time since 
initiation, sex, and initial CD4 count  (per 100 person-years)
Female Male
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Incidence Prevalence Mortality Incidence Prevalence Mortality
Global
24·84
(23·10 to 28·26)
400·98
(385·51 to 435·10)
18·51
(17·38 to 20·46)
1·27
(0·24 to 2·16)
8·87
(8·36 to 9·52)
13·62
(11·93 to 15·38)
-3·92
(-4·50 to -3·15)
-0·20
(-0·42 to 0·05)
-1·54
(-2·36 to -0·59)
High-income Asia 
Pacific
0·49
(0·28 to 0·70)
7·22
(4·81 to 9·97)
0·10
(0·08 to 0·13)
7·74
(3·65 to 13·26)
6·94
(5·12 to 9·46)
0·77
(-1·11 to 2·92)
-1·55
(-5·91 to 1·57)
6·29
(4·49 to 8·22)
1·13
(-0·55 to 3·20)
Central Asia
7·02
(3·62 to 15·56)
61·98
(38·09 to 105·12)
2·67
(1·52 to 4·08)
8·17
(-3·90 to 19·78)
13·11
(1·09 to 24·09)
21·91
(9·43 to 33·39)
4·18
(-2·22 to 12·58)
5·46
(1·76 to 9·62)
2·65
(-2·01 to 5·83)
East Asia
2·28
(1·31 to 4·09)
26·37
(14·36 to 41·32)
0·77
(0·60 to 1·05)
38·86
(27·75 to 62·64)
41·29
(30·82 to 62·45)
45·26
(29·11 to 70·18)
1·41
(-3·60 to 6·83)
8·07
(4·79 to 11·46)
6·09
(2·91 to 10·38)
South Asia
2·69
(0·85 to 5·51)
93·97
(84·36 to 112·06)
5·42
(4·43 to 7·18)
-9·72
(-15·85 to -5·81)
3·91
(1·89 to 5·98)
13·67
(7·68 to 23·47)
-13·93
(-19·71 to -8·09)
-7·85
(-8·67 to -6·64)
-11·58
(-14·45 to -7·11)
Southeast Asia
13·88
(6·66 to 41·04)
176·39
(113·22 to 421·49)
7·54
(3·90 to 23·55)
-10·46
(-15·54 to -4·52)
8·07
(5·78 to 12·44)
29·51
(25·47 to 33·97)
1·29
(-2·74 to 7·36)
0·97
(-0·78 to 3·51)
-3·87
(-6·62 to 1·36)
Australasia
1·50
(0·81 to 2·32)
35·09
(22·80 to 50·24)
0·37
(0·26 to 0·53)
-7·07
(-11·53 to -3·51)
-1·86
(-3·67 to -0·18)
-11·88
(-14·40 to -9·10)
0·41
(-1·27 to 2·85)
1·07
(-0·53 to 2·49)
-4·51
(-6·49 to -2·60)
Caribbean
32·24
(25·95 to 39·68)
497·47
(450·24 to 551·29)
23·30
(19·26 to 29·15)
-6·32
(-8·01 to -4·81)
1·07
(-0·46 to 3·04)
9·02
(4·68 to 12·88)
-2·93
(-4·21 to -1·46)
-0·83
(-1·46 to -0·25)
-6·04
(-6·91 to -5·03)
Central Europe
0·95
(0·71 to 1·23)
16·62
(13·41 to 20·11)
0·44
(0·37 to 0·51)
1·29
(-1·78 to 4·40)
8·90
(6·61 to 11·36)
8·06
(6·44 to 10·09)
-0·55
(-3·44 to 2·08)
2·37
(1·20 to 3·44)
0·19
(-1·28 to 1·41)
Eastern Europe
22·58
(16·56 to 31·65)
263·86
(209·53 to 347·22)
11·14
(8·75 to 14·14)
25·17
(18·06 to 34·84)
18·47
(14·57 to 24·08)
13·07
(9·88 to 16·41)
-1·53
(-3·75 to 0·86)
4·75
(3·18 to 6·14)
8·51
(6·41 to 10·74)
Western Europe
3·26
(2·56 to 4·22)
80·97
(66·16 to 99·08)
1·06
(0·90 to 1·24)
-9·15
(-14·34 to -5·01)
0·92
(-0·14 to 2·04)
-6·75
(-8·06 to -5·34)
0·05
(-1·77 to 2·05)
0·60
(-0·21 to 1·62)
-3·59
(-4·72 to -2·25)
Andean Latin America
7·96
(4·64 to 16·84)
106·52
(76·06 to 171·80)
3·92
(2·40 to 9·39)
1·91
(-16·44 to 14·95)
11·70
(2·21 to 21·36)
19·73
(11·89 to 28·79)
-1·09
(-6·07 to 4·63)
1·15
(-1·96 to 4·60)
-3·52
(-6·58 to 0·62)
Central Latin America
9·43
(7·48 to 11·55)
139·92
(118·12 to 167·80)
4·08
(3·13 to 6·16)
-2·00
(-8·23 to 1·40)
7·04
(3·66 to 9·32)
13·13
(10·27 to 16·05)
-0·64
(-1·81 to 0·37)
0·99
(-1·33 to 2·31)
-5·46
(-7·10 to -3·86)
Southern Latin America
10·11
(7·11 to 14·94)
173·57
(144·31 to 210·86)
3·12
(2·23 to 4·10)
-0·75
(-4·84 to 3·85)
8·44
(5·39 to 12·40)
10·00
(6·17 to 13·76)
-0·24
(-3·40 to 3·08)
2·60
(1·08 to 3·97)
-2·76
(-5·37 to -0·65)
Tropical Latin America
11·64
(8·93 to 15·83)
188·35
(125·90 to 244·16)
4·83
(3·83 to 6·09)
-7·15
(-10·27 to -3·64)
2·20
(0·13 to 4·56)
1·09
(-2·41 to 6·19)
0·37
(-1·16 to 2·50)
1·10
(-0·25 to 2·23)
-2·20
(-4·57 to 0·01)
North Africa and 
Middle East
2·84
(1·93 to 4·93)
26·45
(21·31 to 39·26)
1·66
(1·26 to 2·39)
11·52
(0·35 to 25·42)
16·98
(7·18 to 30·42)
20·66
(9·81 to 35·43)
-0·35
(-4·01 to 5·02)
1·94
(-0·71 to 5·64)
3·05
(-0·99 to 7·85)
High-income North 
America
7·43
(3·46 to 17·16)
135·49
(78·21 to 220·57)
2·65
(1·68 to 3·69)
-8·87
(-13·56 to -3·10)
-3·31
(-6·16 to -1·52)
-10·20
(-13·49 to -7·99)
2·01
(-3·23 to 9·49)
1·24
(-1·09 to 4·97)
-2·89
(-5·95 to -0·10)
Oceania
16·09
(11·07 to 22·43)
341·52
(287·06 to 403·52)
18·80
(13·86 to 25·16)
15·64
(5·25 to 27·08)
23·43
(17·21 to 30·47)
31·68
(27·45 to 36·49)
-9·47
(-11·74 to -7·34)
0·30
(-2·04 to 3·13)
1·21
(-3·80 to 6·92)
Central Sub-Saharan 
Africa
94·53
(78·72 to 113·99)
1328·37
(1222·40 to 1439·78)
94·45
(81·17 to 111·04)
-0·25
(-1·66 to 0·93)
2·92
(1·96 to 3·97)
5·71
(3·57 to 8·17)
-3·89
(-5·15 to -2·60)
-1·43
(-2·09 to -0·78)
-2·42
(-3·47 to -1·14)
Eastern Sub-Saharan 
Africa
177·08
(163·51 to 191·29)
3416·89
(3249·05 to 3609·25)
164·58
(154·75 to 175·06)
-3·87
(-4·99 to -2·81)
5·92
(5·27 to 6·51)
14·50
(12·89 to 16·00)
-4·40
(-5·14 to -3·65)
-1·74
(-1·98 to -1·51)
-3·78
(-4·82 to -2·65)
Southern Sub-Saharan 
Africa
647·13
(606·40 to 693·70)
11 850·47
(11 368·38 to 12 327·29)
511·41
(467·65 to 556·63)
10·60
(9·80 to 11·47)
21·69
(21·08 to 22·58)
31·17
(28·62 to 33·63)
-4·58
(-5·16 to -4·00)
1·13
(0·90 to 1·35)
3·41
(1·54 to 4·88)
Western Sub-Saharan 
Africa
90·89
(77·20 to 107·09)
1833·57
(1692·97 to 1999·25)
114·36
(103·20 to 127·44)
5·79
(3·88 to 8·08)
13·12
(11·69 to 14·69)
18·75
(16·65 to 21·01)
-7·26
(-8·40 to -6·19)
-0·84
(-1·56 to -0·20)
0·82
(-0·38 to 2·01)
Annualized rate of change (%)
Age-standardized rates 
1990-2000 2000-2013
Table 2. Age-standardized HIV/AIDS incidence, prevalence, and mortality rates (per 100 000) and annualized rates of change (%), with 95% UI, for 21 GBD regions.
Location Incidence Prevalence Mortality
(per 100 000), 2013
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Incidence Deaths Incidence Deaths Incidence Deaths Incidence Deaths Incidence Deaths
924 776
(845 603 to 1 104 526)
723 124
(670 708 to 831 754)
922 869
(863 238 to 1 007 549)
617 850
(570 414 to 677 695)
1 847 645
(1 719 830 to 2 101 652)
1 340 974
(1 257 838 to 1 482 611)
1·27
(0·24 to 2·16)
13·62
(11·93 to 15·38)
-3·92
(-4·50 to -3·15)
-1·54
(-2·36 to -0·59)
74 405
(57 060 to 104 422)
35 884
(29 743 to 43 334)
20 947
(15 405 to 29 844)
8746
(6465 to 11 375)
95 352
(72 788 to 132 862)
44 630
(36 750 to 53 676)
1·53
(-1·30 to 4·82)
-5·46
(-7·13 to -4·17)
-0·35
(-2·27 to 2·45)
2·18
(0·76 to 3·83)
850 371
(777 712 to 1 030 189)
687 240
(636 836 to 792 586)
901 923
(842 259 to 987 825)
609 104
(562 000 to 668 733)
1 752 294
(1 631 535 to 2 014 476)
1 296 344
(1 214 834 to 1 435 882)
0·74
(-0·35 to 1·70)
15·07
(12·86 to 17·34)
-4·32
(-4·92 to -3·48)
-2·01
(-2·87 to -1·00)
590
(352 to 847)
149
(120 to 185)
268
(144 to 407)
58
(41 to 104)
857
(493 to 1228)
207
(164 to 270)
7·74
(3·65 to 13·26)
0·77
(-1·11 to 2·92)
-1·55
(-5·91 to 1·57)
1·13
(-0·55 to 3·20)
Brunei 43 (32 to 57)
32 
(27 to 40)
7 
(5 to 11)
2 
(1 to 4)
50 
(37 to 68)
35 
(29 to 44)
3·21 
(-10·55 to 12·48)
21·17 
(14·06 to 29·36)
0·02 
(-2·14 to 2·46)
-0·61 
(-2·49 to 1·95)
Japan 153 (86 to 230)
45 
(30 to 67)
55 
(31 to 82)
17 
(11 to 24)
208 
(120 to 308)
61 
(43 to 90)
3·28 
(-0·33 to 7·00)
-2·54 
(-4·84 to -0·11)
-0·54 
(-4·55 to 1·91)
-2·26 
(-4·86 to -0·13)
Singapore 52 (23 to 110)
16 
(9 to 30)
26 
(11 to 56)
7 
(4 to 12)
78 
(35 to 164)
23 
(14 to 42)
-13·07 
(-20·83 to -1·69)
12·38 
(5·24 to 20·14)
3·37 
(-4·69 to 11·26)
-4·29 
(-8·00 to -0·43)
South Korea 342 (118 to 591)
56 
(37 to 82)
179 
(62 to 308)
32 
(19 to 77)
522 
(184 to 874)
88 
(57 to 148)
15·87 
(9·91 to 26·23)
-3·51 
(-8·50 to 2·60)
-3·46 
(-10·76 to 0·83)
6·76 
(2·61 to 11·41)
4490
(2252 to 10 200)
1711
(965 to 2561)
1784
(913 to 3521)
497
(265 to 801)
6274
(3253 to 13 832)
2207
(1270 to 3346)
8·17
(-3·90 to 19·78)
21·91
(9·43 to 33·39)
4·18
(-2·22 to 12·58)
2·65
(-2·01 to 5·83)
Armenia 20 (9 to 42)
6 
(3 to 10)
5 
(2 to 10)
1 
(0 to 2)
25 
(11 to 51)
7 
(4 to 12)
87·64 
(54·77 to 144·28)
89·27 
(52·19 to 137·94)
-1·36 
(-10·11 to 4·10)
14·06 
(7·12 to 24·32)
Azerbaijan 315 (141 to 603)
161 
(45 to 320)
83 
(37 to 158)
32 
(9 to 78)
398 
(177 to 764)
193 
(53 to 395)
16·42 
(4·71 to 36·74)
22·22 
(7·00 to 33·51)
3·19 
(-3·81 to 8·73)
8·45 
(0·42 to 15·03)
Georgia 45 (22 to 74)
8 
(6 to 10)
23 
(11 to 38)
3 
(2 to 4)
68 
(34 to 110)
11 
(8 to 14)
34·85 
(24·05 to 45·34)
35·00 
(21·69 to 50·13)
8·01 
(3·08 to 13·16)
11·71 
(8·46 to 14·92)
Kazakhstan 2177 (510 to 7608)
899 
(212 to 1708)
633 
(141 to 2224)
173 
(30 to 429)
2810 
(647 to 9972)
1072 
(240 to 2118)
10·31 
(-26·44 to 45·69)
28·30 
(5·67 to 85·36)
5·73 
(-7·49 to 27·27)
3·14 
(-8·16 to 8·76)
Kyrgyzstan 683 (115 to 1720)
214 
(60 to 379)
195 
(33 to 511)
43 
(6 to 93)
878 
(151 to 2218)
257 
(68 to 469)
-2·16 
(-16·93 to 16·12)
25·71 
(12·31 to 38·25)
11·06 
(0·14 to 20·67)
3·14 
(-6·69 to 10·25)
Mongolia 4 (0 to 20)
1 
(0 to 4)
2 
(0 to 9)
0 
(0 to 1)
6 
(0 to 29)
1 
(0 to 6)
-27·80 
(-44·31 to -6·63)
0·06 
(-13·83 to 15·83)
30·42 
(1·12 to 52·69)
-7·87
(-22·36 to 9·43)
Tajikistan 391 (72 to 989)
108 
(18 to 247)
455 
(81 to 1139)
145 
(14 to 290)
846 
(154 to 2119)
253 
(33 to 537)
10·63 
(-23·93 to 51·46)
19·30 
(-4·33 to 63·17)
8·54 
(-3·57 to 23·08)
4·76 
(-10·22 to 17·68)
Turkmenistan 338 (76 to 1209)
114 
(49 to 213)
128 
(28 to 461)
34 
(15 to 65)
466 
(103 to 1667)
148 
(65 to 272)
5·29 
(-29·36 to 34·92)
21·57 
(-2·08 to 68·63)
6·55 
(-5·74 to 27·61)
3·16 
(-3·99 to 7·62)
Uzbekistan 518 (297 to 789)
200 
(115 to 348)
259 
(152 to 403)
66 
(36 to 130)
777 
(458 to 1188)
266 
(156 to 466)
11·31 
(-0·46 to 23·84)
31·77 
(21·98 to 41·37)
-3·01 
(-7·00 to 0·37)
-3·85 
(-8·97 to 0·63)
25 342
(14 456 to 45 002)
9317
(7316 to 12 472)
10 968
(6165 to 19 647)
3259
(2213 to 4653)
36 310
(20 768 to 64 990)
12 575
(9827 to 17 026)
38·86
(27·75 to 62·64)
45·26
(29·11 to 70·18)
1·41
(-3·60 to 6·83)
6·09
(2·91 to 10·38)
China 24 843(13 863 to 44 316)
8988
(7010 to 12 114)
10 822
(6058 to 19 487)
3157
(2118 to 4554)
35 665
(20 128 to 64 616)
12 145
(9418 to 16 555)
38·58
(27·80 to 49·41)
45·85
(28·95 to 79·48)
1·47
(-3·62 to 7·00)
5·99
(2·76 to 10·39)
North Korea 189 (56 to 380)
152 
(118 to 194)
91 
(29 to 185)
75 
(56 to 98)
280 
(83 to 565)
227 
(179 to 287)
21·59 
(12·20 to 37·57)
33·79 
(21·86 to 53·69)
-1·88 
(-12·11 to 4·93)
8·90 
(6·28 to 12·71)
Taiwan (Province of China) 309 (113 to 743)
176 
(129 to 246)
55 
(20 to 130)
26 
(18 to 39)
365 
(135 to 873)
203 
(148 to 283)
28·85 
(16·22 to 48·47)
35·27 
(20·08 to 55·54)
-1·66 
(-12·16 to 13·51)
10·02 
(6·43 to 15·42)
East Asia
Worldwide
Central Asia
Developed countries
Developing countries
High-income Asia Pacific
Table 3. HIV/AIDS incidence and deaths for all ages by sex and combined and annualized rates of change (%), with 95% UI, for 21 GBD regions and 188 countries.
All ages incidence and deaths, 2013 Annualized rate of change (%)
Male Female Total 1990-2000 2000-2013
Location
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28 607
(9 436 to 63 683)
52 794
(41 230 to 70 403)
17 265
(5343 to 30 460)
30 592
(20 739 to 41 289)
45 872
(14 702 to 93 994)
83 387
(68 991 to 106 495)
-9·72
(-15·85 to -5·81)
13·67
(7·68 to 23·47)
-13·93
(-19·71 to -8·09)
-11·58
(-14·45 to -7·11)
Afghanistan 325 (40 to 1346)
117 
(11 to 597)
127 
(15 to 541)
47 
(4 to 215)
452 
(55 to 1897)
163 
(16 to 824)
2·20 
(-19·25 to 18·88)
8·71 
(-3·05 to 28·80)
5·71 
(-2·95 to 16·86)
2·16 
(-5·67 to 9·65)
Bangladesh 710 (459 to 1212)
390 
(303 to 505)
431 
(272 to 713)
181 
(109 to 273)
1141 
(754 to 1885)
571 
(441 to 753)
12·62 
(-20·78 to 41·01)
59·57 
(36·71 to 81·23)
1·68 
(-2·46 to 6·44)
1·87 
(-1·75 to 6·80)
Bhutan 36 (5 to 168)
20 
(3 to 94)
43 
(6 to 197)
20 
(2 to 101)
79 
(11 to 368)
40 
(5 to 199)
8·81 
(-8·17 to 21·25)
18·88 
(6·58 to 30·69)
2·90 
(-3·96 to 13·81)
5·11 
(-1·62 to 11·75)
India 18 408(2247 to 23 936)
49 345
(38 882 to 63 680)
12 649
(1845 to 16 944)
29 318
(20 048 to 38 653)
31 057
(4091 to 39 459)
78 662
(66 197 to 96 173)
-9·78
(-15·95 to -5·85)
13·72
(7·78 to 23·46)
-16·29
(-27·75 to -11·94)
-11·84
(-14·55 to -7·73)
Nepal 710 (96 to 2864)
1202 
(103 to 6065)
372 
(51 to 1512)
326 
(23 to 2170)
1082 
(151 to 4424)
1527 
(130 to 8087)
36·93 
(13·55 to 63·73)
30·17 
(14·86 to 46·41)
-12·91 
(-20·16 to -1·74)
2·47 
(-4·47 to 8·63)
Pakistan 8418 (1124 to 39 250)
1721 
(140 to 7984)
3643 
(497 to 15 460)
701 
(49 to 3405)
12 061 
(1617 to 54 744)
2422 
(191 to 11 133)
11·79 
(-6·98 to 25·04)
14·11 
(4·32 to 25·39)
15·09 
(6·58 to 26·35)
11·47 
(3·15 to 19·37)
65 708
(32 957 to 184 964)
38 199
(20 695 to 113 552)
26 753
(10 929 to 87 732)
10 141
(4248 to 36 852)
92 460
(44 216 to 273 917)
48 340
(24 900 to 150 426)
-10·46
(-15·54 to -4·52)
29·51
(25·47 to 33·97)
1·29
(-2·74 to 7·36)
-3·87
(-6·62 to 1·36)
Cambodia 904 (137 to 4475)
1073 
(125 to 6154)
490 
(71 to 2349)
330 
(40 to 1330)
1394 
(208 to 6873)
1403 
(168 to 7430)
-7·21 
(-25·86 to 7·49)
34·36 
(19·14 to 48·40)
-7·75 
(-15·10 to 3·78)
-11·46 
(-15·95 to -5·90)
Indonesia 29 204 (3669 to 127 307)
9846 
(666 to 48 942)
15 954 
(2027 to 70 429)
4601 
(227 to 24 839)
45 159 
(5646 to 194 375)
14 446 
(912 to 72 555)
0·00 
(0·00 to 0·00)
0·00 
(0·00 to 0·00)
28·07 
(13·66 to 46·43)
87·51 
(52·11 to 113·93)
Laos 576 (83 to 2427)
239 
(25 to 1388)
242 
(34 to 1061)
80 
(7 to 501)
818 
(120 to 3481)
320 
(32 to 1862)
13·35 
(-5·81 to 27·67)
19·67 
(7·19 to 35·71)
-0·18 
(-7·62 to 10·96)
1·11 
(-5·62 to 8·15)
Malaysia 3070 (2313 to 4137)
1994 
(1680 to 2469)
469 
(325 to 674)
131 
(74 to 226)
3539 
(2655 to 4799)
2125 
(1774 to 2652)
3·67 
(-10·07 to 12·94)
21·63 
(14·52 to 29·80)
-0·25 
(-2·43 to 2·20)
-0·65 
(-2·52 to 1·91)
Maldives 0 (0 to 0)
0 
(0 to 0)
0 
(0 to 0)
0 
(0 to 0)
0 
(0 to 0)
0 
(0 to 0)
-9·47 
(-14·88 to -4·94)
14·92 
(10·85 to 17·60)
-8·71 
(-17·42 to -1·64)
-6·22 
(-11·69 to -2·61)
Myanmar 3215 (422 to 18 254)
5831 
(635 to 31 666)
924 
(119 to 5048)
920 
(103 to 5732)
4139 
(557 to 23 177)
6751 
(743 to 38 390)
9·78 
(-8·01 to 23·04)
45·14 
(31·23 to 54·70)
-15·43 
(-24·74 to -3·19)
-6·13 
(-11·88 to 1·03)
Philippines 6590 (3411 to 11 564)
3607 
(2424 to 4613)
2670 
(1362 to 4666)
1466 
(967 to 1924)
9260 
(4907 to 16 077)
5073 
(3423 to 6397)
2·00 
(-15·41 to 13·40)
23·37 
(11·46 to 36·25)
2·32 
(-2·51 to 8·42)
1·04 
(-2·36 to 2·86)
Sri Lanka 84 (52 to 135)
43 
(32 to 57)
49 
(31 to 79)
20 
(12 to 29)
133 
(82 to 211)
63 
(46 to 83)
11·34 
(4·50 to 16·40)
29·55 
(26·10 to 32·38)
-0·15 
(-3·60 to 3·65)
1·04 
(-2·02 to 3·54)
Thailand 8657 (4349 to 13 097)
9421 
(5777 to 15 345)
3879 
(1907 to 5996)
2173 
(1354 to 3324)
12 536 
(6320 to 18 644)
11 595 
(7310 to 18 164)
-27·50 
(-43·89 to -17·76)
29·04 
(24·91 to 32·94)
3·21 
(-7·02 to 15·57)
-9·64 
(-13·16 to -5·95)
Timor-Leste 9 (4 to 35)
3 
(2 to 6)
5 
(2 to 19)
2 
(1 to 3)
13 
(7 to 54)
5 
(4 to 9)
30·46 
(16·69 to 49·60)
39·58 
(17·00 to 61·09)
-1·90 
(-7·73 to 11·22)
10·23 
(4·43 to 50·18)
Vietnam 13 311 (6001 to 22 013)
6087 
(4485 to 8580)
2035 
(914 to 3405)
404 
(271 to 603)
15 346 
(7019 to 25 391)
6492 
(4817 to 9107)
26·87 
(15·01 to 36·30)
34·21 
(25·75 to 44·35)
-2·57 
(-9·79 to 2·24)
6·69 
(3·36 to 11·31)
392
(211 to 608)
105
(70 to 157)
51
(27 to 79)
15
(10 to 23)
444
(240 to 689)
120
(82 to 174)
-7·07
(-11·53 to -3·51)
-11·88
(-14·40 to -9·10)
0·41
(-1·27 to 2·85)
-4·51
(-6·49 to -2·60)
Australia 358 (181 to 576)
94 
(60 to 146)
45 
(22 to 72)
13 
(7 to 20)
403 
(203 to 645)
107 
(70 to 160)
-7·60
(-12·57 to -3·82)
-11·94 
(-14·74 to -8·91)
0·29 
(-1·59 to 2·88)
-4·61 
(-6·80 to -2·48)
New Zealand 34 (19 to 61)
10 
(7 to 15)
7 
(3 to 12)
2 
(1 to 4)
41 
(22 to 73)
13 
(8 to 18)
-0·07 
(-4·38 to 5·45)
-11·22 
(-13·58 to -9·33)
0·95 
(-3·48 to 7·30)
-3·80 
(-6·68 to -1·05)
7561
(6045 to 9227)
5654
(4692 to 7082)
6961
(5436 to 8854)
4805
(3661 to 6350)
14 521
(11 695 to 17 898)
10 459
(8670 to 13 050)
-6·32
(-8·01 to -4·81)
9·02
(4·68 to 12·88)
-2·93
(-4·21 to -1·46)
-6·04
(-6·91 to -5·03)
Antigua and Barbuda 9 (4 to 21)
7 
(5 to 9)
4 
(2 to 9)
3 
(2 to 4)
13 
(6 to 29)
10 
(8 to 12)
-5·71 
(-13·65 to 4·72)
15·77 
(9·28 to 27·19)
-2·30 
(-8·08 to 6·04)
-4·62 
(-7·05 to -2·67)
Barbados 49 (33 to 76)
21 
(14 to 33)
21 
(14 to 33)
6 
(4 to 9)
69 
(48 to 108)
27 
(19 to 40)
-2·18 
(-6·56 to 1·26)
13·21 
(11·66 to 14·86)
-0·14 
(-2·54 to 3·38)
-7·07 
(-9·61 to -4·41)
South Asia
Southeast Asia
Australasia
Caribbean
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Belize 73 (38 to 115)
37 
(24 to 50)
45 
(23 to 72)
12 
(7 to 17)
118 
(63 to 188)
49 
(32 to 65)
15·27 
(5·16 to 27·29)
35·46 
(29·57 to 42·53)
-5·02 
(-10·63 to -0·61)
-2·45 
(-6·17 to 0·55)
Cuba 698 (446 to 1003)
186 
(146 to 239)
217 
(136 to 321)
35 
(25 to 50)
916 
(585 to 1309)
221 
(175 to 284)
8·96 
(3·54 to 12·14)
10·21 
(7·74 to 12·60)
3·26 
(0·73 to 6·30)
-1·61 
(-3·64 to 1·33)
Dominica 5 (2 to 15)
4 
(2 to 6)
3 
(1 to 8)
2 
(1 to 3)
7 
(2 to 23)
5 
(4 to 9)
-8·82 
(-28·52 to 0·28)
10·81 
(3·49 to 21·57)
-1·49 
(-9·18 to 13·52)
-5·87 
(-9·11 to -1·67)
Dominican Republic 1089 (417 to 1746)
445 
(306 to 621)
693 
(264 to 1139)
206 
(139 to 292)
1783 
(699 to 2830)
650 
(459 to 893)
0·57 
(-8·57 to 4·79)
19·83 
(16·78 to 23·02)
-3·22 
(-9·66 to -0·13)
-7·69 
(-10·58 to -5·15)
Grenada 18 (8 to 55)
11 
(9 to 13)
10 
(4 to 31)
5 
(4 to 6)
28 
(13 to 87)
16 
(13 to 19)
-2·69 
(-12·50 to 30·67)
15·29 
(9·87 to 25·13)
-3·02 
(-8·75 to 7·03)
-4·70 
(-6·66 to -3·09)
Guyana 421 (318 to 536)
253 
(171 to 326)
290 
(215 to 377)
92 
(48 to 145)
710 
(549 to 887)
345 
(230 to 443)
4·20 
(-7·06 to 14·46)
25·23 
(17·37 to 34·21)
0·09 
(-1·40 to 2·16)
-2·18 
(-5·58 to 0·21)
Haiti 3339 (2437 to 4692)
3458 
(2648 to 4714)
4299 
(3138 to 5784)
3655 
(2678 to 5042)
7638 
(5740 to 10 244)
7113 
(5556 to 9397)
-8·98 
(-11·68 to -6·91)
7·96 
(3·38 to 12·22)
-5·08 
(-6·73 to -2·93)
-6·95 
(-8·04 to -5·47)
Jamaica 366 (269 to 534)
171 
(133 to 226)
192 
(139 to 287)
57 
(41 to 79)
557 
(418 to 809)
229 
(179 to 296)
-10·26 
(-19·24 to -0·14)
19·83 
(13·08 to 25·24)
-0·76 
(-3·64 to 1·53)
-8·96 
(-11·10 to -6·63)
Saint Lucia 21 (9 to 48)
15 
(12 to 18)
12 
(5 to 27)
7 
(5 to 8)
32 
(14 to 76)
21 
(18 to 25)
-1·48 
(-14·23 to 34·47)
15·22 
(9·92 to 24·76)
-2·63 
(-8·23 to 5·86)
-4·62 
(-6·44 to -3·15)
Saint Vincent and the 
Grenadines
19 
(9 to 56)
13 
(10 to 17)
10 
(5 to 29)
5 
(4 to 7)
28 
(14 to 86)
19 
(15 to 23)
-5·21 
(-16·74 to 16·48)
19·54 
(13·36 to 35·02)
-2·00 
(-7·38 to 9·74)
-4·69 
(-6·83 to -2·79)
Suriname 146 (100 to 204)
77 
(52 to 114)
88 
(59 to 125)
28 
(19 to 42)
234 
(161 to 328)
105 
(75 to 149)
2·59 
(-7·99 to 13·67)
24·68 
(15·58 to 35·47)
-0·68 
(-3·39 to 2·37)
-3·81 
(-6·79 to -0·44)
The Bahamas 104 (79 to 146)
70 
(50 to 92)
59 
(44 to 86)
21 
(14 to 30)
163 
(127 to 229)
90 
(66 to 118)
-9·21 
(-12·37 to -6·27)
10·55 
(8·71 to 12·38)
0·14 
(-2·17 to 3·37)
-6·98 
(-9·45 to -4·59)
Trinidad and Tobago 317 (201 to 489)
188 
(87 to 319)
181 
(109 to 282)
49 
(27 to 92)
498 
(317 to 758)
237 
(119 to 397)
-3·82 
(-6·88 to -1·48)
12·26 
(8·66 to 19·34)
1·31 
(-1·96 to 4·59)
-3·91 
(-8·63 to 0·08)
901
(665 to 1166)
497
(419 to 574)
332
(248 to 426)
123
(99 to 150)
1232
(923 to 1593)
620
(524 to 719)
1·29
(-1·78 to 4·40)
8·06
(6·44 to 10·09)
-0·55
(-3·44 to 2·08)
0·19
(-1·28 to 1·41)
Albania 2 (0 to 4)
1 
(1 to 2)
1 
(0 to 2)
0 
(0 to 1)
3 
(0 to 6)
2 
(1 to 2)
-0·43 
(-21·75 to 16·57)
16·85 
(5·51 to 30·86)
1·19 
(-11·91 to 15·03)
0·29 
(-5·18 to 3·74)
Bosnia and Herzegovina 1 (0 to 3)
0 
(0 to 1)
1 
(0 to 3)
0 
(0 to 0)
2 
(1 to 6)
1 
(1 to 1)
23·41 
(-8·35 to 41·70)
27·08 
(13·51 to 48·89)
2·76 
(-7·44 to 28·85)
13·71 
(9·82 to 18·06)
Bulgaria 179 (99 to 330)
105 
(61 to 157)
41 
(22 to 77)
19 
(7 to 34)
221 
(122 to 400)
124 
(71 to 188)
7·77 
(3·42 to 14·35)
9·07 
(4·50 to 16·42)
3·82 
(0·03 to 8·92)
5·22 
(1·32 to 8·36)
Croatia 21 (12 to 35)
9 
(6 to 13)
10 
(5 to 17)
3 
(2 to 5)
31 
(18 to 53)
12 
(8 to 17)
2·54 
(-2·09 to 6·66)
7·78 
(4·26 to 11·34)
0·91 
(-3·20 to 5·10)
1·47 
(-1·15 to 3·93)
Czech Republic 25 (9 to 43)
12 
(9 to 16)
10 
(4 to 19)
3 
(2 to 5)
35 
(13 to 62)
16 
(12 to 20)
17·51 
(12·02 to 21·32)
12·23 
(7·65 to 16·94)
-5·74 
(-13·40 to -1·53)
3·86 
(1·07 to 6·74)
Hungary 35 (1 to 73)
43 
(33 to 56)
8 
(0 to 18)
8 
(5 to 11)
43 
(2 to 90)
51 
(39 to 66)
1·04 
(-1·27 to 4·30)
-3·52 
(-5·69 to -0·65)
-7·63 
(-29·64 to 0·40)
-5·44 
(-7·02 to -3·66)
Macedonia 2 (0 to 3)
1 
(1 to 2)
1 
(0 to 2)
1 
(0 to 1)
3 
(1 to 6)
2 
(1 to 3)
8·80 
(-6·31 to 18·34)
14·07 
(3·70 to 25·04)
-1·38 
(-10·27 to 6·27)
2·47 
(-1·54 to 6·00)
Montenegro 1 (0 to 2)
1 
(0 to 1)
1 
(0 to 1)
0 
(0 to 1)
1 
(0 to 4)
1 
(1 to 2)
-7·56 
(-30·37 to 5·80)
13·19 
(3·02 to 22·95)
1·33 
(-14·79 to 19·86)
-1·24 
(-7·99 to 3·21)
Poland 359 (166 to 555)
189 
(147 to 236)
110 
(49 to 178)
37 
(26 to 52)
469 
(217 to 728)
226 
(177 to 281)
-1·31 
(-7·24 to 3·30)
20·93 
(15·87 to 27·41)
-1·80 
(-8·76 to 2·35)
1·00 
(-1·25 to 3·10)
Romania 180 (97 to 277)
101 
(69 to 139)
117 
(63 to 185)
42 
(29 to 62)
298 
(162 to 453)
143 
(99 to 194)
4·19 
(-3·96 to 13·76)
21·05 
(15·17 to 35·98)
-1·83 
(-7·61 to 3·00)
-0·70 
(-4·26 to 2·20)
Serbia 73 (31 to 132)
28 
(14 to 52)
24 
(10 to 45)
7 
(3 to 17)
97 
(41 to 177)
35 
(17 to 67)
-11·33 
(-20·97 to -0·67)
4·62 
(1·63 to 7·84)
10·23 
(2·52 to 19·43)
-3·11 
(-8·73 to 2·27)
Central Europe
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Slovakia 12 (6 to 24)
4 
(2 to 5)
5 
(2 to 9)
1 
(1 to 1)
17 
(8 to 33)
5 
(3 to 6)
6·92 
(1·24 to 12·86)
17·06 
(12·39 to 24·48)
3·51 
(-1·36 to 8·87)
3·04 
(-0·55 to 5·98)
Slovenia 12 (2 to 30)
3 
(1 to 6)
2 
(0 to 5)
0 
(0 to 1)
14 
(2 to 35)
3 
(1 to 6)
-6·64 
(-13·05 to 10·19)
-1·26 
(-7·91 to 8·38)
11·29 
(-0·09 to 20·62)
1·76 
(-4·88 to 6·93)
41 070
(30 301 to 58 405)
22 838
(18 002 to 28 949)
11 207
(7772 to 15 653)
4823
(3063 to 7241)
52 277
(38 281 to 73 913)
27 662
(21 651 to 35 479)
25·17
(18·06 to 34·84)
13·07
(9·88 to 16·41)
-1·53
(-3·75 to 0·86)
8·51
(6·41 to 10·74)
Belarus 573 (362 to 820)
379 
(244 to 531)
127 
(77 to 190)
35 
(23 to 50)
699 
(439 to 1013)
413 
(277 to 571)
29·51 
(16·04 to 51·15)
42·29 
(28·40 to 98·54)
0·09 
(-3·53 to 3·25)
9·91 
(5·90 to 12·80)
Estonia 77 (44 to 111)
26 
(21 to 36)
20 
(12 to 29)
5 
(3 to 7)
97 
(55 to 139)
31 
(24 to 42)
50·08 
(34·32 to 73·58)
57·11 
(44·12 to 89·50)
-2·04 
(-7·16 to 0·54)
11·41 
(7·09 to 16·50)
Latvia 134 (75 to 226)
69 
(47 to 98)
115 
(69 to 189)
73 
(53 to 100)
249 
(148 to 408)
142 
(108 to 189)
16·45 
(10·92 to 22·03)
13·96 
(8·23 to 19·03)
1·42 
(-3·52 to 6·38)
9·21 
(6·44 to 11·94)
Lithuania 48 (26 to 88)
38 
(24 to 55)
85 
(46 to 160)
77 
(52 to 108)
133 
(74 to 243)
116 
(77 to 157)
3·04 
(-0·95 to 7·72)
9·24 
(6·12 to 13·00)
0·92 
(-3·70 to 6·42)
2·14 
(-0·56 to 4·26)
Moldova 444 (270 to 674)
233 
(139 to 321)
104 
(62 to 161)
31 
(20 to 46)
548 
(336 to 827)
264 
(162 to 359)
13·94 
(6·78 to 24·00)
12·03 
(7·78 to 19·63)
4·17 
(-0·57 to 8·83)
4·08 
(0·20 to 7·96)
Russia 30 851 (22 352 to 46 994)
14 423 
(10 797 to 19 740)
6672 
(4431 to 10 667)
1715 
(903 to 3196)
37 523 
(27 617 to 57 331)
16 138 
(11 963 to 22 526)
25·22 
(15·86 to 50·69)
9·60 
(6·86 to 13·39)
0·70 
(-1·22 to 3·57)
8·66 
(5·96 to 11·53)
Ukraine 8943 (4013 to 14 168)
7670 
(5455 to 10 529)
4084 
(1803 to 6534)
2889 
(1515 to 4597)
13 027 
(5869 to 20 307)
10 558 
(7415 to 14 758)
30·36 
(16·36 to 72·39)
32·65 
(11·72 to 119·99)
-6·10 
(-12·25 to -2·28)
8·50 
(5·63 to 11·93)
11 225
(8795 to 14 694)
4336
(3542 to 5326)
2896
(2225 to 3750)
1168
(948 to 1457)
14 122
(11 057 to 18 340)
5504
(4591 to 6583)
-9·15
(-14·34 to -5·01)
-6·75
(-8·06 to -5·34)
0·05
(-1·77 to 2·05)
-3·59
(-4·72 to -2·25)
Andorra 18 (4 to 40)
5 
(2 to 7)
4 
(1 to 9)
1 
(0 to 2)
22 
(5 to 48)
6 
(3 to 8)
3·38 
(-24·91 to 15·91)
2·70 
(-5·28 to 20·32)
0·56 
(-7·50 to 13·32)
-1·09 
(-6·77 to 4·30)
Austria 439 (111 to 1114)
58 
(25 to 105)
108 
(28 to 281)
15 
(7 to 29)
547 
(142 to 1378)
73 
(32 to 129)
2·62 
(-1·67 to 10·93)
-4·20 
(-8·86 to 1·90)
7·82 
(0·38 to 15·57)
5·51 
(0·00 to 10·23)
Belgium 155 (66 to 283)
41 
(25 to 66)
64 
(28 to 116)
18 
(11 to 32)
219 
(93 to 392)
59 
(39 to 86)
-2·70 
(-10·42 to 3·11)
3·37 
(0·16 to 6·76)
-0·80 
(-6·58 to 4·69)
-1·48 
(-4·16 to 1·11)
Cyprus 3 (1 to 6)
1 
(0 to 1)
2 
(1 to 3)
0 
(0 to 1)
4 
(2 to 9)
1 
(1 to 2)
19·87 
(-13·23 to 34·14)
26·48 
(16·01 to 41·70)
-1·36 
(-11·44 to 24·06)
3·17 
(-0·67 to 8·77)
Denmark 202 (87 to 433)
28 
(15 to 44)
40 
(17 to 87)
6 
(3 to 9)
242 
(105 to 518)
34 
(19 to 52)
-5·46 
(-10·62 to 0·51)
-11·24 
(-15·04 to -7·09)
4·04 
(-1·37 to 12·18)
-1·13 
(-4·49 to 3·19)
Finland 20 (10 to 37)
6 
(4 to 8)
5 
(2 to 10)
2 
(1 to 2)
25 
(12 to 46)
7 
(5 to 10)
-0·56 
(-5·45 to 3·94)
0·82 
(-1·64 to 3·99)
0·46 
(-4·77 to 5·57)
-2·06 
(-4·73 to -0·10)
France 1816 (840 to 3599)
839 
(486 to 1335)
503 
(223 to 999)
229 
(139 to 366)
2319 
(1076 to 4501)
1068 
(658 to 1636)
-3·96 
(-8·52 to 6·36)
-12·37 
(-15·59 to -8·23)
-0·43 
(-4·61 to 5·10)
-2·80 
(-5·51 to 0·66)
Germany 1401 (827 to 2299)
435 
(285 to 623)
306 
(172 to 523)
99 
(62 to 150)
1707 
(1023 to 2796)
535 
(354 to 752)
-2·80 
(-5·95 to 2·02)
-10·02 
(-12·93 to -6·57)
2·24 
(0·02 to 5·13)
-3·15 
(-4·75 to -1·14)
Greece 39 (22 to 54)
10 
(7 to 15)
13 
(7 to 18)
3 
(2 to 5)
51 
(30 to 71)
14 
(9 to 20)
3·56 
(0·73 to 9·42)
-11·52 
(-15·44 to -6·10)
-1·99 
(-6·00 to 0·18)
-2·49 
(-5·44 to 0·06)
Iceland 1 (0 to 1)
0 
(0 to 0)
0 
(0 to 0)
0 
(0 to 0)
1 
(0 to 2)
0 
(0 to 0)
-0·85 
(-6·56 to 4·83)
-1·07 
(-4·21 to 2·38)
-0·31 
(-6·77 to 7·62)
-3·09 
(-6·63 to 0·48)
Ireland 40 (18 to 73)
12 
(8 to 18)
18 
(8 to 32)
6 
(4 to 9)
57 
(26 to 105)
17 
(12 to 25)
0·83 
(-7·24 to 6·66)
4·51 
(0·68 to 9·85)
-2·78 
(-9·97 to 3·14)
-3·64 
(-6·79 to -0·86)
Israel 52 (25 to 94)
13 
(9 to 20)
58 
(28 to 106)
14 
(10 to 20)
110 
(52 to 193)
27 
(20 to 36)
-3·86 
(-10·49 to 2·30)
6·06 
(3·40 to 8·34)
-0·89 
(-7·21 to 3·44)
-2·94 
(-5·17 to -0·78)
Italy 2328 (1269 to 3636)
775 
(492 to 1290)
646 
(346 to 1042)
242 
(144 to 407)
2974 
(1631 to 4601)
1017 
(651 to 1549)
-16·06 
(-27·75 to -4·02)
-8·82 
(-12·23 to -5·51)
1·90 
(-0·40 to 6·14)
-3·07 
(-5·22 to -0·46)
Luxembourg 1 (1 to 2)
0 
(0 to 1)
1 
(1 to 2)
0 
(0 to 1)
2 
(1 to 4)
1 
(1 to 1)
3·47 
(-5·21 to 13·05)
27·76 
(19·37 to 41·86)
-2·35 
(-8·82 to 2·40)
-2·39 
(-6·22 to 0·92)
Eastern Europe
Western Europe
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Malta 1 (0 to 2)
0 
(0 to 1)
0 
(0 to 1)
0 
(0 to 0)
1 
(1 to 3)
0 
(0 to 1)
-17·62 
(-23·63 to -11·72)
0·34 
(-3·00 to 4·44)
4·19 
(-2·47 to 12·25)
-5·36 
(-9·13 to -1·84)
Netherlands 236 (106 to 456)
73 
(40 to 125)
51 
(22 to 99)
17 
(9 to 30)
287 
(128 to 552)
91 
(52 to 147)
-12·47 
(-19·81 to -5·75)
-3·00 
(-6·29 to -0·13)
0·76 
(-5·61 to 6·65)
-4·36 
(-7·46 to -1·54)
Norway 26 (12 to 45)
8 
(5 to 14)
23 
(11 to 41)
7 
(4 to 12)
49 
(23 to 84)
15 
(10 to 23)
-4·16 
(-13·90 to 1·95)
1·34 
(-1·81 to 6·43)
-1·95 
(-8·14 to 2·80)
-3·79 
(-7·12 to -1·07)
Portugal 1978 (906 to 3669)
679 
(436 to 944)
394 
(184 to 752)
146 
(85 to 234)
2371 
(1102 to 4392)
825 
(574 to 1109)
-0·31 
(-7·39 to 5·92)
12·07 
(6·83 to 18·41)
-1·18 
(-7·84 to 4·58)
-3·32 
(-5·86 to -0·67)
Spain 1811 (1180 to 2780)
1075 
(627 to 1618)
408 
(254 to 639)
252 
(140 to 416)
2219 
(1454 to 3387)
1327 
(792 to 1976)
-15·24 
(-19·37 to -10·81)
-5·11 
(-7·45 to -2·22)
-1·34 
(-4·32 to 0·83)
-6·66 
(-9·66 to -4·50)
Sweden 46 (20 to 82)
15 
(9 to 24)
15 
(6 to 26)
5 
(3 to 9)
61 
(26 to 108)
20 
(13 to 30)
-9·91 
(-18·59 to -2·93)
-1·05 
(-3·98 to 1·43)
-2·54 
(-8·88 to 1·44)
-5·28 
(-8·03 to -2·79)
Switzerland 251 (85 to 539)
79 
(43 to 131)
111 
(39 to 241)
36 
(20 to 59)
362 
(124 to 782)
115 
(69 to 175)
-19·00 
(-24·99 to -8·36)
-6·25 
(-9·63 to -2·61)
6·82 
(0·92 to 12·82)
-3·43 
(-6·63 to -0·05)
United Kingdom 349(24 to 964)
178
(119 to 255)
125
(9 to 342)
68
(43 to 104)
474
(33 to 1316)
246
(168 to 333)
0·83
(-5·08 to 7·15)
-4·45
(-7·40 to -1·00)
-8·49
(-27·01 to -0·11)
-1·57
(-4·46 to 0·53)
3316
(1938 to 7058)
1588
(987 to 3617)
1225
(683 to 2571)
465
(240 to 1304)
4541
(2649 to 9597)
2053
(1258 to 4917)
1·91
(-16·44 to 14·95)
19·73
(11·89 to 28·79)
-1·09
(-6·07 to 4·63)
-3·52
(-6·58 to 0·62)
Bolivia 396 (13 to 1969)
446 
(46 to 2345)
181 
(5 to 845)
171 
(12 to 1043)
577 
(18 to 2770)
617 
(59 to 3398)
21·87 
(-12·59 to 47·06)
46·78 
(11·24 to 77·78)
-11·15 
(-29·50 to 2·73)
-1·91 
(-11·59 to 8·44)
Ecuador 1711 (997 to 3749)
687 
(495 to 1081)
607 
(350 to 1341)
193 
(114 to 330)
2318 
(1378 to 5097)
880 
(645 to 1409)
8·55 
(-4·91 to 19·31)
18·12 
(11·55 to 27·83)
0·17 
(-3·88 to 7·10)
1·89 
(-1·82 to 8·67)
Peru 1209 (503 to 3735)
455 
(287 to 790)
437 
(182 to 1330)
101 
(64 to 178)
1646 
(695 to 5100)
556 
(357 to 960)
-4·68 
(-29·03 to 15·07)
18·81 
(9·18 to 30·45)
0·23 
(-4·84 to 10·22)
-8·83 
(-12·74 to -3·34)
17 775
(14 156 to 21 628)
7555
(6042 to 9924)
5706
(4418 to 7440)
1965
(1207 to 4529)
23 480
(18 630 to 28 703)
9521
(7325 to 14 456)
-2·00
(-8·23 to 1·40)
13·13
(10·27 to 16·05)
-0·64
(-1·81 to 0·37)
-5·46
(-7·10 to -3·86)
Colombia 4464 (2799 to 6030)
1712 
(1294 to 2358)
1188 
(754 to 1645)
321 
(219 to 482)
5651 
(3627 to 7520)
2033 
(1553 to 2791)
7·92 
(-4·88 to 15·09)
29·60 
(23·63 to 34·51)
-0·44 
(-2·72 to 2·70)
-2·88 
(-5·92 to 0·76)
Costa Rica 291 (206 to 395)
110 
(81 to 143)
74 
(51 to 103)
20 
(14 to 27)
366 
(261 to 497)
130 
(95 to 167)
0·21 
(-4·92 to 4·30)
7·98 
(5·90 to 10·21)
0·59 
(-2·11 to 3·52)
-4·58 
(-7·00 to -2·56)
El Salvador 536 (258 to 852)
184 
(124 to 275)
249 
(117 to 418)
59 
(39 to 87)
785 
(382 to 1262)
243 
(166 to 358)
1·30 
(-5·70 to 8·69)
17·00 
(10·64 to 22·67)
-2·27 
(-7·03 to 0·09)
-6·24 
(-9·58 to -2·90)
Guatemala 1163 (545 to 1944)
465 
(271 to 733)
679 
(308 to 1139)
185 
(108 to 308)
1841 
(858 to 3044)
650 
(384 to 1011)
19·84 
(10·31 to 32·38)
32·69 
(26·07 to 41·94)
-4·85 
(-13·12 to -0·29)
-0·24 
(-5·99 to 5·65)
Honduras 381 (54 to 1630)
537 
(49 to 2613)
508 
(75 to 2243)
586 
(38 to 3056)
889 
(131 to 3925)
1123 
(91 to 5692)
-11·00 
(-26·53 to 0·94)
14·55 
(4·46 to 23·16)
-6·65 
(-14·25 to 3·99)
-11·51 
(-16·65 to -5·96)
Mexico 7066(4827 to 9603)
3076
(2343 to 4368)
1797
(1214 to 2539)
514
(339 to 800)
8863
(6156 to 12 054)
3590
(2763 to 5024)
-6·14
(-11·86 to -2·01)
9·58
(6·71 to 12·81)
-0·20
(-1·20 to 0·41)
-6·62
(-8·53 to -4·22)
Nicaragua 978 (522 to 1739)
199 
(130 to 284)
407 
(215 to 741)
53 
(29 to 94)
1386 
(736 to 2471)
252 
(165 to 364)
19·78 
(6·54 to 35·63)
14·90 
(3·90 to 38·22)
10·61 
(2·14 to 17·90)
11·62 
(6·35 to 16·80)
Panama 500 (295 to 763)
282 
(193 to 410)
167 
(95 to 263)
58 
(35 to 107)
666 
(392 to 1011)
340 
(233 to 505)
-8·12 
(-15·64 to -2·07)
12·99 
(9·44 to 16·66)
-0·88 
(-4·14 to 0·97)
-6·63 
(-10·00 to -2·21)
Venezuela 2396 (1506 to 3591)
992 
(770 to 1470)
637 
(386 to 968)
168 
(111 to 248)
3033 
(1912 to 4504)
1160 
(900 to 1687)
1·77 
(-9·28 to 12·66)
17·73 
(9·64 to 32·27)
-0·32 
(-3·01 to 3·08)
-5·43 
(-8·14 to -1·48)
4938
(3436 to 7580)
1722
(1230 to 2253)
1593
(1084 to 2210)
291
(171 to 490)
6531
(4590 to 9658)
2013
(1437 to 2650)
-0·75
(-4·84 to 3·85)
10·00
(6·17 to 13·76)
-0·24
(-3·40 to 3·08)
-2·76
(-5·37 to -0·65)
Argentina 3459 (2343 to 4525)
1396 
(937 to 1932)
1310 
(859 to 1785)
231 
(113 to 420)
4769 
(3211 to 6214)
1627 
(1082 to 2247)
-0·87 
(-4·70 to 3·65)
9·37 
(5·29 to 13·37)
-0·99 
(-4·42 to 1·51)
-2·74 
(-5·78 to -0·30)
Chile 1162 (399 to 3636)
219 
(132 to 386)
184 
(60 to 558)
34 
(20 to 57)
1346 
(461 to 4214)
253 
(154 to 441)
-0·85 
(-13·55 to 11·49)
16·21 
(5·51 to 26·62)
2·44 
(-5·07 to 14·88)
-5·29 
(-9·44 to -0·24)
Central Latin America
Andean Latin America
Southern Latin America
Confidential draft. Please do not cite or circulate.
Uruguay 317 (197 to 457)
107 
(58 to 227)
98 
(60 to 149)
26 
(16 to 48)
415 
(257 to 600)
133 
(77 to 275)
6·73 
(-12·63 to 23·80)
14·36 
(-0·41 to 26·97)
0·36 
(-4·96 to 5·94)
4·14 
(0·28 to 9·24)
17 874
(13 687 to 24 490)
8091
(6273 to 10 287)
7958
(5860 to 11 125)
2353
(1676 to 3175)
25 832
(19 842 to 35 094)
10 444
(8400 to 13 074)
-7·15
(-10·27 to -3·64)
1·09
(-2·41 to 6·19)
0·37
(-1·16 to 2·50)
-2·20
(-4·57 to 0·01)
Brazil 17 156 (13 016 to 23 725)
7912 
(6086 to 10 130)
7661 
(5536 to 10 846)
2305 
(1628 to 3122)
24 817 
(18 802 to 34 189)
10 217 
(8168 to 12 829)
-7·34 
(-10·43 to -3·78)
0·99 
(-2·54 to 6·14)
0·28 
(-1·27 to 2·43)
-2·26 
(-4·65 to 0·02)
Paraguay 718 (376 to 1377)
179 
(132 to 254)
297 
(148 to 573)
47 
(30 to 78)
1015 
(533 to 1909)
227 
(169 to 326)
9·89 
(-2·03 to 20·95)
16·01 
(10·41 to 26·36)
2·29 
(-3·20 to 8·98)
0·94 
(-2·22 to 4·82)
11 022
(7339 to 19 715)
5905
(4360 to 8749)
4482
(3048 to 7671)
2181
(1582 to 3191)
15 503
(10 523 to 27 132)
8087
(6008 to 11 698)
11·52
(0·35 to 25·42)
20·66
(9·81 to 35·43)
-0·35
(-4·01 to 5·02)
3·05
(-0·99 to 7·85)
Algeria 370 (144 to 953)
68 
(45 to 110)
334 
(126 to 815)
50 
(29 to 95)
704 
(278 to 1737)
118 
(78 to 197)
22·04 
(1·42 to 55·08)
31·05 
(19·30 to 58·72)
3·63 
(-4·30 to 14·24)
2·06 
(-4·20 to 10·92)
Bahrain 25 (15 to 47)
11 
(8 to 15)
10 
(5 to 19)
4 
(3 to 5)
35 
(20 to 66)
15 
(11 to 19)
4·50
(-10·68 to 20·37)
19·32 
(9·48 to 41·05)
2·66 
(-1·34 to 7·95)
1·52 
(-1·64 to 8·28)
Egypt 208 (121 to 315)
54 
(36 to 76)
175 
(100 to 264)
55 
(40 to 72)
383 
(224 to 568)
109 
(81 to 143)
8·02 
(3·18 to 13·53)
20·36 
(16·78 to 24·35)
5·61 
(0·35 to 10·52)
4·30 
(1·75 to 6·54)
Iran 1246 (572 to 2287)
308 
(191 to 441)
152 
(66 to 282)
17 
(9 to 28)
1398 
(641 to 2550)
325 
(201 to 464)
32·59 
(7·25 to 56·24)
42·61 
(11·52 to 101·76)
5·64 
(-0·97 to 13·56)
12·98 
(5·92 to 19·99)
Iraq 318 (143 to 685)
139 
(101 to 181)
185 
(83 to 417)
72 
(52 to 98)
503 
(227 to 1092)
211 
(159 to 273)
5·61 
(-7·68 to 23·46)
21·16 
(12·84 to 44·26)
2·85 
(-2·60 to 9·54)
2·38 
(-1·00 to 5·44)
Jordan 8 (4 to 17)
5 
(3 to 6)
10 
(5 to 21)
5 
(4 to 6)
19 
(10 to 37)
9 
(7 to 11)
10·32 
(-4·09 to 38·26)
27·10 
(18·13 to 53·81)
1·09 
(-3·61 to 7·21)
1·60 
(-1·86 to 5·63)
Kuwait 55 (32 to 101)
24 
(18 to 35)
25 
(13 to 48)
9 
(7 to 13)
80 
(45 to 149)
33 
(25 to 46)
4·81 
(-10·41 to 20·69)
19·61 
(9·84 to 41·52)
2·49 
(-1·51 to 7·82)
1·53 
(-1·69 to 10·13)
Lebanon 241 (7 to 1200)
89 
(8 to 471)
93 
(3 to 435)
26 
(2 to 173)
334 
(10 to 1662)
116 
(10 to 645)
20·24 
(-5·86 to 65·16)
4·87 
(-5·96 to 19·21)
5·79 
(-14·18 to 19·40)
6·76 
(-4·92 to 17·15)
Libya 15 (7 to 32)
7 
(5 to 8)
12 
(6 to 24)
5 
(4 to 6)
27 
(13 to 55)
11 
(9 to 14)
10·67 
(-2·77 to 39·02)
23·15 
(14·81 to 48·67)
3·01 
(-1·88 to 8·66)
4·20 
(1·56 to 7·24)
Morocco 343 (213 to 548)
108 
(72 to 161)
294 
(187 to 452)
61 
(42 to 96)
637 
(403 to 980)
169 
(117 to 255)
21·12 
(11·44 to 27·17)
29·89 
(26·98 to 33·37)
0·53 
(-2·02 to 4·36)
4·19 
(0·82 to 8·25)
Oman 180 (92 to 388)
31 
(23 to 43)
43 
(21 to 91)
7 
(4 to 12)
223 
(114 to 480)
38 
(28 to 53)
28·03 
(9·34 to 65·46)
34·56 
(22·53 to 65·06)
1·78 
(-4·83 to 11·39)
4·86 
(0·85 to 13·07)
Palestine 20 (10 to 42)
6 
(5 to 7)
11 
(5 to 22)
3 
(2 to 4)
31 
(15 to 64)
9 
(8 to 11)
17·60 
(3·68 to 45·75)
22·60 
(11·17 to 47·43)
5·85 
(0·32 to 12·81)
10·89 
(8·35 to 13·98)
Qatar 8 (3 to 20)
4 
(2 to 5)
1 
(0 to 3)
0 
(0 to 1)
10 
(3 to 23)
4 
(2 to 6)
-2·05 
(-14·81 to 18·73)
10·34 
(-0·04 to 37·07)
3·15 
(-2·65 to 11·69)
-1·70 
(-5·16 to 2·00)
Saudi Arabia 354 (168 to 771)
197 
(140 to 318)
206 
(100 to 436)
87 
(62 to 118)
559 
(272 to 1200)
283 
(206 to 415)
2·20 
(-14·17 to 18·84)
19·30 
(8·77 to 44·67)
2·77 
(-1·56 to 9·53)
1·49 
(-2·03 to 7·73)
Sudan 4999 (2880 to 9359)
4154 
(2976 to 5843)
1934 
(1141 to 3575)
1533 
(1040 to 2244)
6933 
(4020 to 12 757)
5687 
(4109 to 8024)
11·50 
(-2·67 to 34·18)
22·51 
(8·28 to 53·14)
-4·10 
(-9·07 to 2·83)
2·62 
(-2·11 to 9·16)
Syria 0 (0 to 1)
0 
(0 to 0)
1 
(0 to 1)
0 
(0 to 0)
1 
(0 to 3)
0 
(0 to 1)
25·96 
(9·85 to 59·84)
34·00 
(20·32 to 67·81)
1·74 
(-4·46 to 8·97)
7·05 
(2·48 to 13·48)
Tunisia 227 (31 to 1041)
53 
(4 to 284)
94 
(13 to 435)
19 
(1 to 110)
322 
(44 to 1443)
72 
(6 to 388)
12·85 
(-14·69 to 44·00)
22·94 
(-2·16 to 61·79)
11·96 
(0·97 to 22·98)
2·76 
(-6·40 to 12·29)
Turkey 408 (233 to 698)
107 
(85 to 142)
195 
(110 to 331)
42 
(31 to 59)
602 
(351 to 1029)
149 
(120 to 198)
25·03 
(20·34 to 29·29)
28·45 
(22·14 to 48·56)
1·99 
(-1·56 to 7·16)
9·82 
(6·51 to 15·83)
United Arab Emirates 304 (175 to 560)
101 
(76 to 128)
77 
(42 to 150)
27 
(19 to 36)
382 
(217 to 704)
128 
(97 to 161)
4·68 
(-10·37 to 20·37)
19·26 
(9·51 to 40·77)
2·45 
(-1·53 to 7·73)
1·37 
(-1·78 to 8·62)
Yemen 1677 (215 to 7497)
433 
(45 to 2027)
625 
(77 to 2998)
156 
(10 to 807)
2302 
(289 to 10 511)
589 
(56 to 2857)
8·17 
(-12·05 to 27·46)
17·84 
(-1·57 to 44·45)
10·06 
(1·53 to 21·58)
7·14 
(-1·35 to 16·57)
Tropical Latin America
North Africa and Middle East
Confidential draft. Please do not cite or circulate.
20 227
(9394 to 47 347)
7959
(4591 to 11 627)
6193
(2730 to 14 401)
2560
(1398 to 4064)
26 420
(12 244 to 61 760)
10 518
(6635 to 14 804)
-8·87
(-13·56 to -3·10)
-10·20
(-13·49 to -7·99)
2·01
(-3·23 to 9·49)
-2·89
(-5·95 to -0·10)
Canada 720 (253 to 1205)
263 
(173 to 392)
134 
(47 to 242)
57 
(33 to 95)
854 
(297 to 1445)
319 
(215 to 458)
-9·30 
(-17·42 to -3·34)
-10·55 
(-12·93 to -8·22)
-0·75 
(-9·26 to 3·88)
-4·81 
(-8·13 to -1·82)
United States 19 503 (8675 to 46 702)
7694 
(4306 to 11 351)
6058 
(2608 to 14 298)
2503 
(1333 to 4016)
25 561 
(11 370 to 60 381)
10 197 
(6265 to 14 519)
-8·86 
(-13·93 to -2·53)
-10·19 
(-13·64 to -7·88)
2·13 
(-3·39 to 9·82)
-2·80 
(-5·96 to 0·06)
1137
(774 to 1591)
1461
(1043 to 2000)
515
(359 to 721)
255
(160 to 372)
1652
(1148 to 2288)
1716
(1249 to 2335)
15·64
(5·25 to 27·08)
31·68
(27·45 to 36·49)
-9·47
(-11·74 to -7·34)
1·21
(-3·80 to 6·92)
Federated States of 
Micronesia
2 
(1 to 4)
1 
(0 to 1)
3 
(1 to 5)
1 
(0 to 1)
5 
(2 to 9)
1 
(1 to 2)
1·63 
(-6·48 to 6·93)
17·73 
(13·87 to 23·24)
5·41 
(-2·00 to 11·14)
-2·70 
(-7·89 to 1·15)
Fiji 19 (7 to 34)
7 
(4 to 11)
26 
(10 to 46)
7 
(3 to 12)
45 
(17 to 78)
14 
(7 to 22)
1·63 
(-6·46 to 6·94)
17·76 
(13·92 to 23·26)
5·45 
(-1·98 to 11·19)
-2·68 
(-7·88 to 1·17)
Kiribati 1 (0 to 2)
0 
(0 to 0)
0 
(0 to 1)
0 
(0 to 0)
1 
(0 to 2)
0 
(0 to 0)
-7·11 
(-14·42 to 6·66)
-4·00 
(-7·74 to 1·02)
10·13 
(-0·37 to 19·60)
-1·82 
(-6·60 to 4·26)
Marshall Islands 1 (0 to 2)
1 
(0 to 1)
1 
(0 to 2)
1 
(0 to 1)
1 
(0 to 4)
1 
(1 to 1)
5·87 
(-6·26 to 14·52)
25·45 
(13·97 to 32·22)
-5·17 
(-17·67 to 5·47)
0·67 
(-2·56 to 2·76)
Papua New Guinea 992 (671 to 1404)
1279 
(907 to 1761)
419 
(280 to 596)
213 
(127 to 316)
1411 
(973 to 1972)
1493 
(1071 to 2046)
15·78 
(5·11 to 27·92)
32·78 
(27·56 to 38·72)
-10·09 
(-12·45 to -7·90)
1·09 
(-4·12 to 7·19)
Samoa 2 (0 to 6)
1 
(1 to 2)
2 
(0 to 8)
1 
(1 to 2)
4 
(1 to 14)
2 
(2 to 3)
2·62 
(-17·47 to 13·91)
24·01 
(14·89 to 32·03)
-2·37 
(-17·51 to 10·40)
-0·76 
(-4·60 to 2·35)
Solomon Islands 5 (1 to 15)
4 
(3 to 5)
7 
(1 to 22)
5 
(3 to 6)
13 
(2 to 37)
8 
(6 to 11)
6·58 
(-4·75 to 15·92)
27·79 
(17·67 to 35·23)
-4·58 
(-17·19 to 7·03)
-1·12 
(-4·26 to 1·73)
Tonga 1 (0 to 2)
1 
(1 to 1)
1 
(0 to 3)
1 
(1 to 1)
2 
(0 to 5)
2 
(1 to 2)
6·23 
(-2·77 to 14·77)
26·75 
(15·90 to 33·45)
-5·28 
(-17·56 to 5·29)
0·09 
(-2·85 to 2·26)
Vanuatu 5 (2 to 10)
2 
(1 to 3)
7 
(3 to 13)
2 
(1 to 3)
13 
(5 to 22)
4 
(2 to 6)
1·60 
(-6·49 to 6·93)
17·68 
(13·81 to 23·22)
5·45 
(-1·97 to 11·18)
-2·68 
(-7·86 to 1·16)
40 520
(33 684 to 48 736)
34 484
(29 112 to 40 928)
46 721
(38 841 to 56 310)
33 317
(26 990 to 41 399)
87 241
(73 529 to 104 384)
67 801
(57 201 to 81 462)
-0·25
(-1·66 to 0·93)
5·71
(3·57 to 8·17)
-3·89
(-5·15 to -2·60)
-2·42
(-3·47 to -1·14)
Angola 15 931 (11 412 to 21 253)
7668 
(5298 to 10 586)
18 844 
(14 120 to 24 425)
8531 
(6012 to 11 969)
34 775 
(25 849 to 45 207)
16 199 
(11 785 to 22 209)
4·19 
(0·33 to 7·97)
17·14 
(13·88 to 21·02)
1·01 
(-2·19 to 4·30)
2·30 
(-0·13 to 4·95)
Central African Republic 3030 (2107 to 4276)
3822 
(3112 to 4827)
3830 
(2639 to 5249)
4199 
(3022 to 5765)
6860 
(4771 to 9421)
8021 
(6348 to 10 313)
-5·56 
(-8·92 to -2·29)
5·10 
(0·91 to 9·99)
-5·85 
(-7·56 to -4·06)
-5·43 
(-7·70 to -2·89)
Congo 2115 (1607 to 2798)
2814 
(2208 to 3561)
2450 
(1858 to 3280)
2314 
(1656 to 3222)
4565 
(3534 to 5925)
5127 
(4074 to 6664)
-5·70 
(-8·48 to -3·46)
8·21 
(5·13 to 11·42)
-7·19 
(-9·26 to -4·54)
-6·18 
(-7·41 to -4·45)
Democratic Republic of the 
Congo
17 438 
(13 583 to 22 693)
17 392 
(13 740 to 22 269)
20 175 
(15 383 to 26 302)
17 223 
(13 018 to 23 364)
37 613 
(29 660 to 47 421)
34 615 
(27 369 to 44 771)
0·02 
(-2·40 to 1·29)
3·93 
(2·46 to 6·28)
-5·37 
(-6·62 to -4·03)
-2·55 
(-3·58 to -1·22)
Equatorial Guinea 838 (453 to 1332)
555 
(246 to 945)
905 
(499 to 1414)
490 
(209 to 744)
1743 
(977 to 2789)
1046 
(457 to 1689)
11·45 
(8·33 to 14·54)
15·68 
(10·22 to 34·39)
-1·78 
(-5·32 to 2·40)
4·23 
(0·35 to 8·07)
Gabon 1169 (642 to 1872)
2233 
(1778 to 2582)
517 
(302 to 888)
560 
(376 to 748)
1686 
(986 to 2716)
2793 
(2291 to 3203)
11·49 
(8·03 to 14·5)
23·03 
(19·71 to 26·02)
-12·91 
(-17·46 to -7·35)
1·92 
(-0·64 to 4·99)
259 900
(239 354 to 285 112)
210 586
(198 215 to 224 774)
322 401
(296 688 to 349 447)
205 015
(189 971 to 222 792)
582 301
(537 558 to 630 227)
415 601
(393 233 to 442 517)
-3·87
(-4·99 to -2·81)
14·50
(12·89 to 16·00)
-4·40
(-5·14 to -3·65)
-3·78
(-4·82 to -2·65)
Burundi 2360 (1033 to 4252)
2997 
(2222 to 4069)
3000 
(1304 to 5465)
2515 
(1648 to 3596)
5360 
(2369 to 9678)
5513 
(3966 to 7471)
-16·72 
(-26·18 to -9·75)
20·87 
(17·06 to 24·49)
-2·27 
(-9·44 to 6·08)
-9·50 
(-12·11 to -4·71)
Comoros 41 (5 to 183)
25 
(4 to 117)
18 
(2 to 88)
10 
(1 to 48)
59 
(8 to 276)
35 
(4 to 168)
33·81 
(12·67 to 50·96)
42·10 
(23·55 to 57·50)
-1·72 
(-12·18 to 10·65)
11·67 
(2·98 to 20·10)
Djibouti 129 (52 to 261)
373 
(259 to 492)
152 
(60 to 330)
407 
(273 to 584)
281 
(111 to 571)
780 
(516 to 1027)
22·37 
(12·52 to 28·20)
38·98 
(33·20 to 47·80)
-18·66 
(-25·15 to -12·54)
3·07 
(-2·38 to 8·01)
Eritrea 578 (266 to 964)
1174 
(837 to 1687)
676 
(302 to 1064)
1200 
(861 to 1695)
1254 
(569 to 1996)
2374 
(1703 to 3356)
-6·64 
(-17·29 to 9·76)
20·01 
(13·04 to 33·39)
-11·86 
(-17·58 to -6·58)
-7·36 
(-11·05 to -0·91)
Eastern Sub-Saharan Africa
High-income North America
Oceania
Central Sub-Saharan Africa
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Ethiopia 15 851 (12 139 to 20 542)
27 417 
(22 586 to 33 072)
19 151 
(14 997 to 24 731)
24 989 
(18 874 to 33 145)
35 002 
(27 389 to 44 699)
52 405 
(43 394 to 64 763)
-0·16 
(-3·45 to 2·72)
19·29 
(14·50 to 23·62)
-13·56 
(-15·59 to -10·99)
-7·16 
(-9·66 to -3·28)
Kenya 38 877 (33 698 to 43 684)
30 059 
(25 652 to 34 355)
46 716 
(41 140 to 52 977)
26 704 
(21 777 to 31 960)
85 593 
(78 186 to 93 863)
56 763 
(49 968 to 63 388)
-6·21 
(-8·43 to -3·27)
29·44 
(26·50 to 32·03)
-2·80 
(-4·62 to -1·14)
-4·48 
(-7·33 to -1·48)
Madagascar 1258 (169 to 5565)
1819 
(313 to 8089)
1383 
(187 to 5867)
1904 
(335 to 8507)
2641 
(356 to 11 358)
3722 
(653 to 16 368)
-6·62 
(-23·17 to 5·79)
27·96 
(14·15 to 37·39)
-4·77 
(-13·15 to 6·25)
-0·41 
(-4·72 to 4·04)
Malawi 25 256 (21 686 to 29 780)
21 829 
(19 080 to 24 746)
33 126 
(28 119 to 39 534)
20 006 
(16 290 to 24 470)
58 382 
(51 810 to 67 436)
41 835 
(37 165 to 46 538)
-4·27 
(-5·74 to -3·02)
12·80 
(10·23 to 17·05)
-4·38 
(-5·95 to -2·93)
-3·63 
(-6·36 to -1·44)
Mauritius 75 (51 to 99)
28 
(22 to 37)
19 
(12 to 26)
5 
(3 to 6)
94 
(63 to 124)
32 
(26 to 42)
25·10 
(18·27 to 31·79)
30·68 
(20·31 to 39·63)
-0·82 
(-4·50 to 0·37)
3·21 
(0·35 to 6·23)
Mozambique 64 009 (50 297 to 78 047)
35 558 
(30 206 to 40 857)
73 592 
(59 146 to 89 609)
39 419 
(34 459 to 44 370)
137 600 
(109 740 to 165 615)
74 978 
(66 037 to 83 282)
18·97 
(16·40 to 21·12)
35·66 
(33·58 to 38·21)
-3·88 
(-5·13 to -2·54)
8·71 
(6·97 to 10·42)
Rwanda 4307 (3471 to 5579)
4419 
(3595 to 5205)
5902 
(4708 to 7378)
3724 
(2919 to 4754)
10 209 
(8282 to 13 029)
8143 
(6779 to 9513)
-10·69 
(-15·45 to -7·39)
9·21 
(5·96 to 13·75)
-4·28 
(-6·93 to -0·18)
-8·40 
(-10·82 to -5·09)
Seychelles 3 (0 to 21)
2 
(1 to 2)
2 
(0 to 16)
1 
(1 to 1)
5 
(1 to 36)
3 
(2 to 4)
-3·27 
(-17·68 to 26·72)
30·37 
(22·07 to 54·20)
-1·47 
(-10·74 to 21·52)
-3·28 
(-5·45 to -0·70)
Somalia 1441 (784 to 2358)
1179 
(782 to 1671)
1555 
(823 to 2531)
1177 
(688 to 1801)
2996 
(1629 to 4855)
2356 
(1492 to 3432)
9·81 
(-8·51 to 34·47)
27·10 
(6·39 to 56·79)
-3·01 
(-8·99 to 3·03)
2·36 
(-3·15 to 9·30)
South Sudan 6555 (2895 to 9574)
5755 
(3527 to 7575)
6137 
(2979 to 8666)
4848 
(3142 to 6518)
12 692 
(5963 to 18 663)
10 603 
(6648 to 14 068)
18·26 
(-11·84 to 53·75)
38·10 
(0·83 to 84·78)
-3·84 
(-11·36 to 2·50)
6·90 
(-0·73 to 19·03)
Tanzania 30 308 (24 975 to 37 174)
35 376 
(30 606 to 41 040)
39 352 
(31 857 to 48 818)
33 666 
(26 958 to 40 319)
69 660 
(58 592 to 85 895)
69 041 
(61 368 to 78 390)
-7·83 
(-10·68 to -5·07)
15·73 
(14·13 to 18·32)
-4·64 
(-6·22 to -2·58)
-3·00 
(-5·29 to -0·87)
Uganda 48 542 (33 485 to 60 232)
26 727 
(22 583 to 31 140)
62 057 
(45 900 to 75 069)
26 212 
(21 621 to 31 785)
110 599 
(80 312 to 133 132)
52 939 
(45 914 to 60 909)
-16·94 
(-20·40 to -13·18)
12·54 
(8·09 to 16·61)
3·81 
(1·52 to 6·44)
-5·74 
(-7·21 to -3·73)
Zambia 20 161 (16 536 to 24 105)
15 695 
(12 805 to 19 018)
29 368 
(24 555 to 34 316)
18 086 
(14 231 to 21 569)
49 529 
(42 630 to 56 376)
33 781 
(28 877 to 38 397)
-2·38 
(-4·09 to -0·56)
6·08 
(3·98 to 9·04)
-4·41 
(-5·98 to -2·95)
-5·66 
(-7·75 to -3·21)
222 423
(198 348 to 248 797)
160 280
(142 399 to 180 385)
280 376
(256 508 to 309 801)
160 992
(133 568 to 185 435)
502 799
(470 822 to 537 266)
321 272
(296 529 to 350 970)
10·60
(9·80 to 11·47)
31·17
(28·62 to 33·63)
-4·58
(-5·16 to -4·00)
3·41
(1·54 to 4·88)
Botswana 4457 (3568 to 5441)
2858 
(2225 to 3707)
5232 
(4268 to 6316)
2730 
(2035 to 3583)
9689 
(7945 to 11 571)
5588 
(4576 to 6765)
3·95 
(2·35 to 5·40)
33·85 
(31·41 to 36·43)
-8·02 
(-9·67 to -6·19)
-6·19 
(-9·00 to -2·81)
Lesotho 7068 (5955 to 8215)
4479 
(3813 to 5359)
8259 
(6785 to 9749)
4694 
(3910 to 5581)
15 328 
(12 983 to 17 837)
9173 
(8060 to 10 485)
17·08 
(14·96 to 18·84)
48·45 
(45·79 to 51·23)
-4·27 
(-5·72 to -2·82)
4·03 
(1·60 to 5·76)
Namibia 3058 (2256 to 3881)
2393 
(1709 to 3089)
3886 
(2991 to 4776)
1744 
(1354 to 2172)
6944 
(5240 to 8424)
4137 
(3356 to 5038)
15·63 
(14·02 to 17·22)
35·74 
(32·74 to 38·70)
-8·69 
(-10·19 to -7·14)
-1·81 
(-3·89 to 1·56)
South Africa 175 519 (151 842 to 200 204)
124 429 
(107 696 to 143 955)
221 112 
(198 114 to 249 156)
127 484 
(101 377 to 150 172)
396 631 
(369 966 to 432 109)
251 912 
(229 223 to 280 072)
27·56 
(26·72 to 28·72)
54·64 
(51·50 to 57·39)
-4·68 
(-5·32 to -4·06)
7·12 
(4·50 to 9·04)
Swaziland 4882 (3845 to 5942)
2801 
(2370 to 3265)
5671 
(4582 to 6959)
2465 
(2045 to 2957)
10 553 
(8530 to 12 964)
5266 
(4702 to 5938)
16·56 
(14·67 to 18·68)
54·18 
(50·68 to 58·14)
-3·55 
(-5·40 to -1·84)
2·41 
(-0·69 to 4·81)
Zimbabwe 27 438 (23 254 to 31 845)
23 321 
(19 787 to 27 956)
36 217 
(30 580 to 41 205)
21 874 
(17 670 to 25 549)
63 655 
(55 522 to 71 292)
45 195 
(40 323 to 51 392)
-10·26 
(-12·34 to -8·24)
24·73 
(22·23 to 27·49)
-2·57 
(-4·44 to -0·79)
-3·38 
(-6·12 to -1·03)
139 760
(119 664 to 165 598)
147 892
(131 751 to 171 029)
167 215
(140 949 to 192 831)
152 976
(133 303 to 173 924)
306 975
(263 141 to 356 401)
300 868
(270 318 to 337 006)
5·79
(3·88 to 8·08)
18·75
(16·65 to 21·01)
-7·26
(-8·40 to -6·19)
0·82
(-0·38 to 2·01)
Benin 2367 (1718 to 3196)
2050 
(1541 to 2757)
2590 
(1846 to 3458)
1960 
(1356 to 2827)
4957 
(3622 to 6595)
4010 
(3091 to 5459)
6·90 
(2·75 to 10·95)
26·96 
(21·60 to 31·83)
-7·64 
(-9·56 to -5·86)
-3·12 
(-5·91 to 0·32)
Burkina Faso 2484 (1638 to 3488)
2444 
(1808 to 3188)
3618 
(2393 to 5149)
2683 
(1828 to 3826)
6103 
(4070 to 8571)
5127 
(3737 to 6724)
-20·54 
(-30·80 to -14·01)
9·51 
(5·32 to 13·94)
-2·41 
(-7·84 to 5·77)
-12·63 
(-14·84 to -9·11)
Cameroon 18 364 (14 701 to 22 135)
15 653 
(12 216 to 19 636)
22 103 
(17 903 to 27 084)
15 669 
(12 898 to 18 786)
40 467 
(33 508 to 48 609)
31 322 
(26 088 to 36 873)
11·89 
(9·80 to 14·27)
34·05 
(31·97 to 36·27)
-5·71 
(-7·06 to -4·28)
2·42 
(0·39 to 5·05)
Cape Verde 17 (6 to 40)
21 
(11 to 35)
9 
(3 to 22)
5 
(4 to 8)
26 
(9 to 63)
26 
(15 to 42)
-9·59 
(-23·30 to 1·20)
18·26 
(11·73 to 26·57)
-11·77 
(-18·77 to -1·81)
-13·57 
(-20·21 to -6·18)
Southern Sub-Saharan Africa
Western Sub-Saharan Africa
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Chad 4580 (3216 to 6211)
4715 
(3913 to 5774)
4904 
(3431 to 6421)
4241 
(3314 to 5247)
9484 
(6804 to 12 391)
8956 
(7597 to 10 794)
0·15 
(-5·82 to 6·92)
14·54 
(11·35 to 18·87)
-6·62 
(-10·35 to -3·55)
-1·05 
(-3·90 to 1·46)
Cote d'Ivoire 11 756 (8303 to 15 969)
14 804 
(11 522 to 18 328)
12 913 
(9713 to 16 926)
11 511 
(8942 to 14 260)
24 670 
(18 594 to 32 159)
26 315 
(21 554 to 31 624)
1·29 
(-3·49 to 5·05)
17·76 
(14·34 to 21·24)
-7·91 
(-10·88 to -4·88)
-3·15 
(-5·63 to -0·34)
Ghana 4562 (2807 to 6873)
7302 
(5449 to 9719)
6214 
(3844 to 9119)
7413 
(5136 to 10 470)
10 775 
(6634 to 15 847)
14 715 
(11 072 to 19 639)
2·08 
(-2·57 to 6·45)
19·90 
(15·13 to 25·45)
-10·73 
(-14·08 to -7·89)
-4·28 
(-6·87 to -0·80)
Guinea 5288 (3327 to 7872)
3190 
(2051 to 4909)
6118 
(3853 to 8838)
3236 
(2104 to 4951)
11 406 
(7224 to 16 543)
6425 
(4343 to 9729)
15·40 
(10·07 to 19·71)
22·54 
(18·87 to 27·50)
-2·32 
(-5·40 to 0·42)
4·03 
(1·06 to 7·06)
Guinea-Bissau 1713 (1074 to 2533)
1200 
(845 to 1597)
2052 
(1253 to 3137)
1300 
(914 to 1797)
3765 
(2397 to 5676)
2500 
(1713 to 3432)
21·73 
(16·50 to 25·97)
32·16 
(29·45 to 35·80)
-3·06 
(-6·89 to -0·10)
8·85 
(5·19 to 12·38)
Liberia 315 (137 to 553)
1063 
(842 to 1343)
366 
(155 to 639)
1089 
(843 to 1398)
681 
(293 to 1186)
2152 
(1746 to 2627)
10·04 
(5·46 to 14·39)
34·21 
(24·64 to 42·30)
-19·21 
(-25·38 to -14·51)
-2·69 
(-6·83 to 1·78)
Mali 1976 (847 to 3299)
2616 
(1762 to 3605)
2358 
(963 to 4093)
2230 
(1382 to 3417)
4334 
(1866 to 7275)
4846 
(3188 to 6966)
0·24 
(-8·31 to 8·15)
22·52 
(17·20 to 27·07)
-9·26 
(-16·68 to -3·40)
-4·37 
(-6·98 to -0·98)
Mauritania 123 (11 to 595)
204 
(21 to 1193)
144 
(12 to 716)
249 
(19 to 1486)
267 
(23 to 1293)
453 
(40 to 2640)
13·71 
(-4·12 to 26·42)
22·05 
(10·46 to 32·73)
-14·15 
(-24·77 to -2·41)
-1·00 
(-8·02 to 5·55)
Niger 739 (279 to 1477)
2131 
(1530 to 2889)
600 
(233 to 1234)
1246 
(787 to 1776)
1340 
(516 to 2678)
3377 
(2382 to 4617)
11·14 
(4·39 to 16·80)
26·52 
(19·89 to 36·62)
-18·89 
(-27·70 to -11·84)
-1·62 
(-6·29 to 3·50)
Nigeria 80 309 (61 339 to 100 239)
83 530 
(70 612 to 104 376)
97 025 
(73 874 to 120 279)
92 271 
(74 817 to 111 822)
177 334 
(140 750 to 223 268)
175 801 
(152 011 to 208 115)
8·76 
(5·07 to 13·97)
20·63 
(17·02 to 26·66)
-7·03 
(-9·22 to -5·28)
4·09 
(1·71 to 5·95)
Sao Tome and Principe 33 (4 to 151)
42 
(4 to 230)
19 
(2 to 87)
18 
(1 to 121)
52 
(7 to 235)
59 
(5 to 366)
34·76 
(8·14 to 55·50)
44·76 
(16·38 to 63·23)
-10·01 
(-18·48 to 1·68)
7·12 
(-0·99 to 15·06)
Senegal 668 (169 to 1392)
1447 
(953 to 2073)
934 
(226 to 1967)
2406 
(1483 to 3468)
1602 
(400 to 3361)
3852 
(2494 to 5417)
10·98 
(8·36 to 13·64)
16·05 
(12·65 to 19·20)
-15·04 
(-24·99 to -8·92)
3·50 
(1·37 to 5·39)
Sierra Leone 2058 (759 to 4122)
2050 
(1217 to 3303)
2243 
(838 to 4491)
2018 
(1199 to 3301)
4301 
(1616 to 8689)
4069 
(2504 to 6569)
20·95 
(13·19 to 28·46)
24·42 
(14·25 to 32·72)
-5·30 
(-11·74 to -0·08)
9·12 
(5·02 to 13·17)
The Gambia 306 (170 to 458)
296 
(196 to 411)
392 
(223 to 590)
234 
(144 to 350)
698 
(399 to 1035)
529 
(355 to 739)
21·09 
(18·06 to 24·27)
21·36 
(15·98 to 29·34)
-8·00 
(-12·18 to -4·68)
3·62 
(0·46 to 7·61)
Togo 2100 (1380 to 2771)
3133 
(2563 to 3808)
2611 
(1766 to 3610)
3196 
(2524 to 3915)
4710 
(3259 to 6327)
6329 
(5267 to 7440)
8·40 
(6·28 to 10·25)
24·73 
(19·89 to 31·75)
-11·53 
(-14·44 to -9·09)
0·60 
(-2·10 to 3·14)
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Incidence Prevalence Mortality Incidence Prevalence Mortality
Global 98·65(96·16 to 101·43)
159·00
(154·14 to 164·10)
19·24
(17·44 to 20·98)
0·03
(-0·17 to 0·25)
0·41
(0·23 to 0·58)
-3·29
(-4·07 to -2·58)
-0·60
(-0·73 to -0·50)
-1·31
(-1·41 to -1·20)
-3·72
(-4·42 to -2·99)
High-income Asia Pacific 34·36(33·42 to 35·26)
62·80
(59·34 to 66·56)
2·14
(1·91 to 2·59)
-0·04
(-0·27 to 0·20)
-1·64
(-1·99 to -1·30)
-6·22
(-6·85 to -5·42)
0·11
(-0·06 to 0·27)
0·13
(-0·18 to 0·40)
-5·03
(-5·85 to -3·99)
Central Asia 122·11(118·41 to 125·73)
179·30
(172·60 to 186·59)
11·08
(7·89 to 12·68)
1·03
(0·77 to 1·32)
1·03
(0·82 to 1·26)
5·50
(0·65 to 6·52)
-0·76
(-0·92 to -0·58)
-0·68
(-0·85 to -0·50)
-4·97
(-5·83 to -4·07)
East Asia 74·16(71·90 to 76·54)
130·70
(125·21 to 136·66)
3·44
(3·00 to 3·99)
0·23
(-0·09 to 0·60)
0·68
(0·34 to 1·00)
-6·70
(-7·93 to -5·73)
-2·08
(-2·36 to -1·85)
-3·16
(-3·44 to -2·86)
-7·54
(-8·53 to -6·63)
South Asia 166·45(160·83 to 172·18)
265·95
(256·77 to 275·37)
51·54
(43·79 to 59·81)
-0·77
(-1·10 to -0·41)
0·02
(-0·27 to 0·31)
-4·96
(-6·26 to -3·69)
-1·06
(-1·30 to -0·80)
-2·43
(-2·65 to -2·20)
-4·22
(-5·64 to -2·89)
Southeast Asia 145·16(140·54 to 148·79)
300·95
(289·61 to 311·88)
41·83
(34·22 to 47·27)
1·59
(1·34 to 1·83)
1·42
(1·17 to 1·63)
-4·10
(-4·95 to -3·23)
-0·54
(-0·68 to -0·42)
0·12
(-0·03 to 0·28)
-3·61
(-4·42 to -2·82)
Australasia 6·38(6·17 to 6·58)
11·11
(10·48 to 11·79)
0·24
(0·20 to 0·27)
-0·23
(-0·61 to 0·16)
-1·00
(-1·37 to -0·60)
-4·13
(-5·09 to -3·21)
-0·22
(-0·41 to -0·03)
-0·36
(-0·66 to -0·08)
-3·63
(-4·62 to -2·62)
Caribbean 55·36(53·72 to 57·02)
70·84
(68·52 to 73·41)
7·19
(6·17 to 9·38)
1·89
(1·56 to 2·19)
0·87
(0·62 to 1·08)
-6·30
(-7·35 to -4·92)
-0·20
(-0·35 to -0·05)
-1·15
(-1·32 to -0·98)
-3·93
(-4·93 to -2·50)
Central Europe 26·72(25·97 to 27·46)
41·97
(40·52 to 43·45)
1·69
(1·57 to 1·97)
1·58
(1·40 to 1·75)
0·40
(0·26 to 0·56)
-2·77
(-3·18 to -1·98)
-1·61
(-1·74 to -1·50)
-0·29
(-0·42 to -0·17)
-5·95
(-6·43 to -5·27)
Eastern Europe 79·27(76·34 to 82·09)
118·55
(113·61 to 123·59)
7·89
(5·14 to 8·64)
1·33
(0·99 to 1·69)
1·73
(1·40 to 2·03)
8·28
(5·46 to 9·09)
-0·58
(-0·80 to -0·39)
-0·75
(-0·97 to -0·53)
-4·80
(-7·62 to -3·91)
Western Europe 10·84(10·52 to 11·15)
17·25
(16·56 to 17·93)
0·54
(0·50 to 0·64)
-0·23
(-0·39 to -0·03)
-0·72
(-0·88 to -0·56)
-4·22
(-4·67 to -3·81)
-1·18
(-1·28 to -1·08)
-0·64
(-0·78 to -0·52)
-4·88
(-5·53 to -3·78)
Andean Latin America 117·89(113·83 to 122·14)
161·10
(153·28 to 168·91)
9·37
(8·16 to 11·90)
0·00
(-0·30 to 0·33)
-0·89
(-1·18 to -0·60)
-8·25
(-9·07 to -5·88)
-0·81
(-1·04 to -0·54)
-0·78
(-1·06 to -0·52)
-4·86
(-5·88 to -3·78)
Central Latin America 32·53(31·73 to 33·35)
49·40
(48·00 to 50·99)
3·38
(3·12 to 4·19)
0·75
(0·52 to 0·93)
-0·39
(-0·61 to -0·19)
-7·53
(-7·85 to -6·72)
-1·69
(-1·83 to -1·55)
-1·51
(-1·67 to -1·35)
-4·21
(-4·74 to -3·03)
Southern Latin America 26·56(25·80 to 27·32)
38·76
(37·10 to 40·48)
2·05
(1·85 to 2·30)
1·43
(1·06 to 1·78)
-0·06
(-0·35 to 0·23)
-4·77
(-5·78 to -4·23)
-2·56
(-2·75 to -2·39)
-1·56
(-1·78 to -1·32)
-3·35
(-4·03 to -2·70)
Tropical Latin America 52·99(51·17 to 54·75)
92·22
(86·87 to 97·63)
3·24
(2·40 to 3·64)
0·51
(0·07 to 0·95)
-0·12
(-0·50 to 0·30)
-2·46
(-6·28 to -1·55)
-1·27
(-1·50 to -1·08)
-0·68
(-1·04 to -0·36)
-4·33
(-5·36 to -3·47)
North Africa and Middle East 34·45(33·65 to 35·29)
48·00
(46·50 to 49·55)
4·56
(4·10 to 5·37)
1·07
(0·85 to 1·30)
-0·32
(-0·50 to -0·12)
-3·72
(-4·35 to -3·07)
-1·10
(-1·18 to -1·03)
-1·26
(-1·35 to -1·16)
-4·58
(-5·34 to -3·89)
High-income North America 5·03(4·84 to 5·20)
10·05
(9·49 to 10·63)
0·23
(0·19 to 0·38)
-0·75
(-0·99 to -0·52)
-2·29
(-2·60 to -1·99)
-6·84
(-7·96 to -1·42)
-3·32
(-3·55 to -3·10)
-2·28
(-2·57 to -1·97)
-4·14
(-5·14 to -1·90)
Oceania 109·58(106·38 to 112·83)
174·93
(167·73 to 182·77)
20·21
(12·67 to 40·27)
-0·73
(-1·12 to -0·36)
-0·85
(-1·20 to -0·52)
-6·29
(-8·55 to -2·59)
0·77
(0·60 to 0·98)
0·14
(-0·09 to 0·37)
-2·96
(-4·58 to -0·91)
Central Sub-Saharan Africa 285·76(271·43 to 299·93)
485·43
(453·81 to 520·51)
100·60
(79·63 to 118·71)
0·63
(0·14 to 1·09)
0·31
(-0·12 to 0·74)
-0·12
(-1·35 to 1·27)
0·07
(-0·12 to 0·28)
-0·17
(-0·41 to 0·06)
-3·41
(-4·67 to -1·99)
Eastern Sub-Saharan Africa 203·95(191·93 to 217·39)
311·05
(290·44 to 333·89)
96·61
(82·38 to 104·22)
-0·99
(-1·42 to -0·54)
-1·00
(-1·43 to -0·54)
-0·67
(-1·82 to 0·09)
-0·34
(-0·52 to -0·16)
-0·38
(-0·57 to -0·20)
-3·08
(-4·12 to -2·40)
Southern Sub-Saharan Africa 719·33(642·13 to 823·58)
942·17
(834·80 to 1,079·88)
62·50
(53·16 to 71·44)
-4·74
(-5·78 to -3·50)
-3·70
(-4·66 to -2·54)
1·34
(-0·22 to 2·77)
0·14
(-0·26 to 0·54)
-0·09
(-0·41 to 0·28)
-4·12
(-5·91 to -2·91)
Western Sub-Saharan Africa 153·58(146·18 to 161·45)
262·32
(248·20 to 277·02)
48·48
(41·75 to 55·30)
-0·33
(-0·79 to 0·14)
-0·45
(-0·89 to -0·01)
-0·84
(-1·71 to -0·07)
-0·57
(-0·73 to -0·39)
-0·69
(-0·86 to -0·49)
-3·09
(-3·84 to -2·17)
Table 4. Age-standardized tuberculosis without HIV incidence, prevalence, and mortality rates (per 100 000) and annualized rates of change (%), with 95% UI,  for 21 GBD regions.
Age-standardized rates
(per 100 000), 2013 Annualized rate of change (%)
Location Incidence Prevalence Mortality
1990-2000 2000-2013
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Incidence Deaths Incidence Deaths Incidence Deaths Incidence Deaths Incidence Deaths
4 517 530
(4 398 104 to 4 647 059)
835 602
(739 280 to 958 088)
2 545 138
(2 472 904 to 2 621 788)
454 659
(356 953 to 511 449)
7 062 668
(6 885 472 to 7 270 226)
1 290 260
(1 167 284 to 1 406 183)
0·03
(-0·17 to 0·25)
-3·29
(-4·07 to -2·58)
-0·60
(-0·73 to -0·50)
-3·72
(-4·42 to -2·99)
252 990
(245 783 to 260 127)
28 495
(23 320 to 30 615)
123 333
(120 187 to 125 954)
10 667
(7961 to 12 027)
376 323
(367 117 to 385 671)
39 162
(33 106 to 41 646)
0·55
(0·34 to 0·76)
1·61
(0·82 to 2·05)
-1·18
(-1·30 to -1·07)
-4·94
(-6·29 to -4·37)
4 264 541
(4 146 317 to 4 392 574)
807 106
(711 182 to 928 549)
2 421 804
(2 351 014 to 2 497 867)
443 992
(349 210 to 500 700)
6 686 345
(6 511 240 to 6 894 801)
1 251 098
(1 131 865 to 1 366 785)
-0·38
(-0·59 to -0·17)
-3·93
(-4·69 to -3·23)
-0·91
(-1·04 to -0·80)
-4·01
(-4·70 to -3·29)
51 867
(50 096 to 53 703)
5443
(4666 to 7069)
29 463
(28 593 to 30 398)
3551
(2701 to 4417)
81 331
(78 818 to 83 863)
8994
(7907 to 10 611)
-0·11
(-0·34 to 0·14)
-6·22
(-6·85 to -5·42)
0·03
(-0·13 to 0·20)
-5·03
(-5·85 to -3·99)
Brunei 22 (20 to 23)
8 
(6 to 10)
15 
(14 to 17)
3 
(2 to 4)
37 
(34 to 40)
11 
(9 to 13)
-0·28 
(-0·80 to 0·18)
-1·84 
(-3·80 to 0·30)
-1·23 
(-1·74 to -0·68)
-3·65 
(-5·51 to -1·69)
Japan 17 594 (16 435 to 18 685)
2906 
(2327 to 3961)
10 227 
(9679 to 10 881)
1915 
(1301 to 2618)
27 820 
(26 331 to 29 468)
4821 
(3987 to 5888)
-0·64 
(-1·01 to -0·28)
-3·86 
(-5·02 to -2·79)
-2·73 
(-3·02 to -2·43)
-4·61 
(-5·98 to -2·71)
Singapore 1262 (1195 to 1331)
71 
(57 to 96)
569 
(542 to 595)
27 
(20 to 37)
1831 
(1746 to 1918)
98 
(82 to 124)
-0·58 
(-0·95 to -0·21)
-6·42 
(-7·76 to -5·23)
-1·24 
(-1·54 to -0·93)
-5·48 
(-6·99 to -3·82)
South Korea 32 990 (31 527 to 34 332)
2458 
(2089 to 3220)
18 653 
(17 970 to 19 309)
1606 
(1164 to 2115)
51 643 
(49 712 to 53 364)
4064 
(3512 to 4889)
-0·32 
(-0·62 to 0·06)
-8·27 
(-9·24 to -6·67)
0·90 
(0·68 to 1·10)
-5·53 
(-6·78 to -4·31)
63 244
(61 027 to 65 347)
6644
(4595 to 7743)
40 455
(39 133 to 41 763)
2138
(1317 to 2568)
103 698
(100 303 to 106 922)
8782
(6094 to 10 048)
1·02
(0·77 to 1·30)
5·50
(0·65 to 6·52)
-0·80
(-0·95 to -0·62)
-4·97
(-5·83 to -4·07)
Armenia 1353 (1298 to 1402)
118 
(73 to 139)
425 
(408 to 442)
16 
(8 to 20)
1778 
(1713 to 1840)
134 
(83 to 156)
-1·31 
(-1·81 to -0·72)
4·34 
(-0·73 to 6·06)
0·98 
(0·75 to 1·20)
-2·15 
(-4·25 to -0·86)
Azerbaijan 6617 (6269 to 6969)
595 
(418 to 757)
2767 
(2622 to 2917)
121 
(86 to 160)
9383 
(8942 to 9850)
716 
(525 to 874)
1·00 
(0·57 to 1·43)
3·62 
(-1·43 to 5·12)
-1·88 
(-2·24 to -1·50)
-7·12 
(-8·57 to -5·54)
Georgia 3740 (3595 to 3887)
163 
(132 to 222)
1694 
(1634 to 1765)
32 
(24 to 39)
5434 
(5259 to 5619)
195 
(164 to 249)
-0·17 
(-0·68 to 0·26)
-1·21 
(-2·65 to 0·05)
0·34 
(0·07 to 0·62)
-3·49 
(-4·94 to -1·20)
Kazakhstan 15 156 (14 432 to 15 855)
2009 
(1542 to 2570)
10 657 
(10 282 to 11 060)
474 
(317 to 612)
25 813 
(24 838 to 26 776)
2482 
(1979 to 3028)
1·32 
(0·92 to 1·83)
7·82 
(2·74 to 9·40)
-0·72 
(-0·95 to -0·44)
-6·38 
(-8·04 to -4·45)
Kyrgyzstan 3958 (3790 to 4131)
495 
(292 to 612)
2988 
(2873 to 3109)
142 
(71 to 180)
6946 
(6709 to 7179)
637 
(391 to 760)
0·93 
(0·44 to 1·35)
7·99 
(0·61 to 9·71)
0·50 
(0·26 to 0·74)
-4·42 
(-5·81 to -3·13)
Mongolia 2456 (2347 to 2564)
364 
(265 to 470)
1753 
(1688 to 1808)
141 
(90 to 183)
4208 
(4053 to 4355)
505 
(380 to 624)
0·40 
(0·03 to 0·83)
0·55 
(-0·85 to 2·03)
-0·27 
(-0·45 to -0·07)
-3·36 
(-5·16 to -1·66)
Tajikistan 6765 (6436 to 7088)
420 
(239 to 557)
4827 
(4570 to 5083)
259 
(167 to 351)
11 593 
(11 079 to 12 122)
679 
(436 to 856)
1·58 
(0·89 to 2·17)
7·07 
(0·76 to 8·76)
0·27 
(-0·04 to 0·55)
-3·95 
(-5·58 to -2·32)
Turkmenistan 2929 (2765 to 3107)
433 
(265 to 605)
1675 
(1586 to 1759)
132 
(84 to 193)
4604 
(4391 to 4839)
565 
(368 to 746)
-0·44 
(-0·84 to -0·05)
3·89 
(1·36 to 5·53)
-1·68 
(-2·04 to -1·32)
-4·99 
(-7·19 to -3·02)
Uzbekistan 20 271 (19 309 to 21 224)
2048 
(1002 to 2829)
13 669 
(13 054 to 14 289)
821 
(420 to 1147)
33 940 
(32 505 to 35 238)
2870 
(1486 to 3757)
1·62 
(1·16 to 2·16)
4·43 
(-1·89 to 5·94)
-1·17 
(-1·48 to -0·83)
-3·90 
(-6·12 to -1·90)
791 190
(762 944 to 818 962)
35 550
(29 728 to 43 445)
371 698
(358 536 to 386 706)
13 158
(11 150 to 16 040)
1 162 888
(1 126 383 to 1 201 277)
48 708
(42 203 to 56 411)
0·20
(-0·11 to 0·57)
-6·70
(-7·93 to -5·73)
-2·11
(-2·38 to -1·88)
-7·54
(-8·53 to -6·63)
China 732 136 (703 787 to 759 995)
33 391 
(27 605 to 39 691)
335 017 
(322 040 to 350 436)
11 794 
(9908 to 14 032)
1 067 153 
(1 031 846 to 1 104 841)
45 185 
(39 015 to 50 882)
0·17 
(-0·16 to 0·56)
-6·85 
(-8·22 to -5·83)
-2·32 
(-2·62 to -2·07)
-7·77 
(-8·79 to -6·88)
North Korea 50 156 (48 217 to 52 190)
1442 
(791 to 3100)
31 827 
(30 744 to 32 904)
1117 
(625 to 2029)
81 983 
(79 533 to 84 781)
2559 
(1576 to 5051)
1·49 
(0·64 to 2·56)
-1·38 
(-3·78 to 0·90)
1·74 
(1·42 to 2·07)
-3·11 
(-5·25 to -0·71)
Taiwan (Province of China) 8899 (8465 to 9340)
717 
(598 to 899)
4853 
(4603 to 5129)
247 
(188 to 314)
13 752 
(13 142 to 14 394)
964 
(836 to 1140)
-0·11 
(-0·54 to 0·39)
-6·31 
(-8·33 to -4·24)
0·05 
(-0·23 to 0·29)
-6·30 
(-8·07 to -4·41)
Table 5. Tuberculosis without HIV incidence and deaths for all ages by sex and combined and annualized rates of change (%), with 95% UI, for 188 countries.
All ages incidence and deaths, 2013 Annualized rate of change (%)
Male Female Total 1990-2000 2000-2013
Location
Worldwide
Developed countries
Developing countries
High-income Asia Pacific
Central Asia
East Asia
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1 633 772
(1 569 448 to 1 702 317)
400 912
(312 339 to 503 463)
804 753
(774 985 to 836 828)
215 086
(166 711 to 264 425)
2 438 524
(2 353 624 to 2 531 209)
615 998
(519 374 to 719 825)
-0·73
(-1·05 to -0·37)
-4·96
(-6·26 to -3·69)
-1·02
(-1·26 to -0·77)
-4·22
(-5·64 to -2·89)
Afghanistan 7570 (7322 to 7874)
2876 
(1666 to 5065)
9127 
(8771 to 9459)
6312 
(3402 to 10 689)
16 697 
(16 178 to 17 247)
9188 
(5771 to 14 906)
3·97 
(3·43 to 4·51)
-0·65 
(-2·98 to 1·86)
0·56 
(0·30 to 0·82)
-5·18 
(-7·46 to -2·99)
Bangladesh 161 542 (153 701 to 169 490)
12 257 
(9086 to 16 868)
102 951 
(97 116 to 107 928)
3288 
(2214 to 4983)
264 493 
(253 273 to 276 373)
15 545 
(12 078 to 20 443)
1·36 
(0·86 to 1·86)
-5·55 
(-8·41 to -3·31)
-0·36 
(-0·66 to -0·07)
-6·73 
(-8·99 to -3·68)
Bhutan 544 (517 to 574)
68 
(31 to 109)
445 
(424 to 468)
19 
(9 to 33)
990 
(948 to 1033)
87 
(42 to 139)
0·25 
(-0·09 to 0·61)
-5·97 
(-8·66 to -3·31)
-2·26 
(-2·51 to -2·03)
-6·31 
(-9·09 to -3·32)
India 1 334 126 (1 276 181 to 1 395 002)
356 940 
(271 034 to 454 519)
581 851 
(556 873 to 607 765)
188 577 
(141 824 to 238 149)
1 915 977 
(1 843 861 to 1 993 731)
545 516 
(450 129 to 650 735)
-1·10 
(-1·50 to -0·67)
-5·21 
(-6·68 to -3·77)
-1·13 
(-1·42 to -0·82)
-4·01 
(-5·56 to -2·53)
Nepal 20 479 (19 384 to 21 535)
5460 
(3794 to 7301)
11 092 
(10 611 to 11 594)
2702 
(1700 to 4062)
31 571 
(30 084 to 32 938)
8162 
(6007 to 10 639)
-0·03 
(-0·63 to 0·58)
-4·24 
(-5·88 to -2·53)
-0·51 
(-0·74 to -0·29)
-5·03 
(-6·72 to -3·33)
Pakistan 117 080 (111 322 to 122 526)
23 311 
(16 082 to 32 229)
108 413 
(103 577 to 113 108)
14 188 
(8804 to 19 462)
225 493 
(216 308 to 234 231)
37 499 
(27 926 to 47 069)
0·27 
(-0·12 to 0·65)
-1·27 
(-3·28 to 0·78)
-1·31 
(-1·55 to -1·07)
-5·31 
(-7·55 to -3·08)
541 691
(520 045 to 558 187)
130 046
(109 419 to 150 362)
321 035
(311 259 to 330 942)
63 824
(40 144 to 75 348)
862 726
(833 162 to 886 678)
193 870
(158 363 to 219 911)
1·59
(1·33 to 1·83)
-4·10
(-4·95 to -3·23)
-0·55
(-0·69 to -0·43)
-3·61
(-4·42 to -2·82)
Cambodia 16 661 (15 170 to 17 531)
2545 
(1709 to 3420)
12 926 
(12 358 to 13 427)
1213 
(867 to 1704)
29 587 
(27 838 to 30 741)
3758 
(2878 to 4773)
1·36 
(-0·01 to 1·87)
-3·77 
(-5·90 to -1·71)
-1·45 
(-1·78 to -0·60)
-5·59 
(-7·45 to -3·59)
Indonesia 186 734 (175 949 to 195 308)
71 151 
(53 474 to 85 108)
154 066 
(147 342 to 160 217)
37 572 
(15 822 to 47 009)
340 799 
(325 302 to 352 949)
108 723 
(73 764 to 127 293)
3·13 
(2·71 to 3·53)
-3·86 
(-5·13 to -2·57)
0·43 
(0·11 to 0·71)
-2·62 
(-3·94 to -1·47)
Laos 7204 (6684 to 7594)
859 
(489 to 1466)
3955 
(3715 to 4163)
832 
(393 to 1448)
11 160 
(10 442 to 11 715)
1691 
(987 to 2779)
3·06 
(2·35 to 3·71)
-3·02 
(-5·76 to -0·36)
-0·75 
(-1·02 to -0·44)
-4·16 
(-6·44 to -1·55)
Malaysia 17 498 (16 676 to 18 406)
1334 
(1016 to 1599)
9246 
(8850 to 9667)
389 
(236 to 483)
26 744 
(25 651 to 27 926)
1723 
(1311 to 1991)
-0·36 
(-0·79 to 0·05)
-4·32 
(-8·27 to -2·52)
-1·40 
(-1·70 to -1·07)
-2·48 
(-4·41 to -1·15)
Maldives 85 (82 to 89)
6 
(4 to 8)
63 
(60 to 65)
2 
(1 to 2)
148 
(143 to 153)
8 
(6 to 9)
-1·83 
(-2·21 to -1·43)
-7·65 
(-9·08 to -6·02)
-3·25 
(-3·56 to -2·98)
-4·85 
(-9·44 to -2·97)
Myanmar 59 000 (53 067 to 61 680)
17 233 
(9964 to 26 771)
30 437 
(29 213 to 31 605)
6523 
(3695 to 10 706)
89 437 
(83 011 to 92 987)
23 756 
(13 957 to 37 308)
0·62 
(-0·55 to 1·12)
-2·87 
(-5·51 to -0·43)
-1·09 
(-1·41 to -0·65)
-4·84 
(-7·09 to -2·53)
Philippines 114 611 (110 488 to 119 351)
21 116 
(16 010 to 28 500)
51 534 
(49 589 to 53 349)
8162 
(5945 to 10 868)
166 145 
(160 384 to 172 007)
29 278 
(23 891 to 38 089)
0·35 
(-0·07 to 0·69)
-1·62 
(-2·39 to -0·77)
-0·96 
(-1·23 to -0·68)
-3·39 
(-4·86 to -1·86)
Sri Lanka 10 106 (9609 to 10 617)
942 
(734 to 1334)
5059 
(4814 to 5330)
319 
(231 to 430)
15 166 
(14 454 to 15 881)
1261 
(1036 to 1624)
-0·52 
(-1·09 to 0·02)
-2·87 
(-3·90 to -1·90)
-1·01 
(-1·35 to -0·69)
-4·76 
(-6·19 to -3·23)
Thailand 46 721 (44 411 to 49 189)
5688 
(4374 to 8927)
23 885 
(22 833 to 24 943)
3464 
(2555 to 4696)
70 607 
(67 488 to 73 756)
9152 
(7399 to 12 480)
-0·03 
(-0·49 to 0·40)
-8·31 
(-9·62 to -4·61)
-1·90 
(-2·20 to -1·59)
-4·04 
(-5·60 to -2·51)
Timor-Leste 942 (902 to 985)
91 
(60 to 138)
654 
(627 to 678)
58 
(35 to 83)
1595 
(1534 to 1657)
150 
(108 to 209)
1·57 
(0·94 to 2·19)
-3·62 
(-5·28 to -1·92)
0·27 
(0·01 to 0·50)
-4·37 
(-6·29 to -2·47)
Vietnam 81 050 (77 670 to 84 298)
8851 
(6374 to 12 124)
28 599 
(27 468 to 29 768)
5170 
(3727 to 6860)
109 649 
(105 506 to 113 534)
14 021 
(11 297 to 17 789)
2·52 
(2·07 to 3·02)
-6·25 
(-8·26 to -4·40)
-1·16 
(-1·42 to -0·91)
-6·21 
(-8·09 to -4·22)
1038
(1000 to 1076)
58
(47 to 71)
834
(807 to 863)
46
(34 to 57)
1873
(1810 to 1929)
103
(88 to 118)
-0·24
(-0·62 to 0·14)
-4·13
(-5·09 to -3·21)
-0·24
(-0·43 to -0·04)
-3·63
(-4·62 to -2·62)
Australia 861 (828 to 896)
48 
(37 to 60)
665 
(641 to 690)
36 
(26 to 47)
1526 
(1473 to 1576)
84 
(69 to 98)
-0·65 
(-1·06 to -0·21)
-3·49 
(-4·74 to -2·35)
0·19 
(-0·01 to 0·42)
-3·05 
(-4·21 to -1·86)
New Zealand 177 (170 to 183)
10 
(8 to 13)
170 
(163 to 176)
9 
(7 to 12)
346 
(334 to 358)
19 
(17 to 23)
1·24 
(0·90 to 1·60)
-5·98 
(-7·22 to -4·62)
-1·62 
(-1·82 to -1·41)
-3·85 
(-4·99 to -2·58)
12 755
(12 352 to 13 183)
1948
(1572 to 2687)
8670
(8381 to 8955)
1118
(892 to 1450)
21 425
(20 766 to 22 080)
3067
(2621 to 4000)
1·88
(1·56 to 2·18)
-6·30
(-7·35 to -4·92)
-0·20
(-0·35 to -0·04)
-3·93
(-4·93 to -2·50)
Antigua and Barbuda 23 (22 to 24)
2 
(1 to 2)
16 
(16 to 17)
1 
(0 to 1)
40 
(38 to 41)
2 
(2 to 3)
-0·06 
(-0·51 to 0·32)
-1·38 
(-4·33 to 0·49)
0·41 
(0·16 to 0·68)
-0·50 
(-3·19 to 1·75)
Barbados 32 (30 to 33)
6 
(4 to 8)
35 
(33 to 36)
2 
(1 to 3)
66 
(64 to 69)
8 
(5 to 10)
-0·52 
(-0·90 to -0·13)
-1·47 
(-3·46 to -0·10)
-0·01 
(-0·25 to 0·23)
-0·51 
(-3·35 to 1·44)
South Asia
Southeast Asia
Australasia
Caribbean
Confidential draft. Please do not cite or circulate.
Belize 106 (101 to 110)
7 
(5 to 10)
60 
(58 to 62)
2 
(1 to 3)
166 
(160 to 171)
10 
(6 to 12)
2·05 
(1·45 to 2·53)
3·70 
(1·28 to 5·23)
1·20 
(0·97 to 1·47)
-0·38 
(-3·01 to 1·58)
Cuba 1003 (941 to 1063)
32 
(26 to 39)
309 
(290 to 330)
13 
(10 to 17)
1312 
(1238 to 1383)
44 
(38 to 52)
-0·43 
(-0·72 to -0·07)
-2·31 
(-3·73 to -1·16)
-4·97 
(-5·35 to -4·63)
-5·01 
(-6·19 to -3·79)
Dominica 18 (17 to 19)
2 
(1 to 2)
12 
(11 to 13)
0 
(0 to 0)
30 
(29 to 31)
2 
(1 to 3)
1·02 
(0·61 to 1·47)
-1·40 
(-5·37 to 0·39)
-0·87 
(-1·22 to -0·55)
-1·03 
(-3·45 to 1·20)
Dominican Republic 3194 (3073 to 3331)
303 
(228 to 429)
2117 
(2029 to 2196)
148 
(109 to 199)
5311 
(5129 to 5502)
451 
(365 to 591)
0·92 
(0·47 to 1·29)
-6·10 
(-7·24 to -4·56)
-1·31 
(-1·53 to -1·06)
-5·33 
(-7·05 to -2·88)
Grenada 25 (24 to 26)
3 
(2 to 3)
17 
(17 to 18)
0 
(0 to 1)
42 
(40 to 43)
3 
(2 to 4)
1·64 
(1·11 to 2·14)
0·17 
(-2·84 to 1·57)
-1·54 
(-1·80 to -1·29)
-1·26 
(-3·60 to 0·38)
Guyana 384 (356 to 406)
29 
(19 to 39)
220 
(211 to 229)
8 
(6 to 12)
604 
(568 to 632)
37 
(25 to 47)
3·75 
(3·12 to 4·36)
1·19 
(-3·95 to 2·92)
0·57 
(0·35 to 0·84)
-0·72 
(-2·93 to 1·20)
Haiti 5770 (5514 to 6016)
1211 
(900 to 1759)
4483 
(4273 to 4691)
745 
(564 to 1025)
10 253 
(9848 to 10 657)
1956 
(1598 to 2639)
3·36 
(2·79 to 3·90)
-7·06 
(-8·45 to -5·27)
0·71 
(0·40 to 1·03)
-4·00 
(-5·41 to -2·44)
Jamaica 168 (159 to 175)
24 
(17 to 32)
66 
(62 to 69)
11 
(7 to 15)
233 
(223 to 243)
35 
(27 to 43)
-2·12 
(-2·51 to -1·72)
0·99 
(-1·16 to 2·49)
-2·36 
(-2·71 to -2·04)
-3·24 
(-4·98 to -1·50)
Saint Lucia 27 (26 to 28)
4 
(2 to 5)
23 
(22 to 24)
1 
(1 to 2)
50 
(48 to 52)
5 
(3 to 6)
1·06 
(0·67 to 1·48)
-0·59 
(-3·89 to 0·95)
-2·27 
(-2·46 to -2·07)
-2·91 
(-4·81 to -1·19)
Saint Vincent and the 
Grenadines
23 
(21 to 24)
2 
(1 to 3)
15 
(14 to 15)
0 
(0 to 1)
37 
(36 to 39)
3 
(2 to 3)
1·90 
(1·43 to 2·42)
0·06 
(-3·46 to 1·73)
-2·60 
(-2·92 to -2·28)
-2·93 
(-5·67 to -1·13)
Suriname 154 (145 to 163)
13 
(8 to 19)
70 
(67 to 74)
4 
(3 to 5)
224 
(213 to 235)
17 
(11 to 23)
1·46 
(0·92 to 1·98)
0·49 
(-1·83 to 1·91)
-1·31 
(-1·68 to -0·96)
-1·25 
(-4·23 to 0·96)
The Bahamas 29 (27 to 30)
9 
(6 to 12)
26 
(25 to 27)
3 
(2 to 4)
55 
(52 to 57)
12 
(8 to 15)
-0·74 
(-1·10 to -0·45)
-1·41 
(-3·31 to 0·07)
-4·28 
(-4·62 to -3·93)
-2·24 
(-4·47 to -0·20)
Trinidad and Tobago 217 (207 to 227)
29 
(17 to 36)
85 
(82 to 89)
9 
(5 to 12)
303 
(291 to 315)
37 
(23 to 45)
-0·57 
(-0·93 to -0·19)
-0·20 
(-3·02 to 0·96)
-1·54 
(-1·77 to -1·27)
-2·51 
(-5·01 to -1·02)
25 157
(24 431 to 25 958)
2201
(2014 to 2708)
12 384
(12 026 to 12 741)
646
(566 to 795)
37 541
(36 487 to 38 632)
2846
(2642 to 3395)
1·57
(1·39 to 1·74)
-2·77
(-3·18 to -1·98)
-1·64
(-1·77 to -1·53)
-5·95
(-6·43 to -5·27)
Albania 374 (358 to 390)
16 
(11 to 23)
178 
(170 to 184)
9 
(6 to 13)
551 
(531 to 571)
24 
(19 to 33)
-0·46 
(-0·84 to -0·11)
-5·23 
(-6·94 to 0·46)
-1·70 
(-1·92 to -1·50)
-4·63 
(-6·73 to -2·40)
Bosnia and Herzegovina 944 (902 to 984)
134 
(73 to 160)
509 
(489 to 532)
44 
(34 to 56)
1453 
(1398 to 1513)
178 
(114 to 206)
0·75 
(0·47 to 1·07)
-5·94 
(-8·01 to -4·44)
-1·84 
(-2·07 to -1·60)
-4·75 
(-7·31 to -3·34)
Bulgaria 1805 (1732 to 1878)
113 
(98 to 150)
910 
(876 to 944)
35 
(28 to 47)
2714 
(2627 to 2804)
148 
(131 to 195)
2·87 
(2·39 to 3·40)
1·07 
(0·26 to 2·16)
-0·74 
(-0·95 to -0·53)
-4·99 
(-5·86 to -3·87)
Croatia 807 (757 to 857)
57 
(47 to 95)
420 
(396 to 446)
28 
(22 to 36)
1227 
(1165 to 1296)
85 
(73 to 127)
1·05 
(0·77 to 1·33)
-8·22 
(-9·51 to -3·50)
-4·64 
(-5·03 to -4·26)
-6·92 
(-8·02 to -4·79)
Czech Republic 592 (565 to 621)
40 
(34 to 66)
269 
(257 to 281)
22 
(16 to 41)
861 
(826 to 897)
62 
(52 to 102)
-0·69 
(-1·04 to -0·35)
-5·21 
(-6·97 to 3·07)
-2·93 
(-3·19 to -2·68)
-6·46 
(-7·64 to -4·26)
Hungary 1426 (1375 to 1483)
87 
(69 to 196)
726 
(697 to 757)
46 
(35 to 93)
2152 
(2080 to 2228)
134 
(108 to 272)
-0·26 
(-0·64 to 0·13)
-7·59 
(-9·00 to -0·99)
-1·32 
(-1·55 to -1·10)
-8·16 
(-9·37 to -4·51)
Macedonia 312 (299 to 325)
32 
(26 to 47)
177 
(171 to 183)
11 
(8 to 16)
489 
(473 to 506)
42 
(36 to 61)
-0·71 
(-1·05 to -0·41)
-2·79 
(-3·88 to -1·46)
-2·30 
(-2·52 to -2·10)
-7·49 
(-8·87 to -4·16)
Montenegro 78 (75 to 81)
2 
(1 to 3)
51 
(49 to 53)
1 
(1 to 1)
129 
(125 to 133)
2 
(2 to 4)
1·05 
(0·65 to 1·44)
0·29 
(-2·32 to 4·03)
-0·41 
(-0·63 to -0·21)
-8·11 
(-10·19 to -3·01)
Poland 6141 (5911 to 6350)
658 
(556 to 1110)
2897 
(2783 to 3001)
176 
(133 to 313)
9038 
(8735 to 9314)
834 
(714 to 1394)
-0·38 
(-0·66 to -0·04)
-6·98 
(-8·00 to -2·87)
-1·33 
(-1·56 to -1·13)
-5·35 
(-6·26 to -3·86)
Romania 10 953 (10 478 to 11 423)
919 
(571 to 1059)
5250 
(5082 to 5445)
202 
(92 to 244)
16 203 
(15 631 to 16 796)
1121 
(692 to 1270)
3·94 
(3·65 to 4·29)
3·16 
(-1·58 to 4·24)
-1·43 
(-1·66 to -1·23)
-6·18 
(-7·43 to -5·23)
Serbia 1161 (1110 to 1213)
101 
(88 to 132)
703 
(681 to 728)
46 
(37 to 56)
1864 
(1804 to 1930)
148 
(132 to 181)
0·40 
(0·01 to 0·86)
-0·61 
(-3·10 to 2·29)
-0·39 
(-0·64 to -0·12)
-5·88 
(-6·81 to -3·99)
Central Europe
Confidential draft. Please do not cite or circulate.
Slovakia 410 (391 to 432)
31 
(25 to 37)
203 
(195 to 211)
14 
(10 to 19)
614 
(590 to 639)
45 
(38 to 52)
-1·98 
(-2·29 to -1·70)
-5·90 
(-7·59 to -2·10)
-4·25 
(-4·51 to -3·95)
-4·58 
(-5·77 to -3·34)
Slovenia 155 (148 to 162)
12 
(10 to 15)
91 
(87 to 95)
11 
(8 to 16)
247 
(237 to 256)
23 
(18 to 28)
-1·25 
(-1·50 to -1·01)
-7·84 
(-9·43 to -3·53)
-4·92 
(-5·17 to -4·68)
-4·38 
(-6·46 to -2·82)
133 535
(127 584 to 139 310)
17 428
(11 652 to 19 299)
54 525
(52 459 to 56 300)
3944
(1987 to 4564)
188 061
(181 006 to 194 926)
21 372
(14 337 to 23 390)
1·28
(0·95 to 1·63)
8·28
(5·46 to 9·09)
-0·62
(-0·84 to -0·43)
-4·80
(-7·62 to -3·91)
Belarus 4600 (4412 to 4804)
612 
(340 to 743)
1778 
(1713 to 1842)
110 
(73 to 138)
6378 
(6156 to 6624)
722 
(427 to 852)
0·64 
(0·14 to 1·09)
5·98 
(3·66 to 6·97)
0·20 
(-0·09 to 0·50)
-1·48 
(-5·03 to -0·04)
Estonia 314 (301 to 328)
35 
(28 to 40)
115 
(110 to 120)
8 
(6 to 10)
429 
(414 to 445)
44 
(35 to 49)
0·29 
(-0·20 to 0·75)
4·25 
(0·02 to 5·59)
-3·42 
(-3·70 to -3·14)
-8·24 
(-9·26 to -7·23)
Latvia 780 (747 to 816)
60 
(50 to 77)
368 
(352 to 383)
17 
(14 to 21)
1148 
(1106 to 1192)
78 
(67 to 95)
0·27 
(-0·10 to 0·69)
5·20 
(2·90 to 6·18)
-2·43 
(-2·67 to -2·16)
-8·97 
(-10·32 to -6·96)
Lithuania 1457 (1394 to 1523)
176 
(137 to 205)
594 
(572 to 615)
41 
(29 to 52)
2051 
(1982 to 2127)
217 
(168 to 246)
0·15 
(-0·23 to 0·54)
3·17 
(0·55 to 4·20)
-0·73 
(-0·96 to -0·49)
-4·09 
(-5·19 to -3·09)
Moldova 3218 (3092 to 3354)
328 
(218 to 369)
1245 
(1200 to 1290)
56 
(32 to 67)
4463 
(4316 to 4623)
384 
(258 to 429)
3·21 
(2·66 to 3·69)
7·60 
(1·92 to 8·92)
1·64 
(1·40 to 1·88)
-1·41 
(-2·87 to -0·50)
Russia 99 009 (94 194 to 103 393)
12 075 
(8364 to 13 569)
41 613 
(39 823 to 43 098)
2754 
(1332 to 3200)
140 622 
(135 057 to 146 053)
14 829 
(10 158 to 16 436)
1·37 
(0·95 to 1·82)
8·72 
(5·42 to 9·70)
-0·53 
(-0·84 to -0·28)
-5·19 
(-7·85 to -4·21)
Ukraine 24 157 (22 734 to 25 531)
4141 
(2591 to 4870)
8812 
(8381 to 9239)
958 
(501 to 1222)
32 969 
(31 207 to 34 714)
5099 
(3140 to 5841)
1·16 
(0·77 to 1·60)
7·75 
(5·80 to 8·66)
-1·18 
(-1·51 to -0·84)
-3·34 
(-7·29 to -1·87)
29 517
(28 659 to 30 370)
2660
(2396 to 3516)
19 185
(18 599 to 19 725)
2011
(1640 to 2357)
48 702
(47 293 to 50 021)
4670
(4234 to 5466)
-0·25
(-0·40 to -0·05)
-4·22
(-4·67 to -3·81)
-1·21
(-1·31 to -1·11)
-4·88
(-5·53 to -3·78)
Andorra 10 (9 to 10)
0 
(0 to 0)
8 
(7 to 8)
0 
(0 to 0)
18 
(17 to 18)
0 
(0 to 1)
5·20 
(4·59 to 5·86)
-4·60 
(-7·70 to -1·71)
-2·13 
(-2·37 to -1·89)
-3·14 
(-5·50 to -0·78)
Austria 615 (591 to 641)
35 
(28 to 62)
342 
(329 to 355)
24 
(19 to 35)
958 
(922 to 992)
60 
(49 to 93)
0·31 
(-0·05 to 0·72)
-9·56 
(-11·01 to -3·71)
-1·57 
(-1·83 to -1·35)
-3·97 
(-5·15 to -2·71)
Belgium 737 (706 to 764)
71 
(56 to 88)
438 
(420 to 455)
48 
(34 to 64)
1175 
(1133 to 1214)
118 
(96 to 141)
-0·85 
(-1·16 to -0·58)
-1·72 
(-3·80 to -0·52)
-0·61 
(-0·82 to -0·41)
-3·70 
(-5·02 to -2·34)
Cyprus 36 (35 to 38)
2 
(2 to 3)
40 
(38 to 41)
1 
(1 to 1)
76 
(74 to 79)
3 
(2 to 4)
0·23 
(-0·12 to 0·58)
-4·05 
(-6·10 to -2·04)
0·59 
(0·39 to 0·80)
-5·37 
(-7·18 to -3·24)
Denmark 256 (245 to 267)
23 
(19 to 29)
185 
(177 to 193)
16 
(12 to 21)
441 
(425 to 456)
39 
(34 to 46)
0·57 
(0·25 to 0·93)
-2·51 
(-3·80 to -1·35)
-1·71 
(-1·95 to -1·48)
-3·43 
(-4·68 to -2·17)
Finland 256 (246 to 265)
39 
(31 to 59)
149 
(144 to 154)
42 
(31 to 60)
405 
(392 to 417)
81 
(66 to 114)
-1·10 
(-1·41 to -0·76)
-4·29 
(-5·52 to -2·81)
-1·10 
(-1·31 to -0·88)
-5·56 
(-7·09 to -3·12)
France 4558 (4354 to 4760)
722 
(577 to 977)
3077 
(2944 to 3227)
697 
(485 to 967)
7635 
(7329 to 7949)
1419 
(1151 to 1762)
-1·28 
(-1·54 to -0·98)
-2·71 
(-4·40 to -1·52)
-0·88 
(-1·13 to -0·64)
-5·65 
(-7·12 to -3·43)
Germany 4554 (4353 to 4769)
312 
(258 to 565)
2754 
(2636 to 2874)
196 
(152 to 273)
7309 
(7018 to 7608)
508 
(430 to 808)
-1·13 
(-1·39 to -0·88)
-5·97 
(-6·86 to -4·32)
-3·39 
(-3·63 to -3·14)
-6·22 
(-7·41 to -3·22)
Greece 525 (499 to 548)
124 
(89 to 150)
232 
(221 to 244)
110 
(48 to 152)
757 
(725 to 788)
234 
(150 to 283)
-1·05 
(-1·42 to -0·65)
-8·68 
(-9·95 to -4·50)
-2·04 
(-2·31 to -1·79)
1·37 
(-4·37 to 3·08)
Iceland 19 (18 to 20)
0 
(0 to 1)
20 
(19 to 21)
2 
(1 to 2)
39 
(38 to 41)
2 
(1 to 3)
1·74 
(1·29 to 2·20)
-5·07 
(-7·26 to -1·85)
-1·18 
(-1·45 to -0·91)
-0·74 
(-5·01 to 1·85)
Ireland 307 (293 to 320)
22 
(17 to 27)
181 
(173 to 189)
16 
(12 to 21)
488 
(468 to 507)
38 
(31 to 45)
-0·88 
(-1·27 to -0·49)
-4·71 
(-5·90 to -3·54)
0·51 
(0·29 to 0·74)
-4·49 
(-5·94 to -3·16)
Israel 352 (339 to 364)
25 
(20 to 31)
188 
(180 to 195)
14 
(10 to 20)
539 
(521 to 557)
39 
(32 to 48)
-0·04 
(-0·48 to 0·42)
-0·11 
(-5·05 to 1·53)
-1·46 
(-1·65 to -1·26)
-7·11 
(-8·72 to -3·21)
Italy 2868 (2726 to 2999)
295 
(238 to 389)
1942 
(1858 to 2026)
203 
(144 to 271)
4810 
(4609 to 4999)
498 
(415 to 600)
-0·76 
(-1·05 to -0·42)
-5·22 
(-6·26 to -4·32)
-1·43 
(-1·70 to -1·19)
-4·53 
(-5·78 to -3·13)
Luxembourg 30 (28 to 31)
1 
(1 to 1)
21 
(20 to 22)
1 
(1 to 2)
51 
(49 to 53)
2 
(2 to 2)
0·97 
(0·54 to 1·43)
2·98 
(-6·36 to 5·42)
-2·48 
(-2·76 to -2·22)
-8·56 
(-10·73 to -4·48)
Eastern Europe
Western Europe
Confidential draft. Please do not cite or circulate.
Malta 29 (28 to 30)
0 
(0 to 1)
20 
(19 to 21)
0 
(0 to 0)
49 
(47 to 51)
1 
(1 to 1)
3·82 
(3·35 to 4·33)
-2·94 
(-5·44 to -1·15)
-2·74 
(-3·00 to -2·50)
-6·24 
(-7·80 to -3·55)
Netherlands 781 (751 to 812)
65 
(53 to 84)
553 
(534 to 571)
57 
(43 to 78)
1334 
(1291 to 1378)
123 
(103 to 154)
-1·01 
(-1·24 to -0·76)
-2·75 
(-4·06 to -1·60)
-1·73 
(-1·92 to -1·54)
-4·28 
(-5·58 to -2·52)
Norway 205 (196 to 213)
25 
(20 to 31)
196 
(189 to 203)
25 
(18 to 33)
401 
(387 to 414)
50 
(41 to 60)
-1·75 
(-2·01 to -1·46)
-1·83 
(-4·50 to -0·46)
-0·25 
(-0·46 to -0·05)
-3·95 
(-5·29 to -2·55)
Portugal 1672 (1603 to 1731)
191 
(161 to 223)
889 
(860 to 921)
78 
(50 to 98)
2561 
(2470 to 2639)
269 
(223 to 305)
2·38 
(2·07 to 2·72)
-3·13 
(-5·91 to -2·19)
-2·29 
(-2·51 to -2·10)
-5·45 
(-6·38 to -4·27)
Spain 4983 (4804 to 5160)
324 
(270 to 475)
2959 
(2846 to 3080)
205 
(155 to 270)
7942 
(7683 to 8198)
529 
(451 to 680)
1·09 
(0·80 to 1·40)
-6·41 
(-7·41 to -3·70)
-1·70 
(-1·88 to -1·52)
-4·78 
(-5·74 to -3·77)
Sweden 378 (364 to 392)
53 
(41 to 68)
311 
(299 to 323)
60 
(41 to 83)
689 
(666 to 711)
113 
(91 to 143)
-0·83 
(-1·11 to -0·54)
-1·17 
(-3·35 to 0·05)
-0·14 
(-0·32 to 0·06)
-3·51 
(-5·14 to -1·56)
Switzerland 515 (493 to 536)
42 
(34 to 59)
353 
(339 to 368)
25 
(18 to 39)
868 
(834 to 900)
68 
(55 to 95)
0·05 
(-0·39 to 0·52)
-2·72 
(-4·00 to -1·27)
-0·41 
(-0·65 to -0·21)
-4·58 
(-6·05 to -2·63)
United Kingdom 5798 (5602 to 5988)
285 
(210 to 331)
4306 
(4166 to 4446)
186 
(142 to 213)
10 104 
(9811 to 10 382)
471 
(367 to 530)
0·42 
(0·08 to 0·81)
-3·57 
(-4·51 to -3·16)
1·04 
(0·86 to 1·23)
-2·66 
(-3·91 to -1·71)
36 216
(34 796 to 37 724)
2556
(2128 to 3594)
26 385
(25 388 to 27 420)
1441
(1197 to 1753)
62 601
(60 306 to 64 967)
3997
(3456 to 5090)
-0·01
(-0·31 to 0·32)
-8·25
(-9·07 to -5·88)
-0·81
(-1·04 to -0·54)
-4·86
(-5·88 to -3·78)
Bolivia 7516 (7087 to 7915)
410 
(293 to 571)
5200 
(4952 to 5409)
316 
(223 to 447)
12 716 
(12 140 to 13 247)
726 
(565 to 923)
1·15 
(0·44 to 1·72)
-7·16 
(-9·13 to -5·10)
-0·87 
(-1·16 to -0·56)
-4·80 
(-6·69 to -2·93)
Ecuador 8555 (8105 to 9016)
711 
(562 to 992)
5711 
(5444 to 5981)
324 
(239 to 416)
14 266 
(13 639 to 14 930)
1035 
(863 to 1329)
-0·32 
(-0·77 to 0·20)
-4·72 
(-5·59 to -3·86)
-1·06 
(-1·38 to -0·69)
-5·13 
(-6·60 to -3·45)
Peru 20 145 (19 215 to 21 153)
1435 
(1100 to 2157)
15 475 
(14 761 to 16 181)
801 
(619 to 1074)
35 619 
(34 227 to 37 172)
2236 
(1825 to 3032)
-0·20 
(-0·57 to 0·17)
-9·77 
(-10·94 to -6·02)
-0·67 
(-0·95 to -0·33)
-4·67 
(-6·14 to -3·14)
43 749
(42 613 to 44 861)
4446
(4041 to 5766)
28 824
(28 022 to 29 525)
1800
(1614 to 2107)
72 573
(70 783 to 74 324)
6245
(5761 to 7658)
0·79
(0·55 to 0·96)
-7·53
(-7·85 to -6·72)
-1·67
(-1·81 to -1·53)
-4·21
(-4·74 to -3·03)
Colombia 9703 (9371 to 10 025)
1009 
(765 to 1259)
6397 
(6152 to 6646)
389 
(304 to 504)
16 099 
(15 579 to 16 618)
1398 
(1130 to 1664)
0·62 
(0·20 to 1·07)
-4·70 
(-5·68 to -3·86)
0·14 
(-0·12 to 0·40)
-3·28 
(-4·63 to -1·97)
Costa Rica 581 (556 to 607)
46 
(39 to 67)
278 
(266 to 291)
20 
(16 to 27)
859 
(827 to 891)
67 
(58 to 91)
2·72 
(2·24 to 3·20)
-4·16 
(-5·40 to -1·82)
-4·85 
(-5·10 to -4·61)
-5·35 
(-6·60 to -3·31)
El Salvador 1058 (1021 to 1091)
75 
(58 to 121)
676 
(653 to 700)
35 
(26 to 51)
1734 
(1682 to 1783)
110 
(89 to 166)
3·22 
(2·65 to 3·76)
-8·40 
(-9·59 to -5·49)
-2·71 
(-2·92 to -2·50)
-4·25 
(-5·74 to -1·83)
Guatemala 3210 (3023 to 3404)
281 
(231 to 447)
2289 
(2138 to 2420)
162 
(132 to 220)
5500 
(5193 to 5787)
444 
(384 to 647)
1·96 
(1·60 to 2·33)
-8·36 
(-9·30 to -5·06)
-2·93 
(-3·28 to -2·46)
-4·87 
(-5·90 to -3·15)
Honduras 1871 (1737 to 1973)
163 
(111 to 245)
1202 
(1115 to 1267)
71 
(45 to 104)
3073 
(2868 to 3219)
234 
(170 to 317)
2·15 
(1·26 to 2·69)
-3·08 
(-5·53 to -0·88)
-1·71 
(-2·13 to -0·60)
-3·17 
(-5·35 to -0·69)
Mexico 18 799 (18 137 to 19 577)
2067 
(1900 to 2795)
12 333 
(11 807 to 12 760)
742 
(665 to 934)
31 132 
(30 075 to 32 230)
2808 
(2607 to 3614)
0·21 
(-0·19 to 0·49)
-9·45 
(-9·77 to -8·61)
-2·54 
(-2·76 to -2·33)
-4·83 
(-5·38 to -2·74)
Nicaragua 1308 (1256 to 1356)
131 
(110 to 186)
984 
(950 to 1023)
64 
(53 to 79)
2292 
(2216 to 2364)
195 
(170 to 252)
1·80 
(1·45 to 2·17)
-4·76 
(-5·85 to -3·06)
-2·64 
(-2·84 to -2·43)
-5·94 
(-7·06 to -3·97)
Panama 1108 (1067 to 1149)
147 
(117 to 182)
623 
(602 to 645)
74 
(52 to 94)
1731 
(1681 to 1784)
221 
(178 to 257)
0·46 
(0·14 to 0·80)
-3·18 
(-4·29 to -2·00)
-0·70 
(-0·93 to -0·48)
-2·08 
(-3·44 to -0·78)
Venezuela 6112 (5864 to 6352)
527 
(440 to 672)
4043 
(3900 to 4196)
242 
(193 to 301)
10 154 
(9802 to 10 512)
769 
(671 to 953)
1·30 
(0·80 to 1·78)
-4·11 
(-5·00 to -3·28)
-0·49 
(-0·76 to -0·26)
-3·44 
(-4·56 to -2·09)
9688
(9376 to 10 011)
903
(801 to 1083)
7399
(7165 to 7652)
478
(376 to 569)
17 086
(16 596 to 17 583)
1381
(1245 to 1552)
1·42
(1·06 to 1·78)
-4·77
(-5·78 to -4·23)
-2·60
(-2·79 to -2·43)
-3·35
(-4·03 to -2·70)
Argentina 7099 (6824 to 7376)
483 
(417 to 641)
6036 
(5827 to 6272)
243 
(203 to 301)
13 135 
(12 732 to 13 551)
726 
(650 to 901)
2·19 
(1·71 to 2·64)
-4·75 
(-5·44 to -3·87)
-2·52 
(-2·74 to -2·31)
-3·84 
(-4·64 to -2·91)
Chile 2030 (1945 to 2112)
378 
(307 to 445)
1087 
(1045 to 1128)
214 
(125 to 279)
3117 
(3000 to 3222)
592 
(462 to 682)
-0·95 
(-1·24 to -0·66)
-4·67 
(-8·82 to -3·54)
-3·04 
(-3·30 to -2·80)
-3·09 
(-4·21 to -2·00)
Andean Latin America
Central Latin America
Southern Latin America
Confidential draft. Please do not cite or circulate.
Uruguay 559 (538 to 585)
42 
(34 to 53)
275 
(265 to 285)
21 
(16 to 28)
834 
(809 to 864)
63 
(54 to 75)
0·24 
(-0·09 to 0·54)
-6·04 
(-7·31 to -2·82)
-1·64 
(-1·82 to -1·44)
-3·69 
(-4·84 to -2·50)
73 306
(70 470 to 76 015)
4403
(3323 to 5088)
38 108
(36 706 to 39 505)
1680
(1019 to 2013)
111 414
(107 496 to 115 183)
6083
(4538 to 6844)
0·53
(0·09 to 0·98)
-2·46
(-6·28 to -1·55)
-1·25
(-1·48 to -1·06)
-4·33
(-5·36 to -3·47)
Brazil 70 916 (68 130 to 73 599)
4184 
(3070 to 4864)
36 902 
(35 531 to 38 259)
1604 
(954 to 1934)
107 818 
(103 978 to 111 454)
5788 
(4226 to 6524)
0·51 
(0·06 to 0·96)
-2·48 
(-6·52 to -1·54)
-1·25 
(-1·48 to -1·05)
-4·45 
(-5·55 to -3·58)
Paraguay 2390 (2303 to 2479)
219 
(174 to 284)
1206 
(1159 to 1255)
75 
(57 to 96)
3596 
(3475 to 3717)
295 
(243 to 359)
0·31 
(-0·09 to 0·64)
-1·86 
(-3·01 to 0·40)
-1·95 
(-2·18 to -1·71)
-1·00 
(-2·49 to 0·33)
86 141
(83 903 to 88 660)
8299
(7259 to 10 104)
68 242
(66 546 to 69 943)
6920
(5792 to 8585)
154 383
(150 668 to 158 377)
15 219
(13 553 to 18 407)
1·06
(0·84 to 1·29)
-3·72
(-4·35 to -3·07)
-1·11
(-1·19 to -1·04)
-4·58
(-5·34 to -3·89)
Algeria 11 691 (11 189 to 12 162)
955 
(739 to 1181)
8879 
(8507 to 9238)
773 
(435 to 988)
20 570 
(19 806 to 21 341)
1728 
(1282 to 2038)
2·37 
(1·91 to 2·84)
-4·03 
(-6·09 to -2·11)
-0·39 
(-0·61 to -0·19)
-4·59 
(-6·49 to -2·96)
Bahrain 213 (203 to 224)
6 
(5 to 9)
103 
(98 to 107)
3 
(2 to 3)
316 
(303 to 329)
9 
(7 to 11)
3·34 
(2·94 to 3·74)
0·16 
(-4·67 to 2·36)
-1·11 
(-1·33 to -0·88)
-7·09 
(-9·11 to -5·05)
Egypt 9949 (9524 to 10 386)
566 
(461 to 812)
6400 
(6127 to 6676)
271 
(222 to 342)
16 349 
(15 790 to 16 971)
837 
(715 to 1107)
-0·59 
(-0·98 to -0·24)
-6·15 
(-7·43 to -4·74)
-1·99 
(-2·23 to -1·73)
-5·27 
(-6·55 to -3·58)
Iran 8393 (8006 to 8818)
829 
(373 to 1060)
8093 
(7739 to 8472)
573 
(203 to 757)
16 485 
(15 864 to 17 177)
1402 
(601 to 1689)
0·38 
(-0·05 to 0·80)
-1·99 
(-8·10 to 0·16)
-1·58 
(-1·83 to -1·32)
-3·67 
(-8·62 to -1·85)
Iraq 6817 (6557 to 7089)
531 
(359 to 767)
5875 
(5640 to 6102)
518 
(344 to 741)
12 693 
(12 244 to 13 108)
1050 
(791 to 1352)
2·10 
(1·61 to 2·66)
-0·06 
(-2·54 to 2·43)
0·34 
(0·14 to 0·52)
-2·74 
(-4·90 to -0·53)
Jordan 233 (223 to 243)
14 
(10 to 19)
294 
(283 to 306)
9 
(7 to 12)
527 
(508 to 545)
23 
(19 to 27)
-1·51 
(-1·82 to -1·19)
-4·05 
(-6·24 to -1·60)
-2·61 
(-2·85 to -2·38)
-6·29 
(-8·15 to -4·24)
Kuwait 543 (519 to 569)
16 
(14 to 20)
399 
(383 to 414)
12 
(8 to 15)
943 
(906 to 980)
28 
(24 to 32)
-0·93 
(-1·26 to -0·59)
-4·24 
(-7·68 to -2·34)
0·02 
(-0·16 to 0·19)
-4·47 
(-6·08 to -2·88)
Lebanon 297 (284 to 308)
27 
(18 to 39)
351 
(339 to 364)
18 
(10 to 31)
647 
(627 to 667)
45 
(30 to 61)
-2·56 
(-2·92 to -2·15)
-6·13 
(-8·30 to -3·44)
0·08 
(-0·11 to 0·25)
-3·76 
(-5·73 to -1·72)
Libya 1159 (1107 to 1205)
47 
(34 to 62)
773 
(738 to 808)
27 
(20 to 36)
1932 
(1858 to 1999)
74 
(59 to 90)
-0·17 
(-0·48 to 0·14)
-3·92 
(-6·37 to -1·01)
-0·29 
(-0·51 to -0·09)
-2·09 
(-4·07 to -0·11)
Morocco 13 415 (13 005 to 13 883)
1945 
(1447 to 2587)
10 017 
(9667 to 10 323)
1191 
(772 to 1555)
23 432 
(22 701 to 24 090)
3135 
(2448 to 3831)
2·10 
(1·76 to 2·45)
-4·26 
(-5·86 to -2·60)
-0·35 
(-0·56 to -0·18)
-3·98 
(-5·54 to -2·43)
Oman 324 (308 to 341)
21 
(15 to 29)
212 
(205 to 221)
11 
(8 to 15)
537 
(517 to 558)
32 
(25 to 40)
0·07 
(-0·26 to 0·39)
-4·07 
(-7·49 to -1·27)
-0·93 
(-1·13 to -0·72)
-1·32 
(-4·47 to 1·22)
Palestine 212 (198 to 227)
3 
(2 to 6)
101 
(93 to 109)
2 
(1 to 3)
314 
(294 to 334)
4 
(3 to 8)
-1·13 
(-1·49 to -0·74)
-9·54 
(-11·95 to -6·97)
-0·81 
(-1·12 to -0·54)
-6·67 
(-9·40 to 0·66)
Qatar 628 (599 to 655)
4 
(3 to 5)
136 
(131 to 142)
1 
(1 to 1)
764 
(730 to 794)
5 
(4 to 6)
-1·07 
(-1·39 to -0·69)
-10·71 
(-13·40 to -1·51)
-0·21 
(-0·44 to 0·04)
-6·72 
(-8·60 to -4·88)
Saudi Arabia 3326 (3194 to 3457)
515 
(405 to 678)
2121 
(2035 to 2200)
378 
(287 to 464)
5447 
(5253 to 5623)
894 
(760 to 1066)
-0·24 
(-0·61 to 0·17)
-4·01 
(-6·99 to -1·46)
-1·36 
(-1·57 to -1·15)
-5·23 
(-6·74 to -3·50)
Sudan 12 035 (11 497 to 12 546)
1041 
(619 to 1638)
9052 
(8705 to 9391)
1260 
(688 to 2041)
21 086 
(20 354 to 21 845)
2301 
(1596 to 3312)
3·49 
(3·02 to 3·95)
-1·53 
(-3·42 to 0·50)
-1·42 
(-1·67 to -1·20)
-4·66 
(-6·36 to -3·02)
Syria 2301 (2203 to 2391)
34 
(22 to 76)
2229 
(2149 to 2311)
22 
(16 to 39)
4530 
(4378 to 4678)
56 
(42 to 109)
-0·81 
(-1·17 to -0·47)
-17·86 
(-22·06 to -7·72)
-1·32 
(-1·55 to -1·09)
-4·47 
(-6·76 to -2·18)
Tunisia 1962 (1888 to 2037)
108 
(69 to 150)
1247 
(1201 to 1290)
50 
(28 to 75)
3209 
(3099 to 3306)
158 
(108 to 204)
-0·12 
(-0·56 to 0·33)
-6·73 
(-8·86 to -4·62)
-0·18 
(-0·37 to 0·01)
-3·17 
(-5·22 to -1·07)
Turkey 12 762 (12 296 to 13 256)
769 
(600 to 1000)
8146 
(7902 to 8442)
310 
(199 to 374)
20 908 
(20 284 to 21 577)
1079 
(894 to 1303)
-0·13 
(-0·52 to 0·25)
-7·47 
(-8·63 to -6·29)
-0·63 
(-0·85 to -0·40)
-6·89 
(-8·50 to -5·40)
United Arab Emirates 182 (160 to 205)
41 
(23 to 73)
132 
(122 to 144)
11 
(6 to 20)
314 
(284 to 348)
52 
(33 to 88)
-2·06 
(-2·49 to -1·61)
-5·67 
(-9·36 to -2·35)
-2·43 
(-2·70 to -2·14)
-3·48 
(-5·91 to -1·39)
Yemen 4060 (3889 to 4231)
818 
(454 to 1807)
3532 
(3386 to 3664)
1473 
(797 to 3012)
7592 
(7305 to 7839)
2291 
(1316 to 4607)
1·76 
(1·44 to 2·11)
-2·58 
(-5·41 to 0·43)
-2·88 
(-3·15 to -2·65)
-3·23 
(-5·60 to -0·46)
Tropical Latin America
North Africa and Middle East
Confidential draft. Please do not cite or circulate.
11 875
(11 372 to 12 364)
707
(586 to 1241)
6941
(6674 to 7204)
471
(369 to 816)
18 816
(18 130 to 19 491)
1177
(998 to 1966)
-0·80
(-1·03 to -0·55)
-6·84
(-7·96 to -1·42)
-3·36
(-3·59 to -3·14)
-4·14
(-5·14 to -1·90)
Canada 1100 (1058 to 1143)
76 
(62 to 95)
825 
(793 to 860)
68 
(51 to 89)
1925 
(1856 to 1997)
144 
(121 to 173)
-0·16 
(-0·40 to 0·09)
-4·31 
(-5·58 to -3·26)
-2·78 
(-3·01 to -2·58)
-3·95 
(-5·23 to -2·44)
United States 10 773 (10 289 to 11 246)
630 
(513 to 1154)
6115 
(5872 to 6358)
403 
(304 to 747)
16 888 
(16 246 to 17 509)
1033 
(862 to 1814)
-0·81 
(-1·06 to -0·55)
-7·17 
(-8·41 to -1·17)
-3·39 
(-3·64 to -3·16)
-3·97 
(-5·06 to -1·57)
4645
(4489 to 4814)
704
(400 to 1623)
4218
(4075 to 4362)
446
(267 to 1000)
8864
(8595 to 9143)
1150
(683 to 2513)
-0·68
(-1·08 to -0·32)
-6·29
(-8·55 to -2·59)
0·77
(0·60 to 0·98)
-2·96
(-4·58 to -0·91)
Federated States of Micronesia 43 (39 to 48)
7 
(4 to 11)
40 
(35 to 44)
5 
(3 to 9)
83 
(75 to 93)
12 
(8 to 19)
-0·67 
(-1·17 to -0·17)
-3·90 
(-6·15 to -1·42)
-0·43 
(-0·85 to 0·00)
-4·15 
(-6·50 to -1·65)
Fiji 153 (146 to 159)
22 
(17 to 33)
122 
(117 to 127)
13 
(10 to 18)
275 
(266 to 284)
36 
(29 to 46)
0·06 
(-0·27 to 0·40)
-4·59 
(-6·81 to -2·51)
-3·38 
(-3·61 to -3·14)
-7·39 
(-9·55 to -3·01)
Kiribati 142 (137 to 146)
10 
(7 to 15)
123 
(119 to 127)
8 
(5 to 13)
265 
(258 to 272)
18 
(13 to 25)
3·44 
(2·90 to 3·98)
-5·99 
(-8·49 to -2·65)
1·77 
(1·49 to 1·96)
-4·42 
(-6·74 to -2·12)
Marshall Islands 44 (42 to 47)
3 
(2 to 4)
45 
(42 to 48)
2 
(1 to 4)
89 
(85 to 94)
5 
(4 to 7)
1·13 
(0·54 to 1·75)
-0·90 
(-3·42 to 1·88)
0·18 
(-0·15 to 0·45)
-4·86 
(-7·59 to -1·77)
Papua New Guinea 3343 (3217 to 3481)
475 
(241 to 1242)
3067 
(2954 to 3184)
258 
(134 to 765)
6409 
(6196 to 6628)
733 
(387 to 1938)
-1·30 
(-1·80 to -0·81)
-7·41 
(-10·18 to -2·60)
1·36 
(1·14 to 1·64)
-2·15 
(-4·02 to 0·10)
Samoa 38 (37 to 40)
3 
(1 to 7)
28 
(26 to 29)
6 
(1 to 17)
66 
(64 to 69)
10 
(2 to 20)
0·12 
(-0·18 to 0·39)
-5·63 
(-8·20 to -3·08)
-0·65 
(-0·91 to -0·41)
-3·72 
(-6·24 to -0·78)
Solomon Islands 285 (274 to 294)
51 
(32 to 77)
279 
(267 to 289)
64 
(31 to 106)
563 
(545 to 580)
115 
(67 to 176)
0·65 
(0·19 to 1·01)
-3·63 
(-5·86 to -1·37)
-0·79 
(-0·98 to -0·56)
-3·98 
(-6·07 to -1·56)
Tonga 20 (19 to 21)
2 
(1 to 2)
16 
(15 to 17)
2 
(1 to 4)
36 
(34 to 38)
4 
(3 to 5)
-0·44 
(-0·75 to -0·14)
-3·64 
(-6·23 to -1·28)
-1·91 
(-2·21 to -1·64)
-5·15 
(-7·36 to -2·38)
Vanuatu 63 (60 to 65)
19 
(12 to 29)
68 
(66 to 71)
23 
(11 to 39)
131 
(127 to 136)
42 
(25 to 66)
-1·10 
(-1·41 to -0·79)
-2·90 
(-5·22 to -0·49)
-0·78 
(-1·03 to -0·53)
-4·56 
(-6·71 to -1·95)
114 571
(107 911 to 120 891)
33 525
(25 993 to 41 648)
87 499
(82 703 to 92 494)
17 485
(13 887 to 21 598)
202 070
(191 398 to 212 432)
51 009
(41 734 to 60 076)
0·62
(0·14 to 1·07)
-0·12
(-1·35 to 1·27)
0·06
(-0·13 to 0·27)
-3·41
(-4·67 to -1·99)
Angola 19 588 (18 242 to 20 956)
5969 
(3248 to 9477)
15 174 
(14 016 to 16 231)
2863 
(1863 to 4366)
34 762 
(32 403 to 37 070)
8832 
(5359 to 13 612)
-1·42 
(-2·07 to -0·79)
-1·98 
(-4·23 to 0·51)
-0·13 
(-0·46 to 0·17)
-5·32 
(-8·13 to -2·53)
Central African Republic 7034 (6346 to 7738)
2236 
(1447 to 2967)
5389 
(4875 to 5960)
1637 
(1103 to 2296)
12 423 
(11 309 to 13 628)
3873 
(2704 to 4851)
1·04 
(0·02 to 1·95)
0·03 
(-1·58 to 1·56)
-0·65 
(-1·20 to -0·17)
-1·87 
(-3·39 to -0·30)
Congo 4248 (3927 to 4561)
986 
(463 to 1355)
3486 
(3234 to 3753)
354 
(179 to 488)
7734 
(7204 to 8267)
1340 
(665 to 1727)
-0·31 
(-0·90 to 0·25)
-0·56 
(-2·25 to 1·06)
0·32 
(-0·11 to 0·78)
-3·13 
(-4·78 to -1·42)
Democratic Republic of the 
Congo
79 732 
(74 757 to 84 369)
23 672 
(17 122 to 31 677)
60 129 
(56 560 to 63 798)
12 414 
(9525 to 15 979)
139 861 
(132 598 to 147 281)
36 085 
(28 514 to 45 093)
1·27 
(0·71 to 1·77)
0·54 
(-1·12 to 2·69)
0·16 
(-0·10 to 0·43)
-3·04 
(-4·69 to -1·29)
Equatorial Guinea 518 (455 to 575)
164 
(49 to 278)
389 
(339 to 433)
93 
(29 to 178)
907 
(803 to 1007)
257 
(84 to 422)
-0·71 
(-1·43 to -0·14)
-3·80 
(-7·15 to -1·08)
0·43 
(-0·14 to 0·92)
-5·54 
(-9·39 to -2·50)
Gabon 3450 (3120 to 3833)
497 
(218 to 697)
2932 
(2730 to 3148)
125 
(62 to 179)
6383 
(5896 to 6882)
623 
(299 to 826)
-0·69 
(-1·63 to 0·31)
1·59 
(-0·73 to 3·64)
1·41 
(1·01 to 1·84)
-2·13 
(-3·86 to -0·45)
326 105
(307 524 to 347 855)
100 724
(81 254 to 111 357)
227 786
(214 817 to 242 641)
70 740
(56 858 to 78 604)
553 891
(522 812 to 589 662)
171 464
(145 647 to 185 375)
-0·99
(-1·42 to -0·54)
-0·67
(-1·82 to 0·09)
-0·34
(-0·52 to -0·16)
-3·08
(-4·12 to -2·40)
Burundi 8469 (7891 to 8974)
5140 
(3037 to 7242)
5083 
(4729 to 5420)
2432 
(1539 to 3512)
13 553 
(12 704 to 14 335)
7572 
(5442 to 10 002)
-1·75 
(-2·51 to -1·01)
0·90 
(-0·79 to 2·79)
-0·71 
(-1·22 to -0·20)
-3·35 
(-5·09 to -1·71)
Comoros 274 (249 to 298)
252 
(140 to 388)
163 
(147 to 179)
130 
(77 to 212)
437 
(400 to 475)
382 
(251 to 530)
-1·51 
(-1·93 to -1·07)
1·82 
(-0·60 to 4·34)
-0·99 
(-1·46 to -0·53)
-1·21 
(-3·38 to 0·75)
Djibouti 1238 (1160 to 1318)
249 
(131 to 455)
681 
(638 to 722)
124 
(49 to 246)
1919 
(1808 to 2027)
372 
(213 to 649)
2·29 
(1·36 to 3·33)
4·84 
(1·85 to 7·69)
-1·35 
(-1·74 to -0·91)
-2·05 
(-4·46 to 0·41)
Eritrea 2443 (2265 to 2637)
1862 
(1218 to 2781)
2138 
(1986 to 2301)
1275 
(768 to 1967)
4582 
(4280 to 4895)
3137 
(2364 to 4419)
-2·54 
(-3·18 to -1·95)
-3·50 
(-7·18 to -0·29)
-0·46 
(-0·98 to 0·04)
-0·44 
(-2·52 to 2·32)
Central Sub-Saharan Africa
Eastern Sub-Saharan Africa
High-income North America
Oceania
Confidential draft. Please do not cite or circulate.
Ethiopia 65 303 (60 948 to 69 848)
29 593 
(23 362 to 36 203)
51 751 
(48 490 to 54 753)
20 595 
(16 355 to 25 142)
117 053 
(110 158 to 124 123)
50 188 
(42 276 to 58 367)
-1·43 
(-2·14 to -0·80)
-2·97 
(-4·42 to -1·56)
-0·34 
(-0·78 to 0·13)
-3·43 
(-5·14 to -2·08)
Kenya 61 605 (56 119 to 67 928)
11 395 
(8667 to 14 118)
44 251 
(40 340 to 48 438)
6502 
(4931 to 8374)
105 856 
(96 915 to 115 666)
17 898 
(14 693 to 20 861)
-3·01 
(-3·82 to -2·14)
0·11 
(-1·61 to 1·83)
0·91 
(0·47 to 1·32)
-3·18 
(-4·75 to -1·69)
Madagascar 28 720 (26 533 to 30 590)
2500 
(1536 to 3896)
19 627 
(18 101 to 20 984)
1208 
(722 to 1901)
48 347 
(44 889 to 51 382)
3707 
(2528 to 5317)
3·48 
(2·31 to 4·56)
-1·68 
(-3·78 to 0·22)
-0·11 
(-0·46 to 0·34)
-2·58 
(-4·97 to -0·15)
Malawi 7370 (6519 to 8387)
4849 
(3792 to 6091)
6187 
(5510 to 7018)
3453 
(2663 to 4329)
13 558 
(12 132 to 15 242)
8302 
(6970 to 9744)
-1·14 
(-2·02 to -0·53)
1·45 
(-0·12 to 2·81)
-0·56 
(-0·93 to -0·19)
-3·87 
(-5·49 to -2·42)
Mauritius 230 (215 to 246)
12 
(9 to 15)
100 
(94 to 106)
2 
(2 to 3)
330 
(312 to 349)
14 
(12 to 17)
-0·94 
(-1·36 to -0·46)
-7·88 
(-9·06 to -6·43)
-4·31 
(-4·68 to -3·94)
-3·18 
(-4·76 to -1·55)
Mozambique 29 668 (25 448 to 34 673)
9214 
(7203 to 11 545)
16 854 
(14 214 to 19 640)
5735 
(4380 to 7257)
46 522 
(39 804 to 53 743)
14 950 
(12 303 to 17 475)
-3·04 
(-3·98 to -1·98)
-0·97 
(-2·56 to 0·60)
-1·81 
(-2·31 to -1·17)
-1·94 
(-3·39 to -0·57)
Rwanda 6636 (6158 to 7123)
2827 
(1698 to 4085)
4032 
(3767 to 4311)
1228 
(801 to 1779)
10 668 
(10 014 to 11 354)
4055 
(2621 to 5504)
1·43 
(0·77 to 2·11)
0·81 
(-2·22 to 2·74)
0·22 
(-0·19 to 0·59)
-6·62 
(-8·51 to -5·03)
Seychelles 45 (41 to 48)
1 
(1 to 2)
32 
(30 to 34)
0 
(0 to 0)
77 
(72 to 82)
2 
(1 to 2)
-0·07 
(-0·55 to 0·52)
8·54 
(-5·51 to 11·90)
-2·18 
(-2·58 to -1·75)
-2·85 
(-4·74 to -1·02)
Somalia 12 912 (12 172 to 13 747)
3702 
(2227 to 6112)
7816 
(7323 to 8227)
4964 
(2942 to 7757)
20 728 
(19 605 to 21 824)
8667 
(5501 to 13 266)
0·00 
(-0·67 to 0·73)
3·50 
(0·65 to 6·21)
-0·24 
(-0·57 to 0·08)
-0·04 
(-2·14 to 2·61)
South Sudan 10 187 (9231 to 11 115)
5002 
(3165 to 6780)
5276 
(4768 to 5726)
3376 
(2373 to 4474)
15 463 
(14 087 to 16 764)
8378 
(6420 to 10 484)
-0·26 
(-1·43 to 0·72)
2·66 
(-1·35 to 5·22)
-1·21 
(-2·13 to -0·55)
-1·72 
(-4·17 to 0·41)
Tanzania 23 582 (21 502 to 25 681)
10 942 
(7615 to 14 080)
16 759 
(15 183 to 18 327)
9099 
(6309 to 11 620)
40 341 
(36 939 to 43 710)
20 041 
(14 575 to 24 332)
-0·91 
(-1·47 to -0·32)
0·84 
(-0·52 to 2·22)
-0·34 
(-0·66 to 0·00)
-2·57 
(-4·76 to -1·04)
Uganda 28 674 (25 605 to 31 944)
8923 
(5823 to 11 569)
18 418 
(16 646 to 20 441)
5815 
(3394 to 7326)
47 092 
(42 791 to 52 231)
14 738 
(9637 to 18 062)
0·90 
(0·16 to 1·58)
0·46 
(-1·22 to 2·04)
-1·26 
(-1·61 to -0·94)
-3·76 
(-5·20 to -2·24)
Zambia 26 785 (23 118 to 31 050)
4197 
(3120 to 5379)
19 554 
(17 143 to 22 604)
4760 
(3545 to 5975)
46 339 
(40 875 to 53 310)
8957 
(7242 to 10 668)
0·05 
(-0·60 to 0·63)
3·72 
(2·18 to 5·32)
0·40 
(-0·13 to 0·86)
-2·56 
(-4·03 to -0·99)
272 261
(241 833 to 311 989)
23 357
(19 033 to 27 878)
237 413
(209 522 to 273 154)
13 252
(10 527 to 16 642)
509 674
(455 681 to 580 571)
36 609
(31 228 to 41 720)
-4·68
(-5·73 to -3·43)
1·34
(-0·22 to 2·77)
0·17
(-0·23 to 0·57)
-4·12
(-5·91 to -2·91)
Botswana 4934 (4205 to 5877)
636 
(351 to 996)
4455 
(3757 to 5248)
319 
(167 to 509)
9389 
(8127 to 10 938)
956 
(588 to 1428)
-4·85 
(-5·75 to -3·67)
4·74 
(1·54 to 8·02)
-0·50 
(-1·00 to 0·08)
-6·62 
(-9·80 to -3·70)
Lesotho 3723 (3283 to 4338)
1887 
(1426 to 2373)
2712 
(2373 to 3188)
1539 
(979 to 2165)
6435 
(5692 to 7474)
3425 
(2662 to 4196)
-4·01 
(-5·27 to -2·51)
5·45 
(3·63 to 7·17)
4·05 
(3·77 to 4·32)
-1·52 
(-2·68 to -0·46)
Namibia 5530 (4773 to 6358)
1419 
(1050 to 1840)
4716 
(4055 to 5397)
771 
(580 to 976)
10 246 
(8987 to 11 696)
2189 
(1775 to 2654)
-2·07 
(-3·18 to -0·80)
2·91 
(1·43 to 4·46)
0·74 
(0·38 to 1·15)
-3·39 
(-4·78 to -2·01)
South Africa 217 545 (192 039 to 249 900)
13 138 
(10 056 to 16 480)
190 831 
(166 974 to 221 264)
6779 
(4934 to 9016)
408 376 
(363 668 to 466 379)
19 918 
(16 269 to 23 639)
-5·44 
(-6·61 to -4·11)
0·93 
(-1·12 to 2·79)
-0·08 
(-0·53 to 0·40)
-6·08 
(-8·53 to -4·44)
Swaziland 3426 (2949 to 4025)
652 
(395 to 865)
3086 
(2639 to 3705)
563 
(304 to 828)
6512 
(5645 to 7658)
1215 
(752 to 1536)
-4·20 
(-5·44 to -2·71)
6·31 
(4·21 to 8·34)
3·04 
(2·62 to 3·46)
-3·49 
(-4·98 to -1·90)
Zimbabwe 37 104 (32 309 to 42 857)
5625 
(3921 to 8124)
31 613 
(27 725 to 36 707)
3280 
(2078 to 4815)
68 717 
(60 653 to 78 743)
8905 
(6790 to 11 779)
-4·38 
(-5·13 to -3·64)
1·73 
(-0·26 to 3·54)
2·64 
(2·11 to 3·17)
1·30 
(-0·94 to 3·71)
255 207
(242 139 to 268 854)
53 088
(43 739 to 65 410)
149 320
(141 150 to 157 043)
34 426
(29 093 to 40 604)
404 527
(384 745 to 425 437)
87 515
(77 221 to 101 345)
-0·34
(-0·80 to 0·13)
-0·84
(-1·71 to -0·07)
-0·57
(-0·73 to -0·39)
-3·09
(-3·84 to -2·17)
Benin 6698 (6330 to 7098)
1521 
(1102 to 2066)
3663 
(3461 to 3858)
661 
(455 to 855)
10 361 
(9842 to 10 892)
2181 
(1687 to 2775)
-0·81 
(-1·41 to -0·29)
-0·89 
(-2·59 to 0·70)
-0·60 
(-0·90 to -0·27)
-1·17 
(-2·68 to 0·27)
Burkina Faso 8129 (7660 to 8652)
2690 
(1939 to 3409)
4308 
(4084 to 4545)
2248 
(1603 to 2909)
12 437 
(11 811 to 13 118)
4938 
(3773 to 5839)
-0·68 
(-1·27 to -0·12)
-0·62 
(-2·08 to 0·81)
-0·14 
(-0·64 to 0·37)
-0·27 
(-3·18 to 1·27)
Cameroon 22 407 (20 502 to 24 548)
2837 
(2162 to 3887)
14 476 
(13 221 to 15 747)
1748 
(1132 to 2228)
36 883 
(33 889 to 40 082)
4585 
(3672 to 5728)
-0·60 
(-1·61 to 0·37)
1·33 
(-0·23 to 2·86)
-0·58 
(-0·85 to -0·34)
-2·55 
(-3·99 to -0·96)
Cape Verde 534 (498 to 573)
30 
(16 to 48)
238 
(222 to 255)
12 
(4 to 19)
772 
(725 to 822)
41 
(23 to 63)
-0·19 
(-0·72 to 0·42)
-2·22 
(-5·07 to 0·79)
-0·61 
(-0·95 to -0·25)
-5·03 
(-7·79 to -2·43)
Southern Sub-Saharan Africa
Western Sub-Saharan Africa
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Chad 11 187 (10 264 to 12 122)
2390 
(1692 to 3397)
6101 
(5677 to 6570)
2690 
(1739 to 3764)
17 288 
(16 059 to 18 602)
5079 
(3874 to 6266)
-1·62 
(-2·29 to -0·99)
0·88 
(-0·73 to 2·45)
0·60 
(0·21 to 1·00)
-1·31 
(-2·73 to 0·12)
Cote d'Ivoire 17 640 (16 340 to 19 048)
4389 
(3289 to 5529)
11 389 
(10 512 to 12 294)
2138 
(1379 to 2701)
29 029 
(27 031 to 31 250)
6526 
(4937 to 7802)
-0·47 
(-1·24 to 0·28)
0·76 
(-1·02 to 2·61)
-0·74 
(-1·15 to -0·32)
-1·35 
(-2·69 to 0·02)
Ghana 12 926 (12 176 to 13 666)
2359 
(1804 to 3219)
7499 
(7080 to 7894)
1270 
(945 to 1681)
20 426 
(19 330 to 21 464)
3629 
(2962 to 4525)
-0·55 
(-1·25 to 0·07)
-5·66 
(-7·58 to -3·76)
-2·16 
(-2·49 to -1·85)
-5·38 
(-6·98 to -3·21)
Guinea 10 887 (10 170 to 11 592)
1874 
(1374 to 2509)
5891 
(5511 to 6272)
1605 
(1072 to 2321)
16 778 
(15 772 to 17 779)
3479 
(2696 to 4378)
0·73 
(0·14 to 1·33)
-0·74 
(-2·32 to 1·01)
-1·44 
(-1·79 to -1·10)
-0·68 
(-2·04 to 0·69)
Guinea-Bissau 1887 (1707 to 2058)
406 
(286 to 591)
1244 
(1131 to 1356)
284 
(189 to 402)
3131 
(2855 to 3399)
690 
(497 to 984)
-0·86 
(-1·53 to -0·16)
1·40 
(-1·17 to 4·00)
0·15 
(-0·41 to 0·69)
-1·20
(-3·81 to 1·42)
Liberia 5762 (5418 to 6140)
837 
(595 to 1212)
4623 
(4347 to 4890)
557 
(388 to 742)
10 384 
(9849 to 10 944)
1394 
(1081 to 1843)
-0·29 
(-1·17 to 0·61)
0·72 
(-1·11 to 2·93)
1·76 
(1·38 to 2·16)
-1·69 
(-3·23 to -0·22)
Mali 7940 (7504 to 8410)
2682 
(1849 to 3673)
4349 
(4132 to 4591)
1368 
(972 to 1939)
12 289 
(11 653 to 12 912)
4050 
(3212 to 5232)
-1·06 
(-1·68 to -0·50)
-2·09 
(-3·54 to -0·47)
-0·24 
(-0·55 to 0·14)
-1·21 
(-2·69 to 0·27)
Mauritania 7172 (6635 to 7684)
503 
(329 to 759)
3234 
(2976 to 3463)
321 
(200 to 483)
10 406 
(9667 to 11 067)
824 
(589 to 1108)
-0·01 
(-0·69 to 0·59)
-2·63 
(-5·32 to -0·46)
0·42 
(0·08 to 0·75)
-2·27 
(-3·86 to -0·95)
Niger 13 239 (12 554 to 13 971)
3151 
(2391 to 4336)
5498 
(5251 to 5759)
2218 
(1695 to 2844)
18 737 
(17 926 to 19 676)
5369 
(4389 to 6650)
0·32 
(-0·27 to 0·90)
-0·81 
(-2·45 to 0·62)
-0·33 
(-0·71 to 0·00)
-1·95 
(-3·43 to -0·45)
Nigeria 97 302 (89 158 to 105 772)
22 730 
(15 211 to 31 509)
59 901 
(54 701 to 65 227)
14 719 
(10 135 to 20 468)
157 203 
(145 193 to 169 957)
37 449 
(28 903 to 48 392)
-0·24 
(-0·94 to 0·42)
-0·64 
(-2·26 to 0·79)
-0·84 
(-1·21 to -0·44)
-4·22 
(-5·82 to -2·52)
Sao Tome and Principe 111 (89 to 120)
9 
(5 to 15)
75 
(67 to 79)
4 
(2 to 6)
186 
(157 to 199)
13 
(8 to 19)
0·50 
(-0·74 to 1·40)
-1·80 
(-4·37 to 0·61)
-0·59 
(-1·18 to -0·24)
-2·70 
(-5·55 to -0·04)
Senegal 12 866 (12 178 to 13 535)
2252 
(1492 to 3041)
6142 
(5851 to 6455)
1369 
(824 to 1953)
19 008 
(18 120 to 19 896)
3621 
(2596 to 4579)
-0·07 
(-0·50 to 0·33)
-1·79 
(-3·53 to -0·06)
-0·81 
(-1·10 to -0·48)
-2·28 
(-3·62 to -0·86)
Sierra Leone 13 131 (12 244 to 14 006)
1393 
(964 to 1976)
7366 
(6836 to 7836)
593 
(435 to 778)
20 497 
(19 213 to 21 774)
1986 
(1522 to 2579)
0·99 
(0·35 to 1·62)
1·67 
(-0·21 to 3·51)
1·09 
(0·69 to 1·48)
-2·20 
(-3·70 to -0·55)
The Gambia 2059 (1941 to 2172)
204 
(111 to 334)
1088 
(1024 to 1151)
88 
(49 to 141)
3147 
(2978 to 3308)
292 
(161 to 474)
-0·13 
(-0·53 to 0·31)
-0·23 
(-2·91 to 2·39)
0·32 
(0·08 to 0·55)
-2·19 
(-4·47 to 0·28)
Togo 3325 (3074 to 3607)
832 
(562 to 1231)
2232 
(2060 to 2388)
534 
(388 to 718)
5558 
(5161 to 5966)
1366 
(1038 to 1789)
-1·42 
(-2·23 to -0·63)
-0·83 
(-2·41 to 0·83)
0·51 
(0·22 to 0·81)
-2·43 
(-4·10 to -0·63)
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Incidence Mortality Incidence Mortality
Global 2360·42 (1373·81 to 4051·98)
11·78
 (9·69 to 14·21)
0·26
 (-1·02 to 1·12)
1·96
 (0·84 to 3·06)
-3·27
 (-4·99 to -1·18)
-3·11
 (-4·72 to -1·60)
High-income Asia Pacific 0·40 (0·34 to 0·47)
0·00
 (0·00 to 0·00)
-8·48
 (-9·93 to -7·09)
-18·55
 (-19·35 to -17·73)
-1·67
 (-2·28 to -1·18)
-16·79
 (-17·75 to -15·86)
Central Asia 0·19 (0·16 to 0·21)
0·02
 (0·01 to 0·03)
16·77
 (15·48 to 18·21)
-4·84
 (-9·03 to -0·29)
-38·41
 (-39·92 to -37·09)
-7·32
 (-10·76 to -3·15)
East Asia 0·23 (0·20 to 0·25)
0·01
 (0·01 to 0·01)
-0·60
 (-1·44 to 0·36)
-7·67
 (-9·34 to -6·02)
-19·91
 (-20·96 to -18·98)
-10·95
 (-13·09 to -8·36)
South Asia 4428·64 (1639·86 to 10 388·82)
9·08
 (7·00 to 11·73)
-2·00
 (-3·78 to -0·81)
-2·65
 (-4·27 to -0·91)
-3·33
 (-4·67 to -1·81)
-3·39
 (-5·45 to -1·31)
Southeast Asia 1231·49 (556·12 to 2635·04)
2·28
 (1·68 to 3·15)
-3·89
 (-5·56 to -2·16)
-4·54
 (-6·53 to -2·65)
-5·88
 (-8·59 to -3·01)
-6·89
 (-9·01 to -4·25)
Caribbean 245·54 (227·17 to 263·02)
0·91
 (0·51 to 1·47)
-3·35
 (-3·63 to -3·05)
-4·52
 (-6·90 to -1·78)
-4·08
 (-4·64 to -3·53)
-7·48
 (-11·51 to -3·38)
Andean Latin America 49·36 (42·60 to 55·80)
0·04
 (0·03 to 0·05)
-2·53
 (-3·04 to -2·04)
-5·70
 (-7·28 to -4·09)
-2·79
 (-3·64 to -2·05)
-13·80
 (-15·92 to -11·45)
Central Latin America 46·12 (40·32 to 51·63)
0·05
 (0·04 to 0·07)
-2·29
 (-2·75 to -1·85)
-5·58
 (-7·13 to -4·18)
-2·10
 (-2·76 to -1·51)
-10·06
 (-12·13 to -7·34)
Southern Latin America 0·95 (0·81 to 1·08)
0·00
 (0·00 to 0·00)
-9·52
 (-10·71 to -8·32)
-16·26
 (-17·13 to -15·40)
-3·21
 (-4·06 to -2·48)
-16·29
 (-17·17 to -15·43)
Tropical Latin America 62·80 (53·39 to 71·76)
0·03
 (0·02 to 0·05)
-6·49
 (-7·87 to -5·20)
-17·58
 (-19·80 to -15·41)
-0·11
 (-0·50 to 0·21)
-9·20
 (-12·22 to -5·86)
North Africa and Middle East 396·71 (122·46 to 1028·80)
1·97
 (1·07 to 3·48)
2·14
 (1·31 to 3·18)
3·88
 (0·73 to 7·01)
-5·74
 (-9·08 to -2·40)
-7·07
 (-10·62 to -3·04)
Oceania 10 452·65 (3908·47 to 25 253·80)
20·54
 (11·95 to 33·16)
-0·02
 (-0·25 to 0·19)
-0·30
 (-3·70 to 2·75)
-2·14
 (-3·14 to -1·05)
-2·61
 (-5·49 to 0·65)
Central Sub-Saharan Africa 6628·47 (3171·03 to 13 240·91)
43·15
 (28·36 to 63·55)
-2·74
 (-4·45 to -1·39)
-1·59
 (-4·08 to 1·08)
-5·13
 (-7·81 to -2·43)
-5·73
 (-9·03 to -2·28)
Eastern Sub-Saharan Africa 6411·66 (3214·47 to 12 802·02)
39·58
 (33·03 to 49·36)
0·41
 (-0·29 to 1·52)
0·77
 (-0·82 to 2·33)
-6·68
 (-8·94 to -3·58)
-6·76
 (-8·47 to -4·40)
Southern Sub-Saharan Africa 766·01 (315·25 to 1807·70)
4·21
 (3·22 to 5·76)
2·84
 (1·28 to 4·19)
2·85
 (-0·40 to 5·45)
-5·63
 (-8·37 to -2·64)
-7·30
 (-9·74 to -4·10)
Western Sub-Saharan Africa 11 874·88 (6907·10 to 20 684·35)
85·89
 (68·14 to 105·95)
0·90
 (0·26 to 1·72)
1·45
 (-0·24 to 3·18)
-3·79
 (-5·33 to -2·00)
-3·40
 (-5·15 to -1·56)
Table 6. Age-standardized malaria incidence and mortality rates (per 100 000) and annualized rates of change (%), with 95% UI, for 16 GBD regions.
Age-standardized rates
(per 100 000), 2013 Annualized rate of change (%)
Location Incidence Mortality
1990-2000 2000-2013
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Incidence Deaths Incidence Deaths Incidence Deaths Incidence Deaths Incidence Deaths
80 442 176
(46 673 036 to 138 440 048)
434 792
(337 311 to 564 653)
84 487 696
(48 637 128 to 145 153 824)
419 777
(341 821 to 517 091)
164 929 872
(95 399 904 to 284 354 624)
854 568
(702 884 to 1 032 471)
0·26
 (-1·02 to 1·12)
1·96
 (0·84 to 3·06)
-3·27
 (-4·99 to -1·18)
-3·11
 (-4·72 to -1·60)
357
(305 to 405)
0
(0 to 1)
357
(304 to 407)
0
(0 to 1)
713
(609 to 812)
0
(0 to 2)
-8·36
(-7·03 to -9·74)
-17·90
(-17·07 to -18·68)
-2·13
(-1·63 to -2·74)
-16·22
(-15·27 to -17·20)
80 441 816
(46 672 684 to 138 439 696)
434 792
(337 311 to 564 653)
84 487 336
(48 636 776 to 145 153 472)
419 776
(341 820 to 517 091)
164 929 152
(95 399 192 to 284 353 920)
854 568
(702 884 to 1 032 470)
-0·21
(0·75 to -1·57)
1·49
(2·53 to 0·43)
-3·45
(-1·35 to -5·15)
-3·29
(-1·84 to -4·85)
357
(305 to 405)
0
(0 to 1)
357
(304 to 407)
0
(0 to 1)
713
(609 to 812)
0
(0 to 2)
-8·48
 (-9·93 to -7·09)
-18·55
 (-19·35 to -17·73)
-1·67
 (-2·28 to -1·18)
-16·79
 (-17·75 to -15·86)
South Korea 357 (305 to 405)
0 
(0 to 1)
357 
(304 to 407)
0 
(0 to 1)
713 
(609 to 812)
0 
(0 to 2)
-10·95 
(-12·29 to -9·59)
-18·68 
(-19·49 to -17·87)
-4·01 
(-5·10 to -3·09)
-23·42 
(-24·62 to -22·22)
78
(68 to 87)
8
(4 to 16)
77
(67 to 87)
9
(5 to 15)
155
(135 to 174)
17
(12 to 28)
16·77
 (15·48 to 18·21)
-4·84
 (-9·03 to -0·29)
-38·41
 (-39·92 to -37·09)
-7·32
 (-10·76 to -3·15)
Armenia 0 (0 to 0)
0 
(0 to 0)
0 
(0 to 0)
0 
(0 to 0)
0 
(0 to 0)
0 
(0 to 0)
-9·57 
(-10·69 to -8·41)
-15·72 
(-16·70 to -14·75)
0·00 
(0·00 to 0·00)
0·00 
(0·00 to 0·00)
Azerbaijan 69 (59 to 78)
0 
(0 to 0)
68 
(58 to 78)
0 
(0 to 0)
137 
(117 to 156)
0 
(0 to 0)
-10·20 
(-11·30 to -9·07)
-15·90 
(-16·85 to -15·01)
-5·17 
(-6·43 to -4·07)
-21·56 
(-23·07 to -20·01)
Georgia 0 (0 to 0)
0 
(0 to 0)
0 
(0 to 0)
0 
(0 to 0)
0 
(0 to 0)
0 
(0 to 0)
-9·75 
(-10·91 to -8·56)
-16·20 
(-17·20 to -15·16)
0·00 
(0·00 to 0·00)
0·00 
(0·00 to 0·00)
Kyrgyzstan 0 (0 to 0)
0 
(0 to 0)
0 
(0 to 0)
0 
(0 to 0)
0 
(0 to 0)
0 
(0 to 0)
-41·62 
(-42·09 to -41·15)
-14·46 
(-15·47 to -13·49)
0·00 
(0·00 to 0·00)
0·00 
(0·00 to 0·00)
Tajikistan 9 (9 to 9)
8 
(4 to 16)
9 
(9 to 9)
9 
(5 to 15)
18 
(18 to 18)
17 
(12 to 28)
35·20 
(34·62 to 35·73)
-3·24 
(-6·10 to -0·23)
-72·55 
(-73·12 to -71·75)
-9·16 
(-12·51 to -5·11)
Turkmenistan 0 (0 to 0)
0 
(0 to 0)
0 
(0 to 0)
0 
(0 to 0)
0 
(0 to 0)
0 
(0 to 0)
-10·02 
(-10·94 to -9·05)
-14·45 
(-15·79 to -13·17)
0·00 
(0·00 to 0·00)
0·00 
(0·00 to 0·00)
Uzbekistan 0 (0 to 0)
0 
(0 to 0)
0 
(0 to 0)
0 
(0 to 0)
0 
(0 to 0)
0 
(0 to 0)
-9·49 
(-10·49 to -8·45)
-14·63 
(-15·54 to -13·68)
0·00 
(0·00 to 0·00)
0·00 
(0·00 to 0·00)
1215
(1110 to 1313)
88
(73 to 108)
1283
(1178 to 1379)
56
(45 to 73)
2498
(2299 to 2666)
144
(124 to 168)
-0·60
 (-1·44 to 0·36)
-7·67
 (-9·34 to -6·02)
-19·91
 (-20·96 to -18·98)
-10·95
 (-13·09 to -8·36)
China 1029 (928 to 1124)
88 
(73 to 108)
1091 
(987 to 1187)
56 
(45 to 72)
2121 
(1925 to 2281)
144 
(123 to 168)
-0·04 
(-0·98 to 1·06)
-7·61 
(-9·30 to -5·96)
-27·84 
(-29·46 to -26·45)
-14·23 
(-17·02 to -10·75)
North Korea 185 (161 to 209)
0 
(0 to 1)
192 
(167 to 217)
0 
(0 to 1)
377 
(328 to 425)
0 
(0 to 1)
-10·69 
(-11·70 to -9·61)
-15·7 
(-17·42 to -13·95)
-5·78 
(-7·10 to -4·61)
-20·55 
(-22·72 to -18·14)
28 475 300
(10 587 800 to 67 635 616)
56 349
(37 151 to 77 226)
33 373 982
(13 386 620 to 76 448 012)
65 428
(48 800 to 88 397)
61 849 284
(24 099 755 to 145 007 704)
121 777
(95 871 to 155 492)
-2·00
 (-3·78 to -0·81)
-2·65
 (-4·27 to -0·91)
-3·33
 (-4·67 to -1·81)
-3·39
 (-5·45 to -1·31)
Afghanistan 61 979 (52 009 to 72 293)
490 
(191 to 1019)
156 053 
(129 086 to 184 258)
1292 
(436 to 3052)
218 032 
(181 117 to 256 551)
1783 
(821 to 3659)
0·03 
(0·03 to 0·04)
0·09 
(-3·60 to 3·74)
-2·59 
(-2·62 to -2·57)
-2·59 
(-7·40 to 2·47)
Bangladesh 98 380 (82 421 to 113 840)
19 
(10 to 29)
95 500 
(79 870 to 110 636)
13 
(9 to 19)
193 880 
(162 292 to 224 476)
32 
(23 to 43)
-0·24 
(-0·39 to -0·12)
-4·19 
(-7·61 to -0·47)
-0·39 
(-0·62 to -0·22)
-14·43 
(-18·76 to -10·46)
Bhutan 2330 (2095 to 2541)
5 
(2 to 12)
1901 
(1693 to 2091)
4 
(2 to 9)
4231 
(3783 to 4628)
9 
(4 to 18)
-3·19 
(-3·50 to -2·86)
-4·68 
(-8·00 to -1·25)
-6·95 
(-8·13 to -5·83)
-15·71 
(-21·85 to -8·92)
India 27 961 284 (10 074 561 to 67 098 740)
54 179 
(35 494 to 74 975)
32 739 706
(12 716 841 to 75 811 540)
62 143 
(45 048 to 85 171)
60 700 992
(22 931 083 to 143 871 240)
116 322 
(90 658 to 149 612)
-1·89 
(-3·64 to -0·62)
-2·53 
(-4·23 to -0·79)
-4·41 
(-6·21 to -2·35)
-4·45 
(-7·17 to -1·68)
Nepal 29 278 (24 657 to 34 027)
228 
(47 to 605)
31 161 
(26 244 to 36 214)
243 
(48 to 725)
60 439 
(50 901 to 70 240)
471 
(207 to 983)
-4·76 
(-4·79 to -4·71)
-4·98 
(-8·32 to -1·48)
-7·92 
(-8·04 to -7·78)
-8·71 
(-12·82 to -4·29)
Pakistan 322 049 (296 287 to 347 753)
1427 
(668 to 3316)
349 662 
(319 168 to 380 514)
1733 
(1023 to 2640)
671 710 
(615 243 to 727 902)
3159 
(2008 to 5012)
-2·78 
(-3·00 to -2·54)
-3·39 
(-10·99 to 1·24)
-3·74 
(-4·17 to -3·31)
-5·94 
(-9·45 to -2·45)
4 132 009
(1 852 612 to 8 988 789)
7763
(5510 to 10 731)
3 646 243
(1 692 229 to 7 606 561)
6454
(4571 to 9267)
7 778 252
(3 535 079 to 16 619 553)
14 217
(10 315 to 19 781)
-3·89
 (-5·56 to -2·16)
-4·54
 (-6·53 to -2·65)
-5·88
 (-8·59 to -3·01)
-6·89
 (-9·01 to -4·25)
Cambodia 81 263 (68 959 to 93 966)
616 
(320 to 1034)
59 358 
(50 948 to 67 993)
426 
(232 to 731)
140 621 
(119 933 to 161 846)
1043 
(644 to 1568)
-1·39 
(-1·41 to -1·37)
-1·44 
(-4·84 to 1·64)
-9·94 
(-10·18 to -9·65)
-10·91 
(-14·24 to -7·12)
Location
Worldwide
Developed countries
Developing countries
Table 7. Malaria incidence and deaths for all ages by sex and combined and annualized rates of change (%), with 95% UI, for 105 countries.
All ages incidence and deaths, 2013 Annualized rate of change (%)
Male Female Total 1990-2000 2000-2013
High-income Asia Pacific
Central Asia
East Asia
South Asia
Southeast Asia
Confidential draft. Please do not cite or circulate.
Indonesia 1 076 361 (191 105 to 3 596 748)
1802 
(1320 to 2434)
927 470 
(158 478 to 3 289 462)
1341 
(1002 to 1749)
2 003 831 
(354 339 to 6 883 029)
3143 
(2418 to 4019)
-3·60 
(-5·19 to -1·74)
-3·37 
(-5·99 to -0·89)
-6·95 
(-9·97 to -3·59)
-6·75 
(-9·77 to -3·20)
Laos 19 132 (17 423 to 20 734)
50 
(16 to 104)
19 817 
(18 099 to 21 419)
55 
(17 to 148)
38 949 
(35 519 to 42 170)
105 
(47 to 227)
-3·07 
(-3·54 to -2·62)
-5·53 
(-10·64 to -1·69)
-2·22 
(-2·59 to -1·89)
-4·64 
(-11·51 to 0·25)
Malaysia 63 361 (53 065 to 73 334)
11 
(8 to 19)
65 962 
(55 033 to 76 567)
3 
(3 to 5)
129 323 
(108 082 to 149 901)
15 
(10 to 23)
-0·16 
(-0·36 to -0·01)
-7·42 
(-10·01 to -4·96)
-0·01 
(-0·14 to 0·09)
-11·90 
(-16·45 to -6·16)
Myanmar 2 459 973 (906 379 to 5 902 743)
4834 
(2817 to 7915)
2 156 398 
(835 746 to 4 950 837)
4322 
(2610 to 7099)
4 616 371 
(1 764 904 to 10 800 000)
9155 
(5590 to 14 544)
-3·55 
(-5·33 to -1·76)
-3·76 
(-6·69 to -0·96)
-8·26 
(-12·20 to -4·19)
-8·59 
(-12·30 to -4·30)
Philippines 283 519 (241 103 to 323 938)
155 
(105 to 233)
273 023 
(229 455 to 315 173)
75 
(50 to 105)
556 542 
(470 324 to 639 165)
230 
(166 to 326)
-2·47 
(-3·22 to -1·83)
-12·12 
(-13·41 to -10·84)
-0·37 
(-0·64 to -0·16)
-8·69 
(-12·22 to -4·95)
Sri Lanka 1475 (1246 to 1710)
11 
(7 to 21)
1259 
(1070 to 1453)
9 
(6 to 16)
2734 
(2316 to 3165)
21 
(14 to 34)
-10·46 
(-10·49 to -10·42)
-10·62 
(-14·16 to -7·17)
-18·38 
(-18·64 to -18·06)
-19·48 
(-24·40 to -13·76)
Thailand 83 572 (72 401 to 94 358)
78 
(45 to 136)
82 312 
(69 822 to 94 242)
41 
(29 to 58)
165 884 
(142 197 to 188 453)
118 
(78 to 184)
-8·27 
(-9·64 to -6·94)
-17·72 
(-19·18 to -16·20)
-2·13 
(-2·80 to -1·57)
-14·72 
(-18·69 to -9·75)
Timor-Leste 9968 (8560 to 11 314)
7 
(0 to 70)
10 356 
(9075 to 11 576)
13 
(0 to 69)
20 324 
(17 664 to 22 892)
21 
(3 to 108)
-4·39 
(-5·00 to -3·78)
-7·90 
(-13·71 to -2·64)
-5·40 
(-6·66 to -4·29)
-20·03 
(-42·35 to -5·16)
Vietnam 47 663 (44 070 to 51 177)
187 
(119 to 275)
45 016 
(41 641 to 48 218)
159 
(106 to 237)
92 679 
(85 719 to 99 315)
345 
(248 to 460)
-4·58 
(-4·87 to -4·25)
-5·75 
(-8·86 to -2·80)
-7·79 
(-8·76 to -6·80)
-13·09 
(-16·83 to -8·83)
50 098
(46 165 to 53 745)
165
(18 to 371)
59 643
(55 171 to 64 155)
239
(67 to 548)
109 741
(101 549 to 117 526)
404
(227 to 643)
-3·35
 (-3·63 to -3·05)
-4·52
 (-6·90 to -1·78)
-4·08
 (-4·64 to -3·53)
-7·48
 (-11·51 to -3·38)
Belize 18 (18 to 19)
1 
(1 to 2)
19 
(18 to 19)
0 
(0 to 1)
37 
(37 to 37)
1 
(1 to 2)
-9·26 
(-9·66 to -8·83)
3·53 
(0·26 to 6·57)
-39·76 
(-40·42 to -39·10)
-12·03 
(-17·78 to -6·05)
Dominican Republic 5029 (4326 to 5699)
4 
(2 to 7)
5075 
(4382 to 5736)
4 
(3 to 8)
10 104 
(8707 to 11 435)
8 
(5 to 13)
-1·48 
(-1·64 to -1·35)
-4·33 
(-7·40 to -1·63)
-1·31 
(-1·43 to -1·20)
-4·45 
(-10·01 to 1·21)
Guyana 2825 (2453 to 3184)
3 
(1 to 5)
2559 
(2166 to 2934)
1 
(1 to 2)
5383 
(4619 to 6113)
4 
(2 to 7)
-0·09 
(-0·11 to -0·07)
-0·28 
(-3·14 to 2·67)
-3·33 
(-4·23 to -2·57)
-17·15 
(-24·66 to -11·29)
Haiti 36 035 (33 327 to 38 617)
135 
(6 to 317)
44 517 
(40 927 to 48 139)
203 
(52 to 480)
80 552 
(74 426 to 86 878)
338 
(183 to 551)
-3·92 
(-4·15 to -3·66)
-4·91 
(-7·20 to -2·41)
-6·21 
(-6·81 to -5·59)
-9·61 
(-15·57 to -4·66)
Suriname 348 (312 to 383)
2 
(1 to 3)
183 
(168 to 197)
1 
(0 to 1)
530 
(486 to 575)
2 
(2 to 4)
-0·78 
(-0·92 to -0·66)
-0·24 
(-2·89 to 2·65)
-9·82 
(-10·50 to -9·10)
-13·38 
(-18·18 to -7·67)
0 
(0 to 0)
0 
(0 to 0)
0 
(0 to 0)
0 
(0 to 0)
3 
(3 to 3)
0 
(0 to 0)
0·00 
(0·00 to 0·00)
0·00 
(0·00 to 0·00)
0·00 
(0·00 to 0·00)
0·00 
(0·00 to 0·00)
Greece 0 (0 to 0)
0 
(0 to 0)
0 
(0 to 0)
0 
(0 to 0)
3 
(3 to 3)
0 
(0 to 0)
0·00 
(0·00 to 0·00)
0·00 
(0·00 to 0·00)
0·00 
(0·00 to 0·00)
0·00 
(0·00 to 0·00)
14 203
(12 281 to 16 046)
13
(10 to 16)
13 873
(11 903 to 15 753)
10
(8 to 14)
28 075
(24 173 to 31 791)
23
(18 to 29)
-2·53
 (-3·04 to -2·04)
-5·70
 (-7·28 to -4·09)
-2·79
 (-3·64 to -2·05)
-13·80
 (-15·92 to -11·45)
Bolivia 756 (665 to 841)
1 
(1 to 2)
749 
(657 to 835)
1 
(1 to 2)
1505 
(1323 to 1676)
2 
(2 to 3)
-3·23 
(-3·91 to -2·58)
-7·80 
(-11·61 to -4·50)
-1·92 
(-2·56 to -1·37)
-9·48 
(-12·67 to -6·26)
Ecuador 7617 (6556 to 8628)
6 
(4 to 9)
7625 
(6565 to 8633)
6 
(4 to 10)
15 242 
(13 121 to 17 261)
12 
(9 to 17)
-2·97 
(-3·42 to -2·52)
-5·63 
(-7·68 to -3·48)
-5·13 
(-6·38 to -4·03)
-20·80 
(-24·50 to -16·95)
Peru 5829 (5052 to 6580)
5 
(4 to 8)
5499 
(4672 to 6288)
3 
(2 to 4)
11 328 
(9724 to 12 860)
8 
(6 to 12)
-1·90 
(-2·47 to -1·35)
-5·98 
(-8·41 to -3·66)
-1·76 
(-2·64 to -1·00)
-14·85 
(-18·71 to -10·72)
56 110
(49 168 to 62 758)
69
(50 to 98)
55 170
(47 750 to 62 283)
49
(38 to 68)
111 280
(96 932 to 125 061)
118
(93 to 160)
-2·29
 (-2·75 to -1·85)
-5·58
 (-7·13 to -4·18)
-2·10
 (-2·76 to -1·51)
-10·06
 (-12·13 to -7·34)
Colombia 32 242 (28 091 to 36 221)
35 
(21 to 60)
31 681 
(27 161 to 35 989)
23 
(14 to 37)
63 924 
(55 318 to 72 202)
58 
(38 to 91)
2·72 
(2·19 to 3·33)
10·32 
(8·38 to 12·23)
-2·40 
(-3·18 to -1·74)
-13·59 
(-18·27 to -8·21)
Costa Rica 5 (4 to 5)
0 
(0 to 0)
4 
(4 to 4)
0 
(0 to 0)
9 
(8 to 9)
0 
(0 to 0)
-14·75 
(-15·01 to -14·44)
-15·71 
(-16·55 to -14·88)
-13·71 
(-15·19 to -12·15)
-21·33 
(-22·43 to -20·17)
El Salvador 45 (39 to 51)
0 
(0 to 0)
48 
(41 to 55)
0 
(0 to 0)
92 
(79 to 105)
0 
(0 to 0)
-10·30 
(-11·52 to -9·06)
-17·04 
(-17·93 to -16·11)
-4·25 
(-5·34 to -3·31)
-19·67 
(-21·15 to -18·16)
Guatemala 9936 (8732 to 11 057)
14 
(10 to 21)
10 220 
(8956 to 11 422)
13 
(9 to 19)
20 156 
(17 688 to 22 495)
27 
(20 to 37)
-9·66 
(-10·61 to -8·66)
-14·29 
(-16·36 to -12·07)
-4·70 
(-5·76 to -3·74)
-14·13 
(-17·66 to -10·24)
Honduras 2998 (2669 to 3298)
6 
(3 to 11)
3135 
(2813 to 3423)
7 
(4 to 12)
6133 
(5476 to 6718)
12 
(7 to 20)
-1·96 
(-2·26 to -1·64)
-3·63 
(-7·31 to -0·43)
-4·14 
(-5·02 to -3·31)
-10·59 
(-15·65 to -3·94)
Caribbean
Western Europe
Andean Latin America
Central Latin America
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Mexico 82 (71 to 94)
1 
(0 to 2)
65 
(57 to 74)
0 
(0 to 2)
148 
(128 to 167)
1 
(0 to 4)
-16·51 
(-16·58 to -16·43)
-16·86 
(-17·61 to -16·06)
-17·51 
(-17·99 to -16·95)
-19·50 
(-20·52 to -18·43)
Nicaragua 2410 (2032 to 2776)
1 
(1 to 1)
2463 
(2076 to 2836)
1 
(1 to 1)
4873 
(4108 to 5612)
2 
(1 to 2)
-6·78 
(-7·71 to -5·87)
-12·23 
(-15·27 to -9·58)
-5·09 
(-6·33 to -4·03)
-27·36 
(-31·23 to -23·35)
Panama 409 (396 to 421)
0 
(0 to 1)
427 
(415 to 440)
0 
(0 to 0)
836 
(836 to 836)
1 
(0 to 1)
7·72 
(7·08 to 8·30)
-6·42 
(-9·63 to -3·40)
-4·11 
(-5·07 to -3·37)
-7·59 
(-12·13 to -2·48)
Venezuela 7983 (7025 to 8864)
12 
(7 to 17)
7127 
(6100 to 8102)
5 
(3 to 7)
15 109 
(13 168 to 16 970)
17 
(12 to 23)
-0·99 
(-1·32 to -0·69)
-3·84 
(-6·20 to -1·59)
-1·46 
(-2·03 to -0·97)
-9·49 
(-13·44 to -5·81)
301
(260 to 341)
0
(0 to 1)
308
(264 to 350)
0
(0 to 1)
609
(524 to 691)
0
(0 to 2)
-9·52
 (-10·71 to -8·32)
-16·26
 (-17·13 to -15·40)
-3·21
 (-4·06 to -2·48)
-16·29
 (-17·17 to -15·43)
Argentina 301 (260 to 341)
0 
(0 to 1)
308 
(264 to 350)
0 
(0 to 1)
609 
(524 to 691)
0 
(0 to 2)
-9·26 
(-10·45 to -8·06)
-16·11 
(-16·96 to -15·24)
-4·08 
(-5·16 to -3·16)
-20·83 
(-21·97 to -19·71)
66 015
(56 554 to 75 020)
46
(30 to 68)
65 424
(55 196 to 75 263)
24
(17 to 35)
131 439
(111 720 to 150 238)
71
(50 to 99)
-6·49
 (-7·87 to -5·20)
-17·58
 (-19·80 to -15·41)
-0·11
 (-0·50 to 0·21)
-9·20
 (-12·22 to -5·86)
Brazil 65 965 (56 511 to 74 963)
46 
(30 to 68)
65 376 
(55 156 to 75 209)
24 
(17 to 35)
131 341 
(111 637 to 150 126)
71 
(50 to 99)
-6·47 
(-7·85 to -5·18)
-17·56 
(-19·78 to -15·39)
-0·10 
(-0·61 to 0·31)
-11·91 
(-15·84 to -7·54)
Paraguay 50 (43 to 57)
0 
(0 to 0)
48 
(41 to 55)
0 
(0 to 0)
98 
(83 to 112)
0 
(0 to 0)
-8·20 
(-9·31 to -7·08)
-14·75 
(-15·77 to -13·77)
-3·88 
(-4·89 to -3·00)
-18·91 
(-20·49 to -17·31)
1 257 700
(382 396 to 3 243 600)
5900
(2915 to 11 443)
857 057
(252 567 to 2 356 446)
4703
(2009 to 9594)
2 114 756
(638 796 to 5 569 750)
10 604
(5415 to 19 759)
2·14
 (1·31 to 3·18)
3·88
 (0·73 to 7·01)
-5·74
 (-9·08 to -2·40)
-7·07
 (-10·62 to -3·04)
Algeria 0 (0 to 0)
6 
(3 to 9)
0 
(0 to 0)
4 
(3 to 7)
0 
(0 to 0)
10 
(7 to 14)
0·00 
(0·00 to 0·00)
-2·69 
(-5·57 to 0·50)
0·00 
(0·00 to 0·00)
-9·69 
(-14·44 to -3·99)
Iran 385 (372 to 396)
5 
(3 to 7)
402 
(391 to 415)
6 
(3 to 9)
787 
(787 to 787)
10 
(8 to 14)
-18·17 
(-19·47 to -16·77)
0·52 
(-2·67 to 3·62)
-29·01 
(-30·64 to -27·41)
-10·30 
(-14·04 to -6·03)
Iraq 0 (0 to 0)
0 
(0 to 0)
0 
(0 to 0)
0 
(0 to 0)
0 
(0 to 0)
0 
(0 to 0)
-9·60 
(-10·60 to -8·55)
-14·67 
(-16·70 to -12·66)
0·00 
(0·00 to 0·00)
0·00 
(0·00 to 0·00)
Morocco 0 (0 to 0)
0 
(0 to 0)
0 
(0 to 0)
0 
(0 to 0)
0 
(0 to 0)
0 
(0 to 0)
-0·27 
(-0·29 to -0·25)
-0·33 
(-2·73 to 2·08)
0·00 
(0·00 to 0·00)
0·00 
(0·00 to 0·00)
Oman 0 (0 to 0)
0 
(0 to 0)
0 
(0 to 0)
0 
(0 to 0)
0 
(0 to 0)
0 
(0 to 0)
-2·61 
(-2·83 to -2·38)
-3·48 
(-7·28 to 0·13)
0·00 
(0·00 to 0·00)
0·00 
(0·00 to 0·00)
Saudi Arabia 40 (39 to 41)
11 
(7 to 15)
42 
(41 to 43)
2 
(1 to 3)
82 
(82 to 82)
13 
(9 to 18)
-13·85 
(-14·36 to -13·25)
-3·99 
(-9·06 to 1·16)
-43·55 
(-44·72 to -42·32)
-11·72 
(-16·23 to -7·18)
Sudan 689 118 (190 185 to 1 833 451)
3160 
(1326 to 6839)
366 931 
(78 799 to 1 177 901)
2203 
(605 to 5384)
1 056 050 
(275 911 to 2 940 472)
5363 
(2274 to 11 118)
0·34 
(-0·31 to 1·15)
1·19 
(-2·43 to 4·91)
-10·18 
(-15·26 to -4·92)
-11·32 
(-16·62 to -5·66)
Syria 0 (0 to 0)
0 
(0 to 0)
0 
(0 to 0)
0 
(0 to 0)
0 
(0 to 0)
0 
(0 to 0)
-6·57 
(-6·65 to -6·48)
-6·84 
(-11·33 to -2·88)
0·00 
(0·00 to 0·00)
0·00 
(0·00 to 0·00)
Turkey 534 (456 to 607)
0 
(0 to 1)
540 
(457 to 618)
0 
(0 to 1)
1073 
(913 to 1225)
1 
(0 to 2)
-10·63 
(-11·84 to -9·40)
-17·20 
(-18·35 to -16·09)
-4·67 
(-5·86 to -3·64)
-22·49 
(-24·10 to -20·85)
Yemen 566 320 (192 251 to 1 374 706)
2713 
(1242 to 5640)
488 281 
(161 967 to 1 225 111)
2483 
(941 to 5133)
1 054 601 
(355 535 to 2 646 959)
5196 
(2471 to 10 098)
0·14 
(-0·78 to 1·12)
1·55 
(-2·57 to 5·80)
-4·56 
(-7·08 to -2·21)
-5·34 
(-10·28 to -0·62)
593 916
(232 012 to 1 391 577)
1104
(485 to 1910)
492 920
(207 650 to 1 088 266)
915
(493 to 1565)
1 086 836
(441 330 to 2 484 740)
2019
(1221 to 3218)
-0·02
 (-0·25 to 0·19)
-0·30
 (-3·70 to 2·75)
-2·14
 (-3·14 to -1·05)
-2·61
 (-5·49 to 0·65)
Papua New Guinea 523 910 (197 634 to 1 243 454)
964 
(419 to 1682)
434 724 
(177 464 to 965 172)
804 
(432 to 1383)
958 634 
(376 486 to 2 206 672)
1768 
(1075 to 2810)
-0·25 
(-0·48 to -0·04)
-0·50 
(-3·96 to 2·65)
-3·13 
(-4·47 to -1·70)
-3·53 
(-7·34 to 0·61)
Solomon Islands 9577 (8537 to 10 514)
19 
(4 to 42)
8847 
(7818 to 9787)
14 
(5 to 33)
18 424 
(16 358 to 20 296)
33 
(11 to 66)
-1·17 
(-1·39 to -0·96)
-2·90 
(-6·90 to 0·69)
-2·38 
(-2·94 to -1·89)
-8·00 
(-12·49 to -2·44)
Vanuatu 3289 (2994 to 3565)
9 
(2 to 21)
2990 
(2687 to 3262)
7 
(2 to 19)
6279 
(5684 to 6820)
15 
(5 to 33)
-0·73 
(-0·86 to -0·61)
-1·70 
(-5·70 to 2·06)
-2·87 
(-3·47 to -2·31)
-7·87 
(-13·20 to -2·24)
3 940 130
(1 939 904 to 7 688 653)
28 851
(16 111 to 49 729)
4 301 690
(2 303 019 to 7 982 794)
31 817
(15 802 to 64 045)
8 241 820
(4 297 149 to 15 640 374)
60 667
(35 115 to 99 000)
-2·74
 (-4·45 to -1·39)
-1·59
 (-4·08 to 1·08)
-5·13
 (-7·81 to -2·43)
-5·73
 (-9·03 to -2·28)
Angola 778 653 (352 510 to 1 612 440)
5421 
(2082 to 12 081)
638 443 
(292 224 to 1 338 115)
5240 
(1083 to 12 889)
1 417 096 
(646 248 to 2 901 702)
10 661 
(4178 to 21 870)
-0·62 
(-2·10 to 0·86)
1·22 
(-3·40 to 5·85)
-6·53 
(-9·71 to -3·09)
-6·90 
(-12·30 to -1·09)
Central African Republic 240 694 (129 143 to 433 562)
1611 
(876 to 2611)
297 972 
(167 115 to 517 369)
1964 
(919 to 3569)
538 666 
(298 738 to 947 709)
3575 
(2032 to 5659)
-1·49 
(-2·76 to -0·56)
-0·24 
(-4·56 to 3·72)
-3·64 
(-5·63 to -1·76)
-4·33 
(-9·53 to 0·75)
Southern Latin America
Tropical Latin America
North Africa and Middle East
Oceania
Central Sub-Saharan Africa
Confidential draft. Please do not cite or circulate.
Congo 167 366 (72 013 to 344 886)
977 
(550 to 1804)
159 795 
(72 976 to 323 383)
991 
(298 to 2116)
327 162 
(147 092 to 665 882)
1968 
(1004 to 3472)
-0·01 
(-0·62 to 0·96)
0·73 
(-2·21 to 3·90)
-6·25 
(-9·84 to -3·21)
-7·75 
(-14·16 to -2·72)
Democratic Republic of the Cong 2 641 315 (1 317 961 to 5 137 603)
20 087 
(9338 to 38 586)
3 087 537 
(1 663 453 to 5 670 932)
22 827 
(9178 to 50 451)
5 728 853 
(3 000 717 to 10 800 000)
42 914 
(21 336 to 79 936)
-3·50 
(-5·45 to -1·84)
-2·41 
(-5·40 to 0·76)
-7·04 
(-10·95 to -3·27)
-7·96 
(-13·15 to -2·31)
Equatorial Guinea 37 847 (22 135 to 65 711)
298 
(75 to 572)
45 073 
(26 889 to 76 106)
333 
(106 to 625)
82 920 
(49 005 to 142 294)
631 
(252 to 1064)
0·51 
(-0·35 to 2·06)
1·47 
(-2·65 to 5·61)
-7·72 
(-11·06 to -3·83)
-7·80 
(-12·31 to -2·94)
Gabon 74 255 (35 105 to 144 155)
457 
(225 to 817)
72 869 
(35 969 to 139 716)
462 
(200 to 864)
147 125 
(71 124 to 281 843)
919 
(531 to 1515)
-1·67 
(-2·75 to -0·76)
-1·65 
(-4·39 to 1·27)
-4·76 
(-7·17 to -2·22)
-5·17 
(-9·20 to -1·20)
12 520 054
(6 544 247 to 24 090 664)
85 566
(65 168 to 109 586)
13 377 215
(7 291 825 to 24 578 200)
89 820
(66 224 to 130 417)
25 897 270
(13 782 158 to 48 529 276)
175 387
(140 361 to 221 113)
0·41
 (-0·29 to 1·52)
0·77
 (-0·82 to 2·33)
-6·68
 (-8·94 to -3·58)
-6·76
 (-8·47 to -4·40)
Burundi 603 449 (369 625 to 975 531)
5362 
(2862 to 8974)
710 930 
(446 217 to 1 124 371)
5920 
(3022 to 9518)
1 314 379 
(807 412 to 2 096 773)
11 282 
(6353 to 17 300)
0·99 
(-0·10 to 2·83)
1·93 
(-1·04 to 4·83)
-10·34 
(-15·47 to -4·99)
-10·46 
(-15·23 to -5·97)
Comoros 28 650 (26 480 to 30 862)
117 
(56 to 222)
26 067 
(24 109 to 27 935)
97 
(16 to 246)
54 718 
(50 588 to 58 781)
215 
(98 to 414)
0·05 
(0·04 to 0·05)
0·26 
(-4·13 to 4·99)
-3·76 
(-4·25 to -3·27)
-6·70 
(-13·75 to -1·72)
Djibouti 21 649 (17 792 to 25 716)
184 
(68 to 369)
19 021 
(15 634 to 22 592)
161 
(49 to 297)
40 671 
(33 427 to 48 308)
345 
(147 to 599)
2·61 
(2·61 to 2·61)
2·82 
(-1·60 to 7·69)
-6·38 
(-6·38 to -6·37)
-6·45 
(-12·59 to -0·50)
Eritrea 106 098 (89 697 to 122 962)
815 
(252 to 1836)
106 810 
(90 294 to 123 790)
821 
(264 to 1770)
212 908 
(179 991 to 246 752)
1636 
(615 to 3199)
1·01 
(0·99 to 1·03)
1·29 
(-5·39 to 7·27)
-7·52 
(-7·73 to -7·27)
-8·72 
(-16·37 to -1·61)
Ethiopia 1 638 589 (498 186 to 4 270 533)
9877 
(5029 to 17 293)
1 182 333 
(373 552 to 3 267 067)
8510 
(3506 to 16 787)
2 820 922 
(876 846 to 7 716 426)
18 387 
(9037 to 32 209)
-2·03 
(-2·86 to -1·05)
-1·98 
(-9·18 to 5·43)
-11·74 
(-17·53 to -5·72)
-11·68 
(-19·39 to -3·73)
Kenya 782 119 (236 917 to 2 033 030)
4464 
(2618 to 7478)
627 587 
(175 809 to 1 772 853)
3896 
(1826 to 8102)
1 409 706 
(412 893 to 3 805 649)
8360 
(4891 to 14 436)
0·11 
(-0·62 to 0·92)
1·07 
(-2·51 to 4·74)
-13·61 
(-20·07 to -6·61)
-14·27 
(-19·91 to -8·74)
Madagascar 459 299 (131 674 to 1 198 750)
2123 
(986 to 4137)
612 453 
(212 737 to 1 430 807)
2783 
(1420 to 4868)
1 071 751 
(352 252 to 2 626 270)
4906 
(2985 to 7867)
-2·01 
(-3·47 to -0·96)
-1·42 
(-4·41 to 1·43)
-6·53 
(-9·92 to -2·93)
-5·90 
(-10·64 to -0·59)
Malawi 347 806 (116 374 to 858 925)
2147 
(1094 to 3889)
402 696 
(148 948 to 930 569)
2456 
(1061 to 4910)
750 502 
(268 060 to 1 769 176)
4603 
(2546 to 8195)
-5·03 
(-9·46 to -1·71)
-6·52 
(-10·60 to -2·72)
-8·92 
(-13·62 to -4·24)
-9·13 
(-14·43 to -3·00)
Mozambique 2 773 504 (1 582 152 to 4 911 657)
19 196 
(13 650 to 25 948)
3 244 189 
(1 684 669 to 6 325 806)
20 473 
(14 753 to 26 654)
6 017 693 
(3 266 015 to 11 100 000)
39 669 
(31 008 to 49 712)
1·81 
(0·66 to 3·21)
2·46 
(-0·06 to 5·23)
-5·87 
(-8·11 to -3·10)
-5·47 
(-8·39 to -2·06)
Rwanda 237 157 (89 675 to 564 253)
1806 
(811 to 3293)
232 335 
(89 900 to 553 411)
1764 
(700 to 3613)
469 491 
(179 942 to 1 118 489)
3569 
(1754 to 6572)
1·80 
(0·38 to 4·16)
3·12 
(-0·56 to 6·87)
-17·31 
(-25·45 to -8·58)
-17·07 
(-24·30 to -9·72)
Somalia 474 870 (233 983 to 899 300)
3314 
(1561 to 6276)
356 615 
(172 956 to 709 509)
2806 
(1284 to 5202)
831 485 
(409 498 to 1 610 977)
6120 
(3066 to 10 592)
1·08 
(0·14 to 2·50)
2·13 
(-2·36 to 6·49)
-5·07 
(-7·98 to -2·32)
-5·48 
(-11·10 to 0·45)
South Sudan 301 308 (112 436 to 702 216)
1703 
(841 to 3414)
201 184 
(72 449 to 507 884)
1399 
(430 to 3252)
502 492 
(186 803 to 1 157 572)
3102 
(1547 to 5794)
0·48 
(-0·36 to 1·49)
1·58 
(-2·83 to 6·29)
-10·77 
(-16·54 to -4·95)
-11·56 
(-16·89 to -5·15)
Tanzania 1 873 958 (934 095 to 3 672 184)
13 495 
(7362 to 22 215)
2 307 766 
(1 239 301 to 4 260 696)
16 242 
(7989 to 32 819)
4 181 724 
(2 178 550 to 7 920 536)
29 737 
(17 572 to 48 950)
0·43 
(-0·49 to 1·73)
0·35 
(-2·63 to 3·47)
-10·10 
(-15·13 to -4·82)
-10·28 
(-14·93 to -4·85)
Uganda 1 918 386 (1 036 770 to 3 491 911)
14 247 
(7967 to 22 532)
2 262 354 
(1 245 502 to 4 007 412)
15 298 
(8111 to 25 181)
4 180 741 
(2 285 851 to 7 474 431)
29 545 
(18 946 to 45 298)
1·18 
(0·28 to 2·49)
2·41 
(-0·76 to 5·53)
-7·70 
(-11·20 to -3·80)
-7·96 
(-12·15 to -3·23)
Zambia 945 622 (525 219 to 1 635 147)
6667 
(4445 to 9435)
1 077 049 
(585 683 to 1 925 781)
7145 
(4894 to 10 132)
2 022 671 
(1 112 338 to 3 551 130)
13 812 
(10 076 to 18 903)
1·58 
(0·47 to 2·82)
2·33 
(-1·34 to 5·52)
-9·41 
(-13·90 to -4·49)
-9·10 
(-12·58 to -5·13)
344 868
(147 187 to 780 285)
1896
(1376 to 2580)
275 985
(104 772 to 678 471)
1374
(907 to 2251)
620 853
(252 060 to 1 471 492)
3270
(2462 to 4543)
2·84
 (1·28 to 4·19)
2·85
 (-0·40 to 5·45)
-5·63
 (-8·37 to -2·64)
-7·30
 (-9·74 to -4·10)
Botswana 18 238 (16 153 to 20 347)
112 
(53 to 223)
9133 
(8445 to 9797)
35 
(10 to 91)
27 371 
(24 696 to 30 025)
147 
(79 to 264)
2·81 
(2·54 to 3·04)
3·53 
(-3·49 to 9·77)
-6·54 
(-7·07 to -5·98)
-8·77 
(-15·85 to 0·16)
Namibia 33 857 (31 052 to 36 663)
158 
(97 to 267)
25 990 
(23 915 to 27 914)
83 
(24 to 211)
59 847 
(55 363 to 64 383)
241 
(142 to 420)
1·76 
(1·54 to 1·97)
2·62 
(-1·56 to 6·85)
-5·02 
(-5·60 to -4·43)
-8·26 
(-12·81 to -3·20)
South Africa 2755 (2663 to 2834)
245 
(105 to 537)
2874 
(2795 to 2966)
128 
(86 to 249)
5629 
(5629 to 5629)
374 
(213 to 699)
0·25 
(-0·49 to 1·00)
2·53 
(-0·30 to 5·59)
0·10 
(-1·24 to 1·10)
-17·22 
(-22·98 to -9·58)
Swaziland 12 878 (10 579 to 15 305)
110 
(29 to 241)
6411 
(5268 to 7617)
54 
(13 to 127)
19 290 
(15 847 to 22 922)
164 
(68 to 335)
3·76 
(3·75 to 3·76)
3·44 
(-2·65 to 8·27)
-8·68 
(-8·68 to -8·68)
-8·56 
(-15·69 to -1·74)
Zimbabwe 277 139 (78 586 to 717 290)
1272 
(858 to 1885)
231 578 
(60 882 to 634 297)
1073 
(595 to 1857)
508 717 
(140 095 to 1 364 465)
2345 
(1609 to 3439)
3·02 
(1·17 to 4·87)
2·96 
(-1·94 to 6·75)
-7·75 
(-12·62 to -3·09)
-7·55 
(-12·02 to -2·23)
28 989 748
(18 569 128 to 44 034 576)
246 973
(179 298 to 334 725)
27 966 300
(17 623 922 to 43 268 248)
218 875
(160 016 to 281 613)
56 956 048
(36 282 648 to 86 449 152)
465 848
(356 750 to 590 771)
0·90
 (0·26 to 1·72)
1·45
 (-0·24 to 3·18)
-3·79
 (-5·33 to -2·00)
-3·40
 (-5·15 to -1·56)
Southern Sub-Saharan Africa
Western Sub-Saharan Africa
Eastern Sub-Saharan Africa
Confidential draft. Please do not cite or circulate.
Benin 496 703 (272 131 to 893 268)
3604 
(1769 to 6020)
589 179 
(338 344 to 1 013 545)
4085 
(2429 to 5968)
1 085 882 
(607 392 to 1 908 784)
7689 
(4649 to 11 064)
0·70 
(-0·14 to 1·81)
1·40 
(-1·86 to 4·67)
-6·80 
(-9·48 to -3·55)
-6·72 
(-10·82 to -2·13)
Burkina Faso 1 772 734 (1 091 493 to 2 837 545)
12 942 
(8142 to 19 266)
2 068 269 
(1 260 720 to 3 396 651)
14 319 
(9910 to 19 631)
3 841 003 
(2 364 116 to 6 158 591)
27 261 
(19 599 to 36 230)
1·68 
(0·72 to 2·97)
2·68 
(0·22 to 5·22)
-4·61 
(-6·64 to -2·47)
-5·01 
(-8·11 to -2·10)
Cameroon 1 141 115 (640 140 to 2 003 619)
8634 
(4332 to 14 541)
1 528 984 
(911 130 to 2 529 638)
10 703 
(6168 to 17 005)
2 670 100 
(1 556 196 to 4 539 860)
19 336 
(11 574 to 29 258)
2·64 
(1·22 to 4·14)
3·42 
(0·19 to 6·56)
-8·41 
(-12·31 to -4·15)
-8·32 
(-12·35 to -3·32)
Cape Verde 38 (32 to 44)
0 
(0 to 1)
28 
(24 to 32)
0 
(0 to 0)
66 
(56 to 77)
1 
(0 to 1)
-3·60 
(-3·62 to -3·57)
-3·39 
(-8·78 to 0·84)
-11·72 
(-11·90 to -11·50)
-12·42 
(-17·86 to -6·52)
Chad 638 516 (327 314 to 1 182 104)
4372 
(2095 to 8178)
745 182 
(425 863 to 1 287 409)
5463 
(2674 to 9708)
1 383 698 
(754 840 to 2 472 300)
9835 
(5004 to 16 673)
2·43 
(1·10 to 4·1)
3·70 
(-0·41 to 7·68)
-4·88 
(-7·10 to -2·42)
-5·10 
(-9·91 to -0·23)
Cote d'Ivoire 1 116 108 (616 173 to 1 965 682)
7931 
(3796 to 14 026)
1 270 614 
(746 533 to 2 117 101)
8849 
(4705 to 13 599)
2 386 722 
(1 373 505 to 4 113 535)
16 780 
(9577 to 25 660)
1·71 
(0·73 to 2·79)
2·29 
(-0·63 to 5·30)
-8·10 
(-12·00 to -3·97)
-7·85 
(-12·23 to -3·22)
Ghana 1 131 416 (597 366 to 2 063 095)
7843 
(4899 to 11 682)
1 274 480 
(700 996 to 2 287 354)
8572 
(5486 to 12 246)
2 405 896 
(1 293 177 to 4 322 408)
16 415 
(11 390 to 22 881)
0·84 
(0·18 to 1·91)
1·12 
(-1·55 to 3·85)
-4·36 
(-6·47 to -2·11)
-4·74 
(-8·25 to -1·20)
Guinea 850 008 (528 198 to 1 364 161)
6594 
(3882 to 9881)
1 070 541 
(666 679 to 1 678 739)
8003 
(4779 to 11 599)
1 920 549 
(1 202 796 to 3 033 236)
14 597 
(9576 to 20 495)
1·25 
(0·42 to 2·38)
1·68 
(-2·23 to 5·68)
-5·44 
(-8·02 to -2·68)
-5·72 
(-9·32 to -1·60)
Guinea-Bissau 188 651 (118 426 to 302 109)
1747 
(1155 to 2514)
202 199 
(125 656 to 321 006)
1796 
(1158 to 2502)
390 850 
(244 350 to 622 761)
3543 
(2481 to 4805)
0·68 
(0·07 to 1·55)
1·26 
(-1·71 to 4·49)
-3·55 
(-5·12 to -1·95)
-2·73 
(-6·14 to 0·69)
Liberia 215 778 (119 173 to 385 255)
1467 
(765 to 2519)
254 770 
(147 560 to 431 784)
1686 
(875 to 2731)
470 548 
(269 710 to 826 308)
3154 
(1799 to 4992)
1·24 
(0·14 to 2·72)
2·28 
(-2·18 to 6·27)
-6·32 
(-9·19 to -3·29)
-6·62 
(-10·86 to -2·17)
Mali 1 812 025 (1 148 899 to 2 815 056)
16 526 
(9857 to 24 875)
2 412 241 
(1 441 912 to 3 931 845)
19 164 
(11 403 to 27 092)
4 224 267 
(2 612 582 to 6 660 447)
35 690 
(23 410 to 50 450)
1·92 
(0·85 to 3·23)
2·76 
(-0·57 to 6·17)
-3·79 
(-5·35 to -2·13)
-3·06 
(-6·84 to 0·73)
Mauritania 164 717 (77 085 to 322 374)
974 
(444 to 1838)
105 272 
(49 402 to 215 015)
820 
(290 to 1460)
269 989 
(130 899 to 534 343)
1795 
(844 to 3103)
4·56 
(2·16 to 7·12)
5·77 
(1·59 to 9·62)
-3·04 
(-4·81 to -1·51)
-3·69 
(-7·69 to 0·23)
Niger 1 348 843 (837 303 to 2 127 755)
11 564 
(4559 to 20 485)
1 608 928 
(1 030 476 to 2 443 363)
13 869 
(6688 to 21 584)
2 957 771 
(1 877 757 to 4 481 069)
25 433 
(13 395 to 40 453)
1·60 
(0·44 to 3·22)
3·06 
(-1·34 to 7·27)
-4·31 
(-6·27 to -2·23)
-3·48 
(-9·01 to 1·73)
Nigeria 16 600 000 (10 700 000 to 25 200 000)
151 794 
(95 928 to 223 806)
13 000 000 
(8 224 059 to 19 900 000)
108 611 
(61 160 to 158 184)
29 700 000 
(19 000 000 to 45 300 000)
260 405 
(171 907 to 361 607)
0·23 
(-0·19 to 0·67)
0·63 
(-2·57 to 3·99)
-3·80 
(-5·48 to -2·06)
-3·07 
(-6·94 to 0·93)
Sao Tome and Principe 5915 (5258 to 6577)
35 
(16 to 65)
6027 
(5360 to 6701)
36 
(17 to 61)
11 942 
(10 619 to 13 278)
71 
(37 to 119)
-0·48 
(-0·50 to -0·44)
-0·49 
(-4·15 to 2·96)
-4·43 
(-4·79 to -4·04)
-6·18 
(-10·37 to -2·38)
Senegal 429 236 (185 098 to 920 585)
2970 
(1400 to 5280)
500 762 
(241 439 to 992 049)
3600 
(1687 to 5828)
929 998 
(430 550 to 1 917 898)
6570 
(3511 to 10 420)
-0·43 
(-1·31 to 0·31)
0·65 
(-1·92 to 3·11)
-11·84 
(-17·67 to -5·66)
-11·79 
(-16·98 to -6·62)
Sierra Leone 519 098 (329 919 to 801 942)
4106 
(2244 to 6714)
678 273 
(416 276 to 1 092 241)
4775 
(2912 to 6784)
1 197 371 
(749 248 to 1 872 567)
8882 
(5691 to 12 669)
0·58 
(0·04 to 1·27)
1·10 
(-1·78 to 3·98)
-7·73 
(-11·49 to -3·76)
-7·68 
(-11·41 to -3·72)
The Gambia 153 051 (92 298 to 251 289)
1056 
(648 to 1604)
148 981 
(90 176 to 243 097)
1034 
(644 to 1510)
302 032 
(182 698 to 494 937)
2090 
(1405 to 3029)
-1·07 
(-1·53 to -0·59)
-0·89 
(-3·74 to 1·98)
-4·73 
(-6·86 to -2·39)
-4·91 
(-8·26 to -1·23)
Togo 369 830 (214 148 to 641 934)
2811 
(1429 to 5062)
467 452 
(283 814 to 760 578)
3488 
(1900 to 5575)
837 282 
(499 488 to 1 395 545)
6299 
(3690 to 9808)
-0·48 
(-1·12 to -0·01)
0·07 
(-2·97 to 3·01)
-4·62 
(-6·94 to -2·23)
-3·54 
(-7·86 to 0·42)
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